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SYNOPSIS 
Several reports have linked vitamin D deficiency with an increased risk of gestational 
diabetes mellitus (GDM). Both of these conditions are alarmingly common in Saudi 
Arabia, and pose additional risk of developing future metabolic disease. This study, 
therefore, investigates the vitamin D status amongst pregnant Saudi women, and the 
potential influence of vitamin D deficiency on metabolic dysfunction, such as GDM.  
 
A total of 578 pregnant women (28.8 ± 5.4 years) were recruited for this study during 
their first trimester of pregnancy (8-12 weeks) and followed up in their second trimester 
(24-28 weeks), where data were collected from 297 [51.3% (297/578); 28.9 ± 5.3 years] 
women. The study collected socio-economic, anthropometric and biochemical data, 
along with dietary intake, physical activity and sun indices. 
 
The findings of this study indicate that during the first trimester 81% of women being 
vitamin D deficient, dropping to 77% in the second trimester. It was also noted that 
being younger in age, multiparous, having a lower level of education, being a 
housewife, and living in West Riyadh were all associated with vitamin D deficiency 
during the first trimester (p < 0.05), and this further corresponded to reduced sun 
exposure (p < 0.001). In contrast, physically active pregnant women, women 
adequately exposed to sunlight at noon (p < 0.001), and residents of North Riyadh all 
had significantly higher circulating vitamin D levels (p < 0.05). Furthermore, low levels 
of high-density lipoprotein cholesterol (HDL-cholesterol) during early pregnancy were 
also associated with an increased  risk of vitamin D deficiency (p < 0.05). Ultimately, 
compared with the first trimester, circulating vitamin D levels were significantly higher 
in the second trimester, after adjustment (p < 0.001).  
 
Among the pregnant women studied here, it was subsequently found that 33% 
developed GDM in the second trimester. Vitamin D deficiency in early pregnancy was 
associated with significantly higher risk of GDM, and this risk persisted after adjusting 
for confounding risk factors with regard to both vitamin D deficiency and GDM [odds 
ratio (OR) 3.97, confidence interval (CI) 1.12-14.15, p = 0.033]. In addition, 
XV 
 
significantly higher random blood glucose levels, higher glycated haemoglobin 
(HbA1c), and low HDL-cholesterol in early pregnancy were observed in the GDM 
subjects, compared to those without GDM (p < 0.05). Furthermore, vitamin D 
deficiency in mid-pregnancy increased the risk of metabolic syndrome and low HDL-
cholesterol, thus pointing to the role of vitamin D in the probability of developing 
cardiometabolic disease. 
 
In summary, a high prevalence of vitamin D deficiency was observed amongst the 
subjects in this study, namely pregnant Saudi women. Moreover, hypovitaminosis D in 
early pregnancy was identified as a significant risk factor for the development of GDM. 
The present study, therefore, suggests that maintaining optimal levels of vitamin D 
during pregnancy may be a useful intervention in preventing the development of GDM 
and metabolic syndrome. Along with vitamin D supplementation, lifestyle modification 
also appears to be critical for maintaining optimal vitamin D levels during pregnancy, 
thus avoiding pregnancy-related complications.  
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Introduction 
1 
 
1.1 Vitamin D During Pregnancy 
1.1.1 Background  
Vitamin D was recognised as a fat-soluble vitamin, and identified as a calciferol in the 
early 20th century (Ross et al., 2011). Vitamin D exists in two main forms: vitamin D2 
(ergocalciferol) and vitamin D3 (cholecalciferol) (Holick, 2006a). Although people can 
synthesise some vitamin D in their bodies, the amount may not be sufficient due to 
 a variety of factors, meaning that additional sources may be required to maintain 
adequate levels. Vitamin D is in fact classed as a hormone, rather than a vitamin, due 
to the occurrence of specific receptors (Holick, 2011b). Nearly all cells in the human 
body contain vitamin D receptors (VDRs), implying that they require vitamin D to 
function appropriately (Holick, 2011a; Holick, 2011b).  
 
It is apparent that sufficient vitamin D levels are essential for maintaining other 
functions in the human body, including the brain, heart muscle, and adipose tissue 
(Bikle, 2009). In addition, vitamin D controls certain genes that regulate metabolic 
control, immune function, and cell growth and development (Holick, 2011b; Wacker 
& Holick, 2013b). Research has demonstrated that hypovitaminosis D is linked to 
several chronic disorders, including cancer, infections, autoimmune diseases, 
neurological diseases, cardiovascular diseases, and type 2 diabetes mellitus (T2DM) 
(Holick, 2011a; Holick, 2011b). These findings have led to an investigation into the 
novel functions of vitamin D in various human cells, and shed light on its implications 
for health and disease. 
1.1.1.1 Sources of Vitamin D 
Vitamin D may be acquired through endogenous mechanisms, such as skin-based sun 
exposure, or exogenously from a diet of food naturally rich in vitamin D, or fortified 
food and supplements (Alpert & Shaikh, 2007). For example, vitamin D3 can be 
synthesised by the epidermis in response to ultraviolet-B (UVB) radiation from the sun, 
or obtained from the diet. Whereas vitamin D2 is converted from ergosterol, which is 
synthesised in plants exposed to ultraviolet radiation (DeLuca & Zierold, 1998). The 
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production of vitamin D3 from 7-dehydrocholesterol in the epidermis occurs because 
of stimulation from UVB of wavelength 290-315 nm (Norman, 2001). Hence, the 
endogenous production of vitamin D based on UVB radiation depends on the amount 
of UVB reaching the skin, and the presence of 7-dehydrocholesterol (Holick, 1995a). 
 
Dietary sources constitute less than 10% of daily vitamin D intake, due to the limited 
sources of vitamin D available in food (Holick et al., 2012). According to the Institute 
of Medicine (IOM), foods naturally rich in vitamin D include salmon, oily fish, and 
extracted cod liver oil (IOM, 2010), with lesser concentrations being found in egg yolk 
and sun-dried mushrooms (Ovesen et al., 2003; Holick, 2011a). Although fortified 
foods, such as dairy products, cereals, and juices are good sources of vitamin D (IOM, 
2010), in Saudi Arabia, few foods are fortified with vitamin D. Under the current 
regulations, regularly consumed food is not fortified, but even when it is, it is to a lesser 
degree than is recommended by the United States of America (USA) market guidelines 
(Sadat-Ali et al., 2013). Vitamin D-fortified foods in Saudi Arabia include milk, which 
provides a range from 40-400 international units (IU) and enriched wheat and enriched 
treated flour (55.1 IU/100 gm) (Sadat-Ali et al., 2013).  
 
Conversely, in the USA and Canada, milk is voluntarily supplemented with 
approximately 100-400 IU/cup (IOM, 2010), although cheese, ice-cream, and other 
dairy products are not usually fortified. Additionally, cereals, orange juice, yoghurt, 
margarine, and other nutritional products may be fortified with vitamin D (IOM, 2010).  
Supplementation with over-the-counter medication forms another important dietary 
source of vitamin D (IOM, 2010). A list of vitamin D sources is presented in the 
following Table (Table 1.1).  
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Table 1.1 Vitamin D sources, adapted from Holick (2007) and Holick et al. (2011a). 
Natural Sources  
Cod liver oil  ∼400–1,000 IU/teaspoon vitamin D3  
Salmon, fresh wild and caught  ∼600–1,000 IU/3.5 oz. vitamin D3  
Salmon, fresh farmed  ∼100–250 IU/3.5 oz. vitamin D3, vitamin D2  
Salmon, canned  ∼300–600 IU/3.5 oz. vitamin D3  
Sardines, canned  ∼300 IU/3.5 oz. vitamin D3  
Mackerel, canned  ∼250 IU/3.5 oz. vitamin D3  
Tuna, canned  236 IU/3.5 oz. vitamin D3  
Shiitake mushrooms, fresh  ∼100 IU/3.5 oz. vitamin D2  
Shiitake mushrooms, sun-dried  ∼1,600 IU/3.5 oz. vitamin D2  
Egg yolk  ∼20 IU/yolk vitamin D3 or D2  
Sunlight/UVB radiation  ∼20,000 IU, equivalent to exposure to one minimal erythemal 
dose in a bathing suit. Thus, exposure of arms and legs to a 
0.5 minimal erythemal dose is equivalent to ingesting ∼3,000 
IU vitamin D3.  
Fortified Foods    
Fortified milk  100 IU/8 oz., usually vitamin D3 
Fortified orange juice  100 IU/8 oz. vitamin D3 
Infant formulas  100 IU/8 oz. vitamin D3 
Fortified yogurts  100 IU/8 oz., usually vitamin D3 
Fortified butter  56 IU/3.5 oz., usually vitamin D3 
Fortified margarine  429 IU/3.5 oz., usually vitamin D3 
Fortified cheeses  100 IU/3 oz., usually vitamin D3 
Fortified breakfast cereals  ∼100 IU/serving, usually vitamin D3 
Pharmaceutical Sources in the US  
Vitamin D2 (ergocalciferol)  50,000 IU/capsule  
Drisdol (vitamin D2) liquid  8,000 IU/cc  
Supplementary Sources    
Multivitamins  400, 500, 1,000 IU vitamin D3 or vitamin D2  
Vitamin D3  400, 800, 1,000, 2,000, 5,000, 10,000, and 50,000 IU 
Note: IU = 25 ng; oz. = ounce 
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1.1.1.2 Metabolism and Absorption of Vitamin D 
Vitamin D, which is either synthesised in the body or consumed from food, is 
biologically inactive. It binds to a vitamin D binding protein (VDBP), or lipoproteins 
in the blood, and is transported to the liver (Lips, 2006; IOM, 2010) where the enzyme, 
25-hydroxylase (CYP2R1) hydroxylases it to 25(OH)D (calcidiol). This undergoes 
further hydroxylation in the kidneys, by the enzyme 25(OH)D-1-α-hydroxylase 
(CYP27B1), to yield 1,25-hydroxyvitamin D [1,25(OH)2D] (calcitriol). 1,25(OH)2D is 
the active form, and is primarily produced in the kidneys, but may also be synthesised 
in other tissue, such as the pancreas, immune system, and placenta (Holick, 2006b; 
Wacker & Holick, 2013a; Bikle, 2014). The enzyme responsible for catabolising 
1,25(OH)2D to its less active form and water-soluble metabolites is 1,25(OH)2D3-24-
hydroxlase (CYP24A1), which is upregulated by 1,25(OH)2D itself, in a negative 
feedback mechanism (Wacker & Holick, 2013a; Bikle, 2014).  
 
Renal CYP27B1 stimulators include, higher concentrations of parathyroid hormone 
(PTH), hypocalcaemia, hypophosphatemia, and calcitonin, whereas inhibitors of this 
enzyme include fibroblast growth factor-23, hyperphosphatemia, and 1,25(OH)2D itself 
(Kawashima et al., 1981; Nesbitt & Drezner, 1993; Holick, 2007). Additionally, 
pregnancy, lactation, prolactin, sex steroids, growth spurt, growth hormone, and 
insulin-like growth factor 1, all play a part in improving the induction of renal 
CYP27B1, and therefore the production of 1,25(OH)2D, to meet higher calcium needs 
(Bouillon, 2001; Holick, 2004). However, non-classical CYP27B1 expression in other 
bodily tissues is tissue-specific (Olmos-Ortiz et al., 2015). For example, studies have 
shown that monocyte and macrophage derived CYP27B1 is stimulated by tumour 
necrosis factor-α (TNF-α) and interferon-γ (IFN-γ), but not PTH (Pryke et al., 1990; 
Gyetko et al., 1993). In a comparable manner, pro-inflammatory cytokines stimulate 
CYP27B1 and CYP24A1 production in the placenta for synthesis and inactivation of 
vitamin D, respectively (Noyola-Martínez et al., 2014). Hence, it is interesting to note 
that both the anabolism and catabolism of placental 1,25(OH)2D are locally affected by 
inflammatory cytokines (Noyola-Martínez et al., 2014).  
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In the small intestine, dietary vitamin D (either D2 or D3) is absorbed with other foods 
containing fat, due to its fat-soluble nature. Therefore, its efficiency is based on the fat 
in the gut lumen (Holick, 1995a). When there is sufficient vitamin D, 30% of dietary 
calcium is absorbed, whereas only 10-15% of dietary calcium is absorbed from the 
small intestine if no vitamin D is present (Heaney et al., 2003). During pregnancy, 
lactation, and growth, calcium absorption can increase by up to 80%, due to the higher 
calcium demand (Holick, 2004).  
 
After its absorption, vitamin D is incorporated into chylomicrons before reaching the 
systemic circulation via the lymphatic system, and is finally transported to the liver and 
kidneys, or non-classical tissues (Ross et al., 2011). Excess vitamin D is primarily taken 
up by adipose tissue and skeletal muscle (Jones, 2008). 
1.1.1.3 Functions of Vitamin D 
Vitamin D is vital for several biological actions of the human body. For example, 
1,25(OH)2D binds to VDRs facilitating the control of transcriptional activity, which is 
cell-specific (John et al., 2007; Bikle, 2009). VDRs are extensively distributed 
throughout the body’s tissues, indicating there are many different biological actions of 
vitamin D (John et al., 2007), some considered classical, and others non-classical. 
Classical actions involve the expression of VDR in the intestine, bones, and kidneys, 
along with the synthesis of parathyroid and thyroid hormones, calcium regulation, and 
bone metabolism (Deluca & Cantorna, 2001; Holick, 2002, 2004; IOM, 2010). Non-
classical functions involve the presence of VDRs in other cells, including the pancreas, 
stomach, brain, heart, gonads, activated T and B lymphocytes, skin, and placenta, which 
pertains to the production of active vitamin D (Stumpf et al., 2007; Bikle, 2009). Hence, 
1,25(OH)2D encourages the induction of insulin secretion, apoptosis, inhibition of cell 
proliferation, angiogenesis, and renin production, all of which are also non-classical 
functions of vitamin D (Holick, 2010; Hossein-Nezhad & Holick, 2013).  
 
Vitamin D has other functions, including the reduction of inflammation, and 
modulation of neuromuscular and immune function (Hayes et al., 2003; Holick, 2003b). 
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Moreover, it has a critical role in the immune system, by inhibiting adaptive immunity 
and promoting innate immunity (Bikle, 2009). These extensive activities of 
1,25(OH)2D have been further hypothesised as having a possible role in the prevention 
of cancer or development of cancer therapies (Masuda et al., 2005), long with the 
treatment of other chronic conditions, a such as auto-immune conditions, 
cardiovascular disease, and infections (Holick, 2008). 
1.1.1.4 Homoeostasis of Vitamin D During Pregnancy 
During gestation, the body undergoes numerous changes intended to optimise the 
nutrition and health of the offspring. However, the behaviour of vitamin D during 
gestation is not yet fully understood (IOM, 2010). For example, the conversion of 
vitamin D to 25(OH)D during gestation it not what makes it unique; it is the conversion 
of 25(OH)D to 1,25(OH)2D where the dissimilarities appear. This is due to the location 
of the VDRs and vitamin D-activating enzyme in maternal (decidual) and foetal 
(trophoblastic) components of the placenta, which can synthesise the active form of 
vitamin D (Evans et al., 2004; Shin et al., 2010). By contrast, the vitamin D catabolic 
enzyme is poorly expressed in the placenta during early pregnancy, which coincides 
with the body’s need to preserve active vitamin D, because of the increased bone growth 
demands of the foetus, and the needs of the mother (Evans et al., 2004).  
 
Vitamin D in the form of 25(OH)D can readily pass from the placenta to the kidneys of 
the foetus, whereas, 1,25(OH)2D is incapable of passing through the placenta 
(Thandrayen & Pettifor, 2010). Accordingly, the foetus is wholly dependent on 
25(OH)D placental delivery, so the mother’s vitamin D metabolism undergoes a series 
of adaptations after the maternal intake and production of 25(OH)D (Kovacs, 2008). 
Thus, levels of 1,25(OH)2D in pregnant women increase in both the kidneys and 
placenta (Lapillonne, 2010) (Figure 1.1). 
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Figure 1.1 Vitamin D metabolism during pregnancy. 25(OH)D is thought to easily 
cross the maternal placenta. The placenta expresses VDRs and produces 25(OH)D-1-
α-hydroxylase (CYP27B1) to convert 25(OH)D to 1,25(OH)2D. However, 1,25(OH)2D 
does not readily cross the placenta, and foetal 1,25(OH)2D levels are normally lower 
than maternal serum levels. The low foetal concentrations of 1,25(OH)2D also reflect 
low foetal parathyroid hormone (PTH) and high phosphorus concentrations, which 
suppress renal CYP27B1. Although parathyroid hormone-related protein (PTHrP) is 
elevated in the foetal circulation, it appears to be less capable than PTH to stimulate 
renal CYP27B1 (adapted from Hossein-Nezhad & Holick, 2013). 
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It is noticeable that maternal serum concentrations of 1,25(OH)2D gradually increase 
during gestation, with an increase of 50-100% in the first and second trimester, and   
100% by the end of pregnancy (Ritchie et al., 1998; Christesen et al., 2012) 
(Figure 1.1). However, the reasons for this increase in 1,25(OH)2D remain unclear. It 
may be due to the elevated production of renal CYP27B1 in pregnancy from the mother 
and foetus (Hossein-Nezhad & Holick, 2013), along with extra production from the 
placenta and decidua (Shin et al., 2010; Barrett & McElduff, 2010). However, given an 
increase in 1,25(OH)2D, expectant mothers are likely to have higher cellular exposure 
to vitamin D during the second half of gestation, suggesting a function of vitamin D in 
obstetric well-being.  
 
Regarding serum 25(OH)D levels, it is unclear whether any changes occur during 
pregnancy under normal conditions (Ginde et al., 2010). During pregnancy, the body 
attempts to compensate its levels to achieve sufficiency, by reducing the renal clearance 
of 25(OH)D. However, due to an elevated plasma volume during pregnancy, 
haemodilution is induced, so levels of vitamin D may be subsequently counterbalanced 
(Marwaha et al., 2011; McAree et al., 2013). Furthermore, 25(OH)D levels may vary 
due to environmental or behavioural confounding factors (Bodnar et al., 2007b). Thus, 
both endogenous and exogenous factors during pregnancy can affect vitamin D levels. 
The understanding of 25(OH)D concentration is inconclusive so far, as some studies 
state that 25(OH)D concentrations significantly increase or decrease during pregnancy 
(Zhang et al., 2014; Choi et al., 2015), while others indicate that there is no change  
(Marwaha et al., 2011). It is important to note here that these changes in vitamin D 
levels are not connected to changes in calcium absorption within the intestine (Ross et 
al., 2011). Thus, the increased calcium absorption that occurs during pregnancy is 
independent of 1,25(OH)2D, because calcium is stimulated by maternal hormones, such 
as prolactin and placental lactogen (Kovacs, 2008).  
 
In non-pregnancy, studies have shown that PTH is strongly inversely related to vitamin 
D status, especially in the context of suboptimal 25(OH)D status (Kuchuk et al., 2009; 
Sai et al., 2010). The response of PTH levels to gestation show varied and inconsistent 
results, with a pattern of unchanged levels in early pregnancy and higher levels towards 
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the time of delivery (Kovacs & Kronenberg, 1997; Essley et al., 2012). The reaction of 
parathyroid hormone to pregnancy may be altered by variations in 25(OH)D 
concentration, regularity of calcium intake, and the age of the woman in pregnancy 
(Bezerra et al., 2002; Haddow et al., 2011). A cross-sectional study conducted on 
women in early gestation, showed that parathyroid hormone in African Americans had 
a weak (r = - 0.074) inverse correlation with vitamin D levels (Haddow et al., 2011). 
Another study conducted on women in mid- and late-pregnancy revealed a higher 
inverse correlation between parathyroid hormone and vitamin D levels (r = −0.24 and 
-0.27, respectively) (Hamilton et al., 2010; Brembeck et al., 2013), compared to what 
was found by Haddow et al. (2010). These correlations were also weaker than those 
found in the non-pregnant population (Aloia et al., 2006).  
 
1.1.2 Vitamin D Deficiency During Pregnancy 
The best method for assessing vitamin D concentration in serum, is to measure the level 
of 25(OH)D, as this reflects the main circulating form of vitamin D, and is identified as 
the gold standard measurement (Van den Berg, 1997). This is also the best reflection 
of combined dietary vitamin D intake and vitamin D synthesis in the skin, and it is the 
substrate for both renal and non-renal synthesis of 1,25(OH)2D (Jones, 2008). The 
active form of vitamin D, however, is not used for measuring vitamin D status, due to 
its short half-life and lack of direct correlation with vitamin D status (Jones, 2008). In 
addition, the measurement of 1,25(OH)2D is more difficult than the measurement of 
25(OH)D (Holick, 2003a). 
1.1.2.1 Definition of Vitamin D Deficiency 
To prevent complications of 25(OH)D deficiency, it is recommended that people of all 
age groups have a serum level of more than 75 nmol/L (Heaney et al., 2003). Different 
cut-off points to describe hypovitaminosis D have been used in various population 
studies, but are not well-established and remain controversial. However, a 25(OH)D 
serum concentration of ≥ 50 nmol/L is said to be sufficient because it can maintain an 
optimal PTH concentration, and prevent increased bone calcium mobilisation 
(Malabanan et al., 1998). Hesitation over what constitutes sufficient serum vitamin D 
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concentration during pregnancy is even greater, and while the suggested values remain 
unvalidated in clinical trials, the debate will continue (Grant & Holick, 2005).  
 
Vitamin D status in pregnancy has been classified into two categories based on 
sufficiency and deficiency; 25(OH)D ≥ 50 nmol/L (≥ 20 ng/mL) and 25(OH)D < 50 
nmol/L (< 20 ng/mL), respectively (Farrant et al., 2008; Cho et al., 2013; Parildar et al., 
2013). Other similar cut-off points are used by the Endocrine Society (Holick, 2007; 
Holick et al., 2011b), and have been applied in previous pregnancy studies (Kramer et 
al., 2014; Lacroix et al., 2014; Arnold et al., 2015);  
 Deficient levels: < 50 nmol/L (< 20 ng/mL)  
 Insufficient levels: 50-74.9 nmol/L (20–29.9 ng/mL)  
 Sufficient levels: ≥ 75 nmol/L (≥ 30 ng/mL).  
A slightly different classification, which has the additional category of severe 
deficiency (Hollis & Wagner, 2004; Dawodu & Wagner, 2007), has been applied to 
pregnant subjects in several studies (Flood-Nichols et al., 2015; Ross et al., 2011):  
 Severely deficient levels: < 25 nmol/L (< 10 ng/mL)  
 Deficient levels: 25-49.9nmol/L (10-19.9 ng/mL)  
 Insufficient levels: 50-74.9 nmol/L (20-29.9 ng/mL) 
 Sufficient levels: 75-200 nmol/L (30-80 ng/mL) 
1.1.2.2 Prevalence of Vitamin D Deficiency 
Globally, the prevalence of vitamin D deficiency or insufficiency totals approximately 
one billion cases (Holick & Chen, 2008). Moreover, hypovitaminosis D is present in as 
many as 84% of pregnant women (Brannon & Picciano, 2011), depending on several 
factors, such as, country of origin and lifestyle (Holmes et al., 2009). According to the 
World Health Organization (WHO), the prevalence of vitamin D deficiency in pregnant 
women [25(OH)D < 50 and < 25  nmol/L] by region, was as follows: the Americas - 
64%, 9%; Europe - 57%, 23%; Eastern Mediterranean - 79%, 46%; South-East Asia - 
87%, not available, and Western Pacific - 83%, 13% (Saraf et al., 2015). Other studies 
11 
 
conducted in the Mediterranean region noted high a prevalence of hypovitaminosis D 
in gestation, reaching 90.3% (Karras et al., 2016).  
 
Low vitamin D levels are not typically regarded as a potential problem in countries such 
as Saudi Arabia, due to the amount of sunshine it receives. However, some studies have 
suggested that up to 78% of Saudi’s females, across all age groups, have low vitamin 
D levels (Al-Turki, 2008; Alfawaz et al., 2014). For example, one study conducted on 
12,575 Saudi adolescents reported that 95.6% were vitamin D-deficient (AlBuhairan et 
al., 2015). Additionally, some studies have investigated women of childbearing age in 
Saudi Arabia, highlighting varying prevalence rates of vitamin D deficiency, ranging 
from one-third (Al-Turki, 2008) to two-thirds of the population studied (Kanan et al., 
2013). Another recent study observed that 36.8 % of Saudi women aged 36 years 
exhibited vitamin D levels < 25 nmol/l (Al-Daghri et al., 2015).  
 
To date, however, only limited studies have examined hypovitaminosis D in pregnant 
Saudi women (Serenius et al., 1984; Taha et al., 1984; Azhar, 2009; Aly et al., 2013; 
Al-Ajlan et al., 2015; Al-Faris, 2016; Al-Shaikh et al., 2016). Furthermore, the majority 
of these measured vitamin D just once, namely during the third trimester, or at the time 
of delivery, which does not reflect vitamin D levels during the entire pregnancy. 
However, Al-Faris (2016) did measure vitamin D in 160 pregnant women during the 
early stages of gestation, and noted that 50% had < 50 nmol/L, and 43.8% had 50-74 
nmol/l.  
 
Table 1.2 presents the worldwide prevalence of vitamin D deficiency during gestation 
in different trimesters and countries. Figure 1.2 shows the incidence of vitamin D 
deficiency around the world, both in pregnant women and in the general population 
(Hossein-Nezhad & Holick, 2013).  
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Table 1.2 Worldwide prevalence of Vitamin D deficiency during pregnancy 
Note: Definition of Vitamin D deficiency - 25(OH) D < 50 nmol/L. KSA and UAE indicate Kingdom of Saudi 
Arabia and United Arab of Emirates, respectively. 
a Vitamin D deficiency < 25 nmol/L 
b Vitamin D deficiency < 37.5 nmol/L  
c Vitamin D deficiency < 30 nmol/L 
d the sample consisted of young nulliparous women. 
  
Country 
Year of 
publication 
Trimester 
(gestational week) 
Prevalence (n/N) Reference 
USA 2010 First trimester 33% (102/309) Ginde et al. (2010) 
2015 First trimester a 10% (23.5/235) d Flood-Nichols et al. (2015) 
(2015) Canada 2011 First trimester (12-18) 39% (272/697)  Wei et al. (2012) 
UK 2011 First trimester 57% (90/158)  Makgoba et al. (2011) 
Spain 2016 First trimester 18% (366/2036) Rodriguez et al. (2016) 
UAE 2010 First trimester 78% (56/75) Narchi et al. (2010) 
Oman 2011 First trimester  98% (101/103) Al Kalbani et al. (2011) 
India 2017 First trimester 78% (214/275) Kumari et al. (2017) 
Finland 2011 First trimester 70% (481/686)  Miettinen et al. (2012) 
Korea 2015 First trimester 91.8% (45/49) Choi et al. (2015) 
KSA  2015 First trimester a 68% (350/515) Al-Ajlan et al. (2015) 
 2016 First trimester 50% (80/160) Al-Faris (2016) 
Qatar 2013 Second trimester (> 24) 48% (907/1873) Bener et al. (2013) 
Spain 2011 Second trimester 
2828228) 
59% (157/266)  Perez-Ferre et al. (2012) 
USA 2013 Second trimester (≤ 26) b  34.8% (713/2048) Gernand et al. (2013) 
China 2015 Second trimester 78.7 % (4583/5823) Xiao et al. (2015) 
 2017 Second trimester 77.4% (9288 
/12,000) 
Zhao et al. (2017) 
India 2009 Second trimester 74% (103/139) Sahu et al. (2009) 
Korea 2015 Second trimester 80.7% (67/83) Choi et al. (2015) 
Japan 2008 Third trimester (> 30) 90% (83/93)  Shibata et al. (2011) 
Korea 2015 Third trimester 65.9% (58/88) Choi et al. (2015) 
China 2017 Third  trimester c 78.8% (1393 /1768) Zhao et al. (2017) 
KSA 2013 Third trimester c 14.2% (13/92)  Aly et al. (2013) 
 2016 At delivery 86.4 % (864/1000) Al-Shaikh et al. (2016) 
Egypt 2013 Third trimester (≥ 37) 40% (54/135) El Rifai et al. (2013) 
Turkey 2012 Third trimester (≥ 37) 90% (233/258) Halicioglu et al. (2012) 
Denmark 2010 Third trimester (39) 23% (32/141)  Milman et al. (2012) 
New 
Zaeland 
2014 Third trimester (> 27) 57.7% (/150/260) Grant et al. (2014) 
Belgium 2012 First & third trimester 44.6% (585/1311) Vandevijvere et al. (2012) 
London 2013 At delivery a 36% (125/346) McAree et al. (2013) 
Kuwait 2005 At delivery 83% (178/214) Molla et al. (2005) 
Iran 2012 At delivery 74% (74/100) Khalesi et al. (2012) 
 2016 At delivery 48.9% (139/284) Abbasian et al. (2016) 
Tunisia 2016 At delivery 97% (84/87) Ayadi et al. (2016) 
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Figure 1.2 Incidence of vitamin D deficiency around the world in pregnant women, 
and the general population (adapted from Hossein-Nezhad & Holick, 2013). 
 
1.1.2.3 Adverse Health Effects of Vitamin D Deficiency 
Hypovitaminosis D during gestation has been connected with multiple long-term health 
complications in both the mother and offspring (Barrett & McElduff, 2010). 25(OH)D 
levels during pregnancy may also predict levels in the neonate, as circulating vitamin 
D in the new-born is strongly correlated with levels in the mother, reaching up to 75% 
(Kovacs, 2013). Thus, early exposure to reduced vitamin D levels by the foetus may 
influence metabolic health and development.  
 
It is known that a deprivation of 25(OH)D can lead to long-term complications, such as 
bone reabsorption, myopathy, inadequate calcium homoeostasis (Mulligan et al., 2010), 
osteomalacia, and osteoporosis in adults (Stumpf et al., 2007; Yu et al., 2007). Maternal 
deficiency of vitamin D has also been linked with metabolic disorders, such as insulin 
resistance, GDM (Parlea et al., 2012), and pre-eclampsia (Wei et al., 2012). 
Additionally, it has been suggested that low vitamin 25(OH)D status elevates the risk 
of caesarean section (Perez-Ferre et al., 2012), and also predisposes the subject to 
bacterial vaginosis (Bodnar et al., 2009), pre-term delivery (Perez-Ferre et al., 2012), 
and infections (Kaludjerovic & Vieth, 2010). Short-term comorbidities of the foetus 
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with low concentrations of vitamin D include, impaired foetal growth, low infant birth 
weight and height (Haliloglu et al., 2011), low serum calcium, congenital rickets, 
abnormal tooth enamel formation, and lower bone mineral content (Haliloglu et al., 
2011). Long-term foetal complications include skeletal problems, such as lower bone 
mineral density (Javaid et al., 2006) and immunomodulatory effects (Clifton Bligh et 
al., 2008). Other complications seen in children of deficient mothers include 
inflammatory and immunity disorders, such as type I diabetes mellitus (T1DM) (Barrett 
& McElduff, 2010), respiratory infections (Morales et al., 2012b), eczema, small size 
for gestational age (Bodnar et al., 2010), delayed mental and psychomotor development 
in infants (Morales et al., 2012a), language difficulties in children (Whitehouse et al., 
2012), and infantile autism (Grant & Soles, 2009). Therefore, any risk factors that could 
potentially contribute towards deficiencies should be minimised to prevent 
complications.  
 
 
 
 
 
 
 
 
 
 
  
  
Figure 1.3 A schematic representation of the major causes of vitamin D deficiency and 
the potential adverse health effects (adapted from Holick & Chen, 2008). AODM, adult 
onset diabetes mellitus; CHD, coronary heart disease; FEV1, forced expiratory volume 
in 1 s; HAART, highly active antiretroviral therapy; HBP, high blood pressure; MS, 
multiple sclerosis; RA, rheumatoid arthritis; TB, tuberculosis; URI, urinary tract 
infection. 
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1.1.2.4 Risk Factors of Vitamin D Deficiency 
Multiple factors may increase an individual’s susceptibility to vitamin D deficiency in 
different populations. The main risk factors of vitamin D deficiency are restricted sun 
exposure and reduced dietary intake, along with ethnicity, medication, smoking, and 
chronic diseases (Holick & Chen, 2008; Vandevijvere et al., 2012; Toher et al., 2014). 
Moreover, 25(OH)D status cannot be universally applied to all populations of different 
ages across varied geographical locations. This is because 25(OH)D levels are affected 
by distinct behavioural parameters associated with each population group. Thus, 
pregnant women may be vulnerable to low 25(OH)D levels due to increased maternal 
and foetal demands, haemodilution, and increased body fat (Wortsman et al., 2000; 
McAree et al., 2013). 
 
One non-modifiable recognised risk factor for hypovitaminosis D in the pregnant and 
non-pregnant population is ethnicity. Some studies have highlighted the fact that 
pregnant women from ethnic minorities, such as African-Americans or Hispanics, are 
often deficient in vitamin D (Reeves et al., 2014). Pregnant women from Sub-Saharan 
Africa, the Middle East, and North Africa also tend to have low vitamin D levels, 
compared to their counterparts in other regions, indicating regional and ethnic 
variations in levels of vitamin D (Toher et al., 2014).  
 
Several factors can limit sun exposure, thereby reducing the dermal production of 
vitamin D; these include age, skin colour, season, latitude, whole body coverage with 
clothing, exposure time, and daily sunscreen use in the pregnant and non-pregnant 
population (MacLaughlin & Holick, 1985; Holick, 1995b; Vercruyssen et al., 2012; 
Karras et al., 2014). Dark people absorb more UVB in the melanin of their skin than do 
white people and, therefore, require more sun exposure to produce the same amount of 
vitamin D (Holick, 1995b). A study conducted at Northern latitudes, namely in Sweden 
(latitudes 57-58°N)  has proposed that during the winter, the majority of fair-skinned 
pregnant women suffer from vitamin D deficiency in their third trimester (Brembeck et 
al., 2013). When sun exposure is minimal, the dietary intake of vitamin D is essential 
to protect against such deficiency, with, some studies observing that low dietary intake 
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of vitamin D during pregnancy is associated with vitamin D deficiency (Vercruyssen et 
al., 2012; Karras et al., 2014). However, certain factors may alter vitamin D intake, 
such as the ingestion of substances that affect its absorption or metabolism, or the 
presence of certain kinds of disease, such as malabsorption, or liver and kidney disease 
(Holick, 2007). All of these may be considered classical risk factors for both the 
pregnant and non-pregnant population. 
 
Some of the non-classical risk factors proposed by other studies, with regard to 
aggravating vitamin D deficiency, include disturbed inflammatory markers, obesity, 
physical inactivity, altered lipid profile, and multiparity (Wortsman et al., 2000; Tao et 
al., 2012; Cannell et al., 2014; Kluczynski et al., 2011; Andersen et al., 2013; Karras et 
al., 2014). Conversely, vitamin D plays an important role in the development of 
inflammatory diseases through its function in the immune system, whereby it inhibits 
the proliferation of pro-inflammatory cells and regulates the production of 
inflammatory cytokines (Haussler et al., 2008). However, the presence of inflammation 
may, in turn, indicate vitamin D deficiency. Prior studies have shown that the processes 
involved in contributing to chronic inflammatory disease appear to impact vitamin D 
levels (Autier et al., 2014). It has been suggested that as inflammation causes oxidative 
stress, this then disturbs the liver enzymes that are responsible for the synthesis of 
25(OH)D, thereby reducing the levels of 25(OH)D (Mangge et al., 2015). Another 
possible explanation is that inflammation could induce metabolic clearance through the 
conversion of 25(OH)D to 1,25(OH)2D3 as a means of controlling inflammation and 
self-healing, thus lowering the concentration of 25(OH)D (Cannell et al., 2014).  
 
Numerous studies have been conducted on non-pregnant individuals to explore the 
correlation between vitamin D and inflammatory markers. For example, studies by 
Eleftheriadis and co-authors (2012) observed an inverse correlation between levels of 
vitamin D, c-reactive protein (CRP), and interlukin-6 (IL-6) in haemodialysis patients. 
Comparable findings have also been derived for individuals with diabetes undergoing 
coronary angiography (O'Hartaigh et al., 2013), and in asymptomatic adults (Amer & 
Qayyum, 2012).  
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A study on healthy subjects observed an occurrence of low vitamin D that was linked 
with higher leptin concentrations, however, no substantial correlations were seen 
between serum vitamin D and plasma concentrations of resistin and adiponectin 
(Vilarrasa et al., 2010). Studies on 25(OH)D concentrations and inflammatory markers 
during pregnancy, are in fact scarce, with some being undertaken on healthy pregnant 
women and others on pregnant women in poor states of health (Bodnar et al., 2007b; 
McManus et al., 2014; Bobbitt et al., 2015). One study performed on healthy African-
American women determined a negative correlation between early-pregnancy vitamin 
D levels and pro-inflammatory cytokines, including TNF-α, Interleukin 1 beta (ILI-β) 
and IL-6 in mid-pregnancy, after adjusting for confounding factors, such as the season 
(Bobbitt et al., 2015).  
 
In addition, some studies conducted in pregnancy have shown that obese women are 
more likely to suffer from vitamin D deficiency than their non-obese counterparts 
(McAree et al., 2013; Karlsson et al., 2015), but others have failed to find an association 
in this regard (Choi et al., 2015; Flood-Nichols et al., 2015; Al-Faris, 2016; Ates et al., 
2016). The studies claim that adiposity is a risk factor for vitamin D deficiency, and 
this is explained by the storage of 25(OH)D in adipose tissue through decreasing 
vitamin D bioavailability (Wortsman et al., 2000). Moreover, one study that measured 
fat mass percentage throughout all trimesters of pregnancy, deduced a significant 
inverse association with 25(OH)D exclusively in the first trimester, but failed to find 
this in the second and third trimesters (Karlsson et al., 2015). Furthermore, several 
studies conducted during pregnancy have revealed an inverse correlation between 
vitamin D and total cholesterol, low density lipoprotein cholesterol (LDL-cholesterol) 
(Tao et al., 2012), and a positive correlation with HDL-cholesterol (Makgoba et al., 
2011). 
 
Studies conducted on non-pregnant populations have explored physical activity and its 
relation to vitamin D status, revealing an association between outdoor physical activity 
and increased vitamin D levels (Scragg & Camargo, 2008; Brock et al., 2010; 
Kluczynski et al., 2011). More recently, several studies have observed that physical 
activity is related to higher vitamin D levels, independent of sun exposure in adults 
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(Touvier et al., 2015; Wanner et al., 2015), children, and adolescents (Al-Othman et al., 
2012). However, Wanner et al. (2015) identified no significant association between 
vitamin D levels and outdoor physical activity, while a significant association was 
observed with indoor physical activity, indicating that other factors, independent of sun 
exposure, may play a role. One study followed up pregnant women from the first to 
third trimester, correcting for the season in terms of vitamin D, and noted that higher 
levels of physical activity were associated with increased 25(OH)D concentrations in 
early and late pregnancy (Moon et al., 2015). Furthermore, a German cross-sectional 
study revealed that physical inactivity was an important risk factor for low vitamin D 
levels, after controlling for season and independent risk factors, such as vitamin D 
supplementation, pre-pregnancy body mass index (BMI), intact parathyroid hormone, 
parity, and time spent outdoors (Wuertz et al., 2013).  
 
Parity is another risk factor proposed in some studies. A positive relationship was found 
between multiparity and vitamin D deficiency, irrespective of the season (Andersen et 
al., 2013; Karras et al., 2014). All the above mentioned are risk factors for 
hypovitaminosis D during pregnancy, therefore, preventing these factors, while also 
accessing ample sources of vitamin D will help to maintain optimal 25(OH)D 
concentrations. 
1.1.2.5 Vitamin D Requirements Met Through Sun Exposure and Food  
Sun exposure alone is sufficient to provide most people with their entire vitamin D 
requirements (Holick, 1995a). Sun exposure of 5-10 minutes, three times a week, 
between 11:00 am and 2:00 pm (noon), and at 42 degrees latitude will provide an 
individual with sufficient 25(OH)D, with minimal risk of skin damage (Holick, 2003a). 
To achieve this, the arms and legs, or face and arms should be sufficiently exposed 
(Holick, 2003a). When sun exposure is minimal, dietary intake of sufficient vitamin D 
appears to be crucial for avoiding vitamin D deficiency (Holick, 2011a). Additionally, 
the recommended daily allowance (RDA) of vitamin D during pregnancy, for 
maintenance of serum 25(OH)D concentration of 50 nmol/L, is 400-600 IU/day (IOM, 
2010; Ross et al., 2011). Saudi Arabia has recently adopted vitamin D recommendations 
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from the USA, therefore, according to the Saudi Osteoporosis Society (SOS), 
supplementation of 600 IU/day is recommended for pregnant women (Al-Saleh et al., 
2015). 
 
In many countries, however, vitamin D intake from food is often lower than the 
recommended requirements. For example, in the US and Canada vitamin D intake in 
non-pregnant women is approximately 228 IU/day, and in the UK it is 88 IU/day. 
Meanwhile, in Europe it is 144 IU/day, and in Australia, 52 IU/day (Blumfield et al., 
2012). In the USA during pregnancy, the average intake of vitamin D is estimated to be 
225 IU from dietary sources and 319 IU from supplements (Camargo et al., 2007). 
However, daily intake for pregnant women in KSA has been reported to be less than 
50% of the RDA (Ibrahim et al., 2013), which could contribute to low blood levels of 
vitamin D during pregnancy. Another study in early pregnancy reported that 91.9% of 
pregnant Saudi women ingested inadequate amounts of vitamin D, amounting to less 
than 600 IU/day (Al-Faris, 2016). 
 
1.2 Obesity in Pregnancy 
1.2.1 Definition of Maternal Obesity 
Obesity is an international epidemic, and a major cause of illness and death worldwide 
(WHO, 2000). During pregnancy, a BMI of 30 kg/m2 or more is considered obese 
(Modder & Fitzsimons, 2010). Women tend to have more body fat than men, so it is 
usually accepted that females with > 25 percent body fat are considered obese (WHO, 
2000). However, there is no accepted definition for gestational obesity, due to the 
variability in weight gain, and the short duration of this status (Liat et al., 2015). 
 
1.2.2 Components of Maternal Obesity  
During pregnancy, maternal weight is determined by multiple factors, such as socio- 
economic characteristics, lifestyle habits, metabolic rate, genetics, weight prior to 
pregnancy, and gestational weight gain (GWG) (Gaillard et al., 2013). This means that 
pregnant women are more vulnerable to obesity if they have a high BMI before 
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pregnancy, if they have gained more weight than is recommended during pregnancy, or 
both (Gore et al., 2003; Restall et al., 2014). 
1.2.2.1 Gestational Weight Gain  
A normal pregnancy is accompanied by a normal weight gain increment (Rode et al., 
2012). As pregnancy progresses, the amount of body fat increases, and approximately 
30% of the GWG is attributed to increased adipose tissue (Devine et al., 2000). 
Although there are many studies addressing the determinants and outcomes of maternal 
weight gain, they are incapable of distinguishing the constituents of weight gain (fat 
mass vs. lean mass), or the effect of these constituents on the health of both the mother 
and the foetus. This could partially be explained by the difficulty of assessing the body 
composition of pregnant women, owing to the dynamic nature of gestation, and the 
absence of any methods for distinguishing between maternal and foetal components 
(Widen & Gallagher, 2014). The most frequently used method for assessing change to 
body composition in pregnant women, is through the anthropometrics of skinfold 
thickness and mid-upper arm circumference (MAC) (Widen & Gallagher, 2014).  
 
GWG differs by trimester, but during the first trimester, it disproportionately constitutes 
fat (Devine et al., 2000). The second and third trimester are then characterised by fat 
accumulation, which influences subsequent insulin resistance in pregnant women, and 
therefore, progressive insulin resistance (Buchanan & Xiang, 2005; Hedderson et al., 
2010). The pattern of maternal weight gain is greater in the second half of pregnancy, 
when, on average, it increases by 0.563 kg per week, with foetal weight strongly 
correlating with GWG during this period (Rasmussen et al., 2009).  
 
In order to identify what is normal for GWG during pregnancy, in 1990 the IOM 
established recommendations for maternal weight gain in order to reaffirm ample 
weight gain. The aim was to avoid small-sized foetuses in relation to gestational age, 
as well as premature infants (IOM, 1990). Later in 2009, due to increased cases of being 
overweight or obese prior to pregnancy, the IOM recommendations for GWG were 
updated, with a modification concerning women’s health outcomes in pregnancy. The 
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recommendations also aimed to reduce postpartum weight retention (PPWR) and 
obesity in childhood (Rasmussen & Yaktine, 2009). The WHO was the body 
responsible for reviewing recommendations for pregnancy weight in different 
trimesters, setting out range guidelines based on BMI prior to pregnancy (Rasmussen 
& Yaktine, 2009) (Table 1.3). 
 
Table 1.3 IOM recommendations for total, and rate of, weight gain during 
pregnancy, by pre-pregnancy BMI 
Note: Calculations assume a 0.5-2 kg weight gain in the first trimester. BMI = kg/m2; independent of age, parity, 
smoking history, race, and ethnic background. 
 
A recent study on Canadian women noted that 59.4% gained more than the 
recommended weight for their BMI during gestation (Dzakpasu et al., 2015), and 
excessive GWG has been reported in several industrialised countries, reaching as high 
as 74% (Rasmussen & Yaktine, 2009; Schiessl et al., 2009; Restall et al., 2014). 
However, to date, only a few studies have addressed GWG in Saudi Arabia (El-Gilany 
et al., 2011; Janbi et al., 2013). El-Gilany et al. (2011) observed that GWG was both 
below and above the IOM recommendations, at 16.4% and 47.3% of all pregnant 
women, respectively.  
 
One study followed up a sample of women at 3 and 15 years postpartum, and revealed 
that women with adequate GWG gained an extra 3.06 kg compared to those with 
excessive GWG, who gained an extra 4.72 kg (Nehring et al., 2011). Therefore, 
excessive weight gain during pregnancy, may lead an individual to gain more 
postpartum weight and thus become overweight, and even obese (Mamun et al., 2010; 
Nehring et al., 2011). Hence, gestation is usually accompanied by additional weight 
Pre-pregnancy BMI 
Total weight 
gain (kg) 
Rates of weight gain in 
second and third trimester 
Mean (range) in kg/week 
Underweight women (< 18.5 kg/m2) 12.5-18 kg 0.51(0.44-0.58) 
Women of normal weight (18.5-24.9 kg/m2) 11.5-16 kg 0.42 (0.35-0.50) 
Overweight women (25.0-29.9 kg/m2) 7-11.5 kg 0.28 (0.23-0.33) 
Obese women (≥ 30.0 kg/m2) 5-9   kg 0.22 (0.17-0.27) 
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gain, as women tend to retain part of their weight gain in each gestation (Rode et al., 
2012). Furthermore, excessive GWG from previous pregnancies can worsen gestational 
obesity (Cohen et al., 2014). 
1.2.2.2 Pre-Pregnancy Weight 
A fundamental component of gestational obesity is pre-pregnancy BMI. Pre-pregnancy 
BMI in relation to gestational obesity is equivocal. One meta-analysis that studied pre-
pregnancy BMI and PPWR, highlighted that the mean PPWR decreased in the group 
with increasing BMI (Rong et al., 2015). Elsewhere, it has been found that high pre-
pregnancy BMI increases the possibility of maternal and infant health comorbidities 
(Doherty et al., 2006; Yan, 2015). Furthermore, the relationship between pre-pregnancy 
BMI and its effect on GWG is inconsistent; some studies found that mothers with 
excessive maternal weight gain were more likely to be overweight or obese prior to 
gestation, compared to expectant mothers of normal weight (Weisman et al., 2010; 
Restall et al., 2014). Other studies have highlighted that pregnant women with higher 
pre-pregnancy BMI experienced lower GWG (Nohr et al., 2008; Ebrahimi et al., 2015). 
 
1.2.3 Prevalence of Maternal Obesity 
Obesity in pregnancy is a global burden, with variable prevalence (Heslehurst et al., 
2010). Based on WHO statistics, Ono et al. (2005) state that “the rank order in Arabian  
countries for obesity in females is Kuwait (55.2%), Egypt (48%), and UAE (42%), 
which is higher than all the European countries and about the same as USA (48.3%) 
and Mexico (41%)”. They add that “countries such as Bahrain (37.9%), Jordan (37.9%), 
Saudi Arabia (36.4%) and Lebanon (27.4%) have higher obesity rates in females than 
UK (26.3%), Greece (26.4%), and Israel (25.9%)” (Ono et al., 2005). In KSA, the 
prevalence of obesity and being overweight is high in both Saudi males and females, 
reaching 40% (Al-Nuaim et al., 1997; Al-Nozha et al., 2005; Al-Baghli et al., 2008; 
Garawi et al., 2015). According to the WHO, 43% of the adult Saudi female population 
aged ≥ 25 years is obese (WHO, 2014), and among Saudi females of childbearing age, 
31.5% are overweight, and 21.1% are obese (Al-Malki et al., 2003). 
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There are limited statistics documenting the indices for obesity in pregnant women 
worldwide, especially in the Middle East, but the prevalence varies globally between 
1.8% and 25.3% (Guelinckx et al., 2008; Meher un et al., 2009; El-Gilany & Hammad, 
2010; Bener et al., 2013). In the US and Australia, more than half of all prospective 
mothers are overweight or obese (Dodd et al., 2011; Flegal et al., 2012). In the UK, the 
prevalence of obesity in gestation reaches 19% (Kanagalingam et al., 2005; Shah et al., 
2006; CMACE, 2010; Heslehurst et al., 2010). In Spain, specifically in the Canary 
Islands, 25% of pregnant women are recorded as being overweight, with 17.1% of these 
being obese (Bautista-Castaño et al., 2011). The proportion of overweight and obese 
pregnant women is 33% and 30% in Saudi Arabia, and 28.8% and 25.6% in Qatar (Nisa 
et al., 2009; Bener et al., 2013). A more recent study conducted on 14,568 pregnant 
Saudi women observed that the combined rates of pre-pregnancy overweight or obesity 
amounted to 68% of the sample population, and at ≥ 28 weeks of gestation, this 
increased to 69.7% (Wahabi et al., 2016). 
 
1.2.4 Adverse Health Effects of Maternal Obesity 
Obese pregnant women are identified as being at high risk because this health status 
may have major consequences for the mother, foetus, and child later in life (Weiss et 
al., 2004; Vesco et al., 2009; Nohr et al., 2012). The common complications noted in 
maternal obesity are metabolic, such as Hypertension (HTN), pre-eclampsia, GDM and 
PPWR (Weiss et al., 2004; Vesco et al., 2009). Obese pregnant women experience 
foetal overgrowth and a higher rate of delivery by caesarean section (Ehrenberg et al., 
2004). Additionally, maternal obesity is accompanied by disturbances of inflammatory 
markers known as adipokines, and vascular dysfunction (Huda et al., 2010). 
Complications for the foetus include, increased prematurity, stillbirth, congenital 
malformation, and increased risk of infant mortality (Boots & Stephenson, 2011; Nohr 
et al., 2012; Gardosi et al., 2013). These problems may then lead to long-term 
complications, such as infant and childhood obesity, and T2DM later in life (Cedergren, 
2006; Raatikainen et al., 2006). 
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1.2.5 Risk Factors for Maternal Obesity 
As mentioned earlier, the impact of pre-pregnancy weight on the risk of excessive 
GWG varies in the literature (Restall et al., 2014; Ebrahimi et al., 2015). Nevertheless, 
there are well-known risk factors of obesity, which are similar to the factors potentially 
provoking obesity during pregnancy, such as specific eating habits, a diet rich in fats 
and carbohydrates, and a sedentary lifestyle (Scholl et al., 1991; Olafsdottir et al., 2006; 
Ebrahimi et al., 2015). A limited number of studies have examined the relationship 
between food intake and GWG (Scholl et al., 1991; Olafsdottir et al., 2006; Ebrahimi 
et al., 2015). For example, Olafsdottir et al. (2006) claim that dietary energy intake is 
completely associated with excessive GWG, and this consists entirely of the total 
amount of protein, fat, and carbohydrate consumed, which leads to excessive GWG. 
Whereas, physical activity during pregnancy may reduce, or even prevent, this 
excessive weight gain (Streuling et al., 2011). Other classical risk factors of gestational 
obesity are age, a low educational level, multiparity, ethnicity, and genetic 
predisposition (Melzer & Schutz, 2010; Gaillard et al., 2013).  
 
Some non-classical risk factors that may contribute towards obesity in pregnancy 
include, chronic inflammation and low vitamin D status. However, these are still 
debatable, and only a small number of studies have been conducted in this regard. 
Normal pregnancy is associated with both systemic and localised inflammation, either 
may enhance insulin resistance and cause hyperinsulinaemia, which will contribute to 
increased lipogenesis, and therefore, a susceptibility towards obesity (D'Anna et al., 
2006; Sethi & Vidal-Puig, 2007; Yu et al., 2007; Karpe et al., 2011). This relationship 
will be discussed further, later in this thesis.  
 
There is inconsistency in the research addressing vitamin D concentration and 
gestational obesity (Bodnar et al., 2007a; Josefson et al., 2013; McAree et al., 2013; 
Karras et al., 2016). A recent systematic review revealed a null association between 
25(OH)D concentration and GWG, based on two studies conducted in the third 
trimester (Karras et al., 2016). However, a longitudinal study from the first to the third 
trimester identified that decreased levels of season-corrected 25(OH)D correlated with 
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higher GWG (Moon et al., 2015). This may occur as a result of low vitamin D status, 
resulting in elevated PTH, which in turn decreases 25(OH)D, and increases intracellular 
calcium in adipocytes. In this way, lipolysis is inhibited and lipogenesis is stimulated, 
resulting in obesity (Xue et al., 2001; McCarty & Thomas, 2003). 
1.3 Gestational Diabetes Mellitus  
1.3.1 Background  
1.3.1.1 Definition of GDM 
According to the American Diabetes Association (ADA), GDM is defined as 
“carbohydrate intolerance resulting in hyperglycaemia of variable severity, with onset 
or first recognition during pregnancy” (Metzger et al., 1998). GDM is one of the most 
common comorbidities of pregnancy, usually diagnosed between 24 and 28 weeks of 
pregnancy (ADA, 2003). Although the mechanisms involved in its pathogenesis are 
still ambiguous, it is believed to be due to either insulin resistance, or impaired insulin 
secretion (Aguiree et al., 2013). 
1.3.1.2 Pathophysiology of GDM 
The mechanisms involved in the aetiology of GDM appear to be multi-factorial 
(Buchanan et al., 2007; Arora & Hobel, 2010). The dysregulation of insulin secretion 
and resistance are important factors because they are altered by gestational and 
placental steroid hormones, and cytokine production (Fowler, 2007). Placental growth 
hormones, such as human placental lactogen, along with increased levels of cortisol 
and prolactin have been implicated in insulin insensitivity (Metzger et al., 2007; Reece 
et al., 2009). A lack of insulin resistance following delivery suggests a significant 
contribution of placental factors (Buchanan et al., 2007). 
 
The low-grade inflammatory state that is associated with human pregnancy, can be 
attributed to cytokine production from different sources, including the placenta, uterine 
epithelium, uterine smooth muscles, cervix, immune system (T-lymphocytes and 
maternal and foetal macrophages), and adipose tissue, which increases the complexity 
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of the immune-metabolic network in pregnant women (Arora, 2011). Both adipose 
tissue and the placenta can produce inflammatory markers, such as leptin, adiponectin, 
resistin, TNF-𝛼, and IL-6, which are collectively known as adipokines, or 
adipocytokines (Desoye & Hauguel-de Mouzon, 2007; Miehle et al., 2012). Thus, 
normal pregnancy is associated with a state of systemic inflammation that can activate 
defined inflammatory pathways, which could be vital for inducing the insulin resistance 
necessary for the progression of a normal pregnancy (Radaelli et al., 2003; Koerner et 
al., 2005; Desoye & Hauguel-de Mouzon, 2007; Gomes et al., 2013). The indicators of 
systemic inflammation, associated with pregnancy, are higher levels of serum CRP 
and/or IL-6 (D'Anna et al., 2006; Yu et al., 2007). As described earlier, the combination 
of systemic and localised inflammation may result in pregnancy complications, such as 
diabetes, obesity, and pre-eclampsia (Lepercq et al., 1998; Benyo et al., 2001; Coughlan 
et al., 2001; Romero et al., 2007).  
 
Conversely, there is growing evidence to suggest that the dysregulation of beta cells (β-
cells), in response to increased insulin resistance, leads to GDM (Buchanan et al., 2007; 
Fowler, 2007). Moreover, the increased need for insulin during gestation places an extra 
burden on the pancreatic β-cells, contributing to further dysregulation of insulin 
secretion (Buchanan et al., 2007). Inflammatory proteins are also implicated in β-cell 
damage and insulin resistance (Vrachnis et al., 2012), while genetic mutations and auto-
immune destruction may be responsible for β-cell dysfunction, thus contributing to the 
induction of GDM (Buchanan et al., 2007). Moreover, insulin resistance may be 
ascribed a dysfunction of the insulin receptors (Desoye et al., 1994; Desoye et al., 
1997).  
 
As already mentioned, a vitamin D deficiency has been linked to the induction of GDM 
(Alvarez & Ashraf, 2009; Eliades & Pittas, 2009). Vitamin D is considered an anti-
inflammatory vitamin (Bikle, 2009), and low levels have also been implicated in insulin 
receptor dysfunction, thus contributing towards the cause of GDM (Desoye et al., 1994, 
1997). Together, hypovitaminosis D and insulin receptor dysfunction contribute to the 
inflammatory effect, which is exacerbated by maternal factors, such as obesity and a 
genetic predisposition towards GDM (Kahn et al., 2006; Arora, 2011). As a result, there 
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is a growing body of evidence indicating that vitamin D deficiency can impact upon 
metabolic diseases, such as GDM. Although, further data on the role of vitamin D in 
GDM is required (Zhang et al., 2008; Arnold et al., 2015). 
1.3.1.3 Screening and Diagnostic Criteria for GDM 
The screening and diagnosis of GDM are of paramount importance for preventing 
complications associated with GDM (Taylor & Burley, 2015). However, there is no 
consensus on a unified approach to diagnosing GDM by screening patients, whether 
based on the selective screening for risk factors, or the universal screening of all 
pregnant women (O’Dea et al., 2014). Similarly, the adoption of globally accepted 
diagnostic guidelines for GDM screening has also been a subject of debate (Agarwal et 
al., 2005). In order to attain a single approach for GDM diagnosis worldwide, in 2010 
the International Association of Diabetes and Pregnancy Study Group (IADPSG) issued 
consensus guidelines for the consideration of glycaemia and pregnancy outcomes 
(Panel IADPSG Consensus, 2010). The corresponding data were obtained from the 
Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study, which was 
conducted in 15 field centres, across nine different countries, along with other important 
observational epidemiological and randomised controlled trials (RCT). 
 
The IADPSG diagnosis criteria stipulates that GDM rates will increase, as evidenced 
by the HAPO study, which saw the prevalence rate of GDM increased from 11.3% to 
16.1%, a 42% increment (Metzger et al., 2008). Thus, the recent IADPSG and WHO 
2013 diagnostic criteria recommend the inclusion of all high-risk pregnant women, 
resulting in higher percentages of women with GDM being reported (Panel IADPSG 
Consensus, 2010). Hence, women are now more aware of their high-risk status during 
pregnancy, which will help prevent pregnancy complications. 
 
Numerous studies in different countries have revealed an increase in prevalence upon 
the adoption of the IADPSG criteria, as shown in Table 1.4. The New Zealand Society 
for the Study of Diabetes (NZSSD) reported a 6% prevalence of GDM, whereas using 
the IADPSG criteria, this increased to an estimated prevalence of 9.7% (Ekeroma et al., 
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2015). Similarly, in the UAE, and using ADA criteria, of GDM was found to be 12.9%, 
as opposed to 37.7% reported using the IADPSG criteria (Agarwal et al., 2010). From 
previous studies, along with Jenum et al. (2012), it may be observed that the prevalence 
of GDM in a multi-ethnic population is 2.4 times greater using the altered IADPSG 
criteria, compared with the WHO criteria (Jenum et al., 2012). On a wider scale, 
national and international bodies, whether wholly or in substantial part, have endorsed 
the IADPSG, including the ADA, the Endocrine Society, and the WHO. This has led 
to the issue of guidelines for the diagnosis of hyperglycaemia in pregnancy, with a 
contribution made to the standard diagnostic approach to GDM (Blumer et al., 2013; 
WHO, 2013). However, certain other bodies, such as the American College of 
Obstetricians and Gynaecologists (ACOG) still favour other diagnostic criteria (ACOG, 
2013) along with the ADA which proposed in 2014 that either the IADPSG or ACOG 
could be acceptable (ADA, 2014). 
 
1.3.2 Prevalence of GDM 
The global prevalence of GDM in the population ranges between 1% and 14% of all 
pregnancies (Krishnaveni et al., 2007; Jang, 2011). The IADPSG has reported the 
overall prevalence of GDM to be between 9.3% and 25.5%, thus averaging 17.8% 
(Sacks et al., 2012). In the US, the prevalence of GDM ranges from 3.47 to 7.15% 
depending on the State, and in Canada, the prevalence is 17.8% (Ryan, 2011; 
Bardenheier et al., 2013). In contrast, the GDM prevalence in Middle Eastern countries 
ranges from 13.9% in Qatar to 7% in Iran (Maghbooli et al., 2008; Bener et al., 2013). 
However, in 2015, one study in Saudi Arabia reported a 39.4% prevalence of GDM, 
among all pregnancies in the Kingdom (Alfadhli et al., 2015).  
 
Table 1.4 shows GDM prevalence across these and other countries. However, the 
variation observed may be due to differences in diagnostic approaches and ethnic 
diversity (Krishnaveni et al., 2007). 
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Table 1.4 Worldwide prevalence of GDM, especially in the Middle East 
Note: Australasian Diabetes in Pregnancy Society (ADIPS) criteria; American Diabetes Association (ADA); National Diabetes 
Data Group (NDDG); Carpenter and Coustan (C&C), and the New Zealand Society for the Study of Diabetes (NZSSD). 
 
  
Country    Year  Prevalence (n/N) Criteria Reference 
USA 2013 
3.47 to 7.15% 
(620332 to 1278207/1,787,703) 
Different criteria  
in different States 
  Bardenheier et al. (2013) 
Canada 2011 17.8% (4,150/ 23,316) IADPSG Ryan (2011) 
Ireland 2011 
12.4% (682/5,500) 
9.4% (517/5,500) 
IADPSG 
WHO 1999 
O’Sullivan et al. (2011) 
New Zealand 
 
2015 
9.7% (619/6376) 
6% (381/6376) 
IADPSG 
NZSSD 
Ekeroma et al. (2015) 
France 2013 14.4% (2703/18,775) 
French and/or WHO 
recommendations 
Cosson et al. (2013) 
Germany 2011 2.3% (14,990/647,385) Not clear Schneider et al. (2011) 
 2016 6.81% (10,816 /158,839) IADPSG Tamayo et al. (2016) 
Australia 2011 
9.6% (122/1275) 
13.0% (166/1275) 
ADIPS criteria 
IADPSG 
Moses et al. (2011) 
India 2013 11% (55/500) WHO 1999 Sharma et al. (2013) 
 2017 17% (71/417) IADPSG Sharma et al. (2017) 
North India 2015 9% (459/5100) WHO 1999 Arora et al. (2015) 
  35% (1785/5100) WHO 2013  
Asia 2014 
28.8% (246/855) 
21.1% (180/855) 
WHO 1999 
WHO 2013 
Yew et al. (2014) 
China 
2011 6.8% (7172/105 473) WHO 1999 Zhang et al. (2011) 
2011 
8.9% (1293/14593) 
14.7% (2138/14 593) 
NDDG 
IADPSG 
Wei & Yang (2011) 
2013 17.5% (3007/17,186) IADPSG Zhu et al. (2013) 
2015 
8.1% (1505/18589) 
9.3% (1728/18589) 
WHO 1999 
IADPSG 
Leng et al. (2015) 
Saudi Arabia 
2010 
12.5% (96/770) 
3.8% (29.3/770) 
WHO 1999 
ADA 
Al-Rowailly & 
Abolfotouh 
 (2010) 
2013 18% (569/3157) ADA Wahabi et al. (2014) 
2015 39.4% (183/445) IADPSG Alfadhli et al. (2015) 
 2015 13.8% (238/1718) Different criteria Serehi et al. (2015) 
 2016 24.2% (2355/9731) WHO 2013 Wahabi et al. (2016) 
 2016 11.1% (111/1000) WHO  1999 Al-Shaikh et al. (2016) 
UAE 2010 
12.9% (1,328/10,283) 
37.7% (3,875/10,283) 
ADA 
IADPSG 
Agarwal et al. (2010) 
Bahrain 2012 10.1% (5004/49 552) 
National Diabetes Data 
Group, 1979 
Rajab et al. (2012) 
Qatar 2011 16.3% (335/2056) WHO 1999 Bener et al. (2011) 
 2013 13.9% (260/1873) WHO 1999 Bener et al. (2013) 
Oman 2002 21.3% (120/564) ADA Dashora et al. (2002) 
Yemen 2016 5.1% (16/311) ADA Ali et al. (2016) 
Nigeria 2015 
3.8% (40/1059) 
8.1% (86/1059) 
8.6% (91/1059) 
WHO 1999 
WHO 2013 
IADPSG 
Olagbuji et al. (2015) 
Turkey 
2012 
8.1% (65.5/808) 
5.6% (45/808) 
15.7% (127/808) 
C&C 
NDDG 
New criteria 
Kösüs et al. (2012) 
2015 4.3% (39/815) C&C Erem et al. (2015) 
Iran 
2015 4.9 % (62.5/1276) C&C 
Mohammadzadeh et al. 
(2015) 
2016 29.9% (224/750) IADPSG Shahbazian et al. (2016) 
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1.3.3 Adverse Health Effects of GDM 
GDM has been implicated in both long- and short-term health complications in mothers 
and their offspring. The short-term effects of GDM among expectant mothers include 
maternal HTN, pre-eclampsia, urinary tract infections, and caesarean delivery (Getahun 
et al., 2010; Catalano et al., 2012). On the other hand, the long-term maternal 
complications include a 35-80% higher possibility of recurring GDM (Ben-Haroush et 
al., 2004) and 7-8 times higher risk of T2DM later in life (Bellamy et al., 2009). The 
offspring of mothers with GDM, also tend to have higher blood glucose levels, amino 
acids, and lipids, due to the transplacental transfer from the mother, along with elevated 
insulin (Catalano & Ehrenberg, 2006). This in turn leads in changes in foetal body 
composition and metabolism (Catalano & Ehrenberg, 2006). The short-term 
complications for offspring of mothers with GDM include macrosomia (Alberico et al., 
2014), birth trauma, congenital malformation, respiratory distress syndrome (Chen et 
al., 2009), neonatal jaundice (Sobande et al., 2005), and perinatal morbidity and 
mortality (Bellamy et al., 2009). Whereas the long-term complications include, 
childhood obesity, impaired glucose tolerance, T2DM (Boney et al., 2005; Ferrara, 
2007; Hiersch & Yogev, 2014), and cardiovascular diseases (Chen et al., 2009). 
 
 GDM accounts for an increase of 636 million United states dollar (USD) in national 
medical costs (Chen et al., 2009), and in 2013, the global health expenditure on the 
treatment of diabetes and the management of its health effects totalled 548 billion USD 
(Aguiree et al., 2013). Therefore, by gaining further understanding and minimising the 
high-risk factors of GDM, the prevalence can be reduced, and hence the cost of treating 
its complications. 
 
1.3.4 Risk Factors of GDM 
The well-established risk factors of GDM include obesity, maternal age > 35 years, past 
GDM, and a family history of GDM and/or T2DM. Other risk factors are ethnicity, 
multiparity, history of foetal death, history of prior caesarean section, history of a 
macrosomic infant, low birth weight, recurrent miscarriages, presence of glycosuria, 
alcohol consumption, short stature, cigarette smoking, low physical activity before or 
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during pregnancy, excessive GWG, poor diet, socio-economic factors, HTN, genetic 
susceptibility to polymorphism, and diagnosis of polycystic ovarian syndrome (PCOS) 
(Dode & Santos, 2009; Al-Rowaily & Abolfotouh, 2010; Lewis et al., 2010; Zhang & 
Ning, 2011; Nankervis et al., 2012; Erem et al., 2015). 
 
However, the known risk factors only contribute to approximately 50-60% of the risk 
of future GDM (Savvidou et al., 2010). Ethnicity is believed to be a strong and non-
modifiable risk factor (Yuen & Wong, 2015), with GDM prevalence being especially 
high among women from Hispanic, Native American, African-American, Pacific 
island, indigenous Australian, and South or South East Asian backgrounds (Kjos & 
Buchanan, 1999).  
 
Obesity during pregnancy is considered to be a well-known independent risk factor of 
GDM (Teh et al., 2011; Singh et al., 2012; Mao et al., 2015), and pre-pregnancy obesity 
has a strong direct correlation with GDM prevalence (Li et al., 2013; Gabbay-Benziv 
et al., 2015). Erem et al. (2015) demonstrated that women who were obese pre-
pregnancy were up to 60 times more likely to develop GDM than underweight women 
(Erem et al., 2015). In the first trimester of pregnancy, obesity proxies, such as visceral 
fat mass percentage, have been shown to positively correlate with hyperglycaemia, 
insulin resistance, dyslipidaemia, and high diastolic blood pressure (Gur et al., 2014). 
Similarly, BMI, subcutaneous fat, and serum leptin have been shown to have a direct 
correlation with GDM (Sommer et al., 2015). In addition, waist to hip ratio (WHR) in 
early pregnancy has been found to be significantly correlated with GDM at 7-12 weeks 
of gestation (Alptekin et al., 2016).  
Nevertheless, it must be taken into account that the results of studies addressing 
maternal weight gain and GDM risk have not always been consistent. For instance, 
some have addressed early GWG before GDM screening, and observed that it is an 
independent risk factor of GDM (Saldana et al., 2006; Hedderson et al., 2010; Gaillard 
et al., 2013; Sommer et al., 2014; Zheng et al., 2014; Erem et al., 2015; Mao et al., 
2015). In 2015, two meta-analyses noted that excessive GWG (based on IOM) 
occurring prior to the diagnosis of GDM, increased the risk, even after adjusting for 
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confounding factors (Brunner et al., 2015; Robitaille, 2015). In contrast, other meta-
analyses have failed to demonstrate an association between GWG and GDM (Ruifrok 
et al., 2014). Furthermore, another set of studies noted an inverse association, i.e. 
maternal weight gain was lower in GDM women compared to women without GDM 
(Catalano et al., 1993; Nohr et al., 2008; Heude et al., 2012). These differences may be 
due to cut-off point used, maternal body weight, the timing of the measurements, for 
example, the GWG measured was the total weight gain over the entire pregnancy. This 
could have been affected by either behavioural or treatment changes after diagnosis, 
thus influencing weight increase and foetal weight (Dode & dos Santos, 2009; 
Hedderson et al., 2010; Zheng et al., 2014). 
Physical inactivity in non-pregnant individuals is a well-known major risk factor for 
the development of diabetes. The health benefits of physical activity are well 
documented, and include reducing weight gain and decreasing insulin resistance (Jeon 
et al., 2007). Physical inactivity prior to pregnancy, or in the first trimester of 
pregnancy, has been shown to be a significant risk factor for the development of 
GDM in late pregnancy (Harizopoulou et al., 2010). A prospective cohort study of 
Pakistani women who were ≤ 18 weeks pregnant, revealed that an increased risk 
of GDM was directly associated with physical inactivity (Iqbal et al., 2007). A number 
of observational studies have demonstrated that regular physical activity, both prior to 
and during the first trimester of pregnancy, will reduce the risk of GDM (Dempsey et 
al., 2004; Oken et al., 2006; Zhang et al., 2006; Liu et al., 2008; Mørkrid et al., 2014).  
Other non-traditional risk factors that could play a role in GDM development, include 
higher levels of triglycerides (TG) (Brisson et al., 2010), low vitamin B12 (Sukumar et 
al., 2015), vitamin D deficiency (Zhang et al., 2008; Lau et al., 2011; Parlea et al., 2012) 
and high PTH in small studies (Kramer et al., 2014); all of which have been 
independently linked with higher GDM risk. Pregnancy is normally associated with 
insulin resistance, along with altered maternal lipid metabolism in the latter half of 
pregnancy (Alvarez et al., 1996). There are reports documenting that TG levels increase 
progressively during pregnancy, with significantly higher levels in the later stages of 
gestation (Alvarez et al., 1996; Herrera & Ortega-Senovilla, 2010). Elevated levels of 
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TG, total cholesterol and LDL-cholesterol, across the three trimesters, have also been 
reported among women with GDM, compared to their counterparts without GDM 
(Ryckman et al., 2015). However, other studies that have measured lipid levels in early 
pregnancy, with the risk of insulin resistance later in pregnancy and GDM occurrence, 
are still debatable and unclear (Nolan et al., 1995; Zhou et al., 2012; dos Santos-Weiss 
et al., 2013; Ryckman et al., 2015). Shaung & Huixia (2014) revealed that high serum 
TG levels in early pregnancy are an independent risk factor for GDM. Furthermore, one 
study noted that pregnant women with higher TG levels, irrespective of their BMI, were 
at greater risk of developing GDM, while lean women with high HDL-cholesterol were 
protected (Li et al., 2015). 
In addition, low vitamin D levels have been shown to increase the risk of GDM in 
several meta-analyses (Aghajafari et al., 2013; Wei et al., 2013), which has been 
attributed to the presence of VDRs in the pancreatic cells. Therefore, vitamin D plays 
a role in insulin resistance, stimulating insulin secretion, and in turn glucose 
homoeostasis (Alzaim & Wood, 2013). Several observational studies have measured 
vitamin D levels, either after GDM occurrence in the second or third trimester (Zuhur 
et al., 2013; Burris & Camargo, 2014), or in early pregnancy before GDM diagnosis 
(Lacroix et al., 2014; Jain et al., 2015), and found that hypovitaminosis D increases the 
risk of GDM. RCT studies are limited, but fundamental to gaining an understanding of 
the role of vitamin D in decreasing the risk of GDM, or enhancing glucose tolerance in 
pregnant women with GDM (Burris & Camargo, 2014). Interestingly, Zuhur et al. 
(2013) highlighted, amongst women in their second trimester of pregnancy, that severe 
vitamin D deficiency is independently associated with GDM, along with raised PTH 
levels, which were significantly greater in women with GDM. Thus, vitamin D 
deficiency and elevated PTH levels may place an additional burden on glucose 
tolerance during pregnancy. 
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1.4 Study Hypothesis and Aims  
The current study hypothesis is that a vitamin D deficiency, early in pregnancy has a 
deleterious impact on the health of pregnant women, due to an increased risk of 
metabolic disease. To test this hypothesis, the present study measured serum vitamin D 
twice in a sample of pregnant Saudi women: testing once in early pregnancy, then a 
second time in mid-pregnancy to assess the onset of GDM, along with its markers. 
These measurements, in addition to a detailed characterisation of all other confounding 
factors, may affect the independent association between vitamin D deficiency and 
GDM, such as parity, education, income, season, pre-pregnancy BMI, GWG, dietary 
factors (food and supplements), physical activity, sun exposure, skin colour, age, family 
history of diabetes, past GDM, ethnicity, and health status. These extensive 
measurements provide a more holistic approach to understanding how pregnancy 
influences vitamin D. To explore this understanding; the following aims were 
addressed: 
1. Determining the prevalence and determinants of vitamin D deficiency in 
early pregnancy, amongst women in Saudi Arabia.  
2. Comparing the vitamin D levels and risk factors that change from early to 
mid-pregnancy. 
3. Assessing the prevalence and determinants of GDM in Saudi population. 
4. Exploring possible independent association of vitamin D deficiency in 
early pregnancy and GDM risk with adjustment for confounding factors. 
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Materials and Methods
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2.1 Research Methodology 
2.1.1 Study Design  
A total of 773 pregnant women, aged 18-39 years, were assessed for eligibility. Thirty 
were subsequently excluded from the study because they did not meet the inclusion 
criteria; 27 were taking vitamin D supplements, and 3 had diabetes mellitus type I or 
II. In total, 743 pregnant women assessed during the first trimester of pregnancy (8-12 
weeks) were eligible to proceed in the study. Out of these, 578 completed the 
questionnaire for the 1st visit, with a blood sample. The mean age of these subjects was 
28.8 ± 5.4 years. At the 2nd visit (24-28 weeks), 281 were lost to follow-up [refusal to 
consent to a glucose tolerance test (n = 41); refusal to complete a questionnaire at the 
2nd visit (n = 41); spontaneous abortion (n = 34); vitamin D supplementation after the 
1st visit  (n = 45); cancellation of appointments for a variety of reasons at the time of 
the GDM screening (n = 120)]. These follow-up losses included Corona cases (viral 
respiratory disease) at King Khalid University Hospital (KKUH), which caused the 
outpatient department to close for a month, and follow-ups elsewhere. Finally, a total 
of 297 pregnant women were fully assessed at the 2nd visit.   
 
The present study was a prospective observational study of 297 pregnant women, with 
a mean age of 28.9 ± 5.3 years. The data were collected from three tertiary antenatal 
clinics in Riyadh, Saudi Arabia (latitude: 24° 42' N, 46° 43' E). The study was accepted 
by the institutional review boards of King Fahd Medical City (KFMC) and KKUH, in 
Riyadh ( Appendix I). Each pregnant woman gave informed consent for their 
participation ( Appendix II). The Consolidated Standard of Reporting Trials 
(CONSORT) form (Figure 2.1) describes the flow of participants through the study. 
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Figure 2.1 CONSORT statement describing flow of participants through the study. 
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2.2 Sample Population 
2.2.1 Inclusion and Exclusion Criteria 
Pregnant Saudi women, aged 18-39 years prior to 16 weeks of gestation, were involved 
in the current study. Singleton pregnancy was another criterion for inclusion, together 
with no previous history of diabetes mellitus (type I or II). Exclusion criteria included 
non-Saudi subjects, a gestational age of over 16 weeks, vitamin D supplementation one 
month prior to pregnancy, previous history of diabetes mellitus, calcium or parathyroid 
disorders, treatment with cardiac medication or diuretics, and women with chronic HTN 
or malabsorption syndrome. Pregnant women with chronic conditions, such as thyroid 
disease, epilepsy, or malignancy were also excluded. 
 
2.2.2 Power of the Study 
At the time of this study, there were no prospective data on pregnant Saudi women with 
GDM, and the association of this with vitamin D, so no direct power calculation could 
be performed. Therefore, in order to show vitamin D deficiency as a risk factor for 
GDM in pregnant women, a relative risk of 3.0 at 5% level of significance and 80% 
power was calculated, similar to a previous prospective study (Zhang et al., 2008). This 
indicated a 30% incidence of GDM among vitamin D deficient pregnant women and 
10% incidence of GDM without vitamin D deficiency. For this power, it was observed 
that 250 pregnant women would need to be recruited for the study. Assuming a 10% 
drop-out rate, the estimated sample size was 275. However, another interest of the study 
was the prevalence of vitamin D deficiency among pregnant Saudi women. Assuming 
a prevalence of 80% vitamin D deficiency (Azhar, 2009), at a 5% level of significance 
and with ± 5% level of precision [width of 95% CI], 246 pregnant women were 
required. The total sample size for the above study was ultimately 297, and this is a 
similar number of participants used in some of the studies conducted previously 
(Makgoba et al., 2011; Arnold et al., 2015). 
 
38 
 
2.3 Recruitment and Medical Screening  
Banners and brochures were placed in prenatal clinics in all three of the hospitals 
sampled: KKUH, KFMC, and Prince Salman Hospital. Additionally, obstetricians were 
asked to introduce the research to their pregnant patients at their first prenatal 
appointment. Patients who met the criteria and consented to contribute in the present 
study were given the appropriate information. At their early pregnancy visit, 
prospective candidates were asked to sign consent forms that included information 
about their participation in the study, such as data collection, procurement of blood 
samples, and anthropometric measurements. Their permission for data collection from 
their medical records and blood stocks in a bio-bank (Appendix II) were also obtained. 
Moreover, the participants were informed of their freedom to withdraw from the study 
at any point, without it affecting their usual care. Finally, a questionnaire specifically 
designed for data collection was used to collect the relevant information, such as socio- 
economic information, medical history, diet, sun exposure, and levels of physical 
activity (Appendix III). 
 
2.4 Study Visits 
Clinical assessments were conducted twice during the early and mid-pregnancy visits. 
In early visit baseline, non-fasting blood samples were obtained (8-12 weeks); lipid 
profile and 25(OH)D levels were measured, gestational age was calculated from the last 
menstrual period (LMP), and the GDM screening in mid-pregnancy visit was scheduled 
during the second trimester (at 24-28 weeks). For the oral glucose tolerance test 
(OGTT), the women were asked to fast for at least 10 hours, and a fasting blood sample 
was subsequently withdrawn, following this, the participants were asked to drink 75 
gm of glucose within a period of five minutes. Blood samples were collected after one, 
and then after two hours, for assessment of glucose and insulin levels.  
 
IADPSG guidelines were applied to diagnose GDM, based on one or more values equal 
to, or exceeding, the following threshold: fasting ≥ 5.1 mmol/L and/or 1-hour post 
glucose ≥ 10 mmol/L and/or 2-hour post-glucose load ≥ 8.5mmol/L (Panel IADPSG 
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Consensus, 2010). During both visits, maternal health status was assessed by the 
obstetrician for acute illnesses, such as viral and/or bacterial gastrointestinal and 
respiratory diseases. Anthropometric assessment and questionnaire-based interviews 
were also conducted. These visits were arranged alongside obstetric appointments for 
the sake of the participants’ convenience, and each was assigned to a unique number 
and file, for data storage purposes. 
 
 
Figure 2.2 The follow-up visits 
 
2.5 Data Collection 
Data were collected between January 2014 and December 2015. The study tools 
included anthropometric measurements, blood biochemical tests, and an interview 
questionnaire. The interview questionnaire included questions to gather socio-
economic information, clinical measurements, and past medical and treatment history. 
It also contained a food frequency questionaire (FFQ) and questions on sun exposure 
and physical activity (Al-Daghri et al., 2011; Harrison et al., 2011; Al-Musharaf et al., 
Visit 1 
(8-12 weeks) 
•Fullfilling inclusion/exclusion criteria
• Obstetrician clinical examination 
•Blood sampling at baseline
•Anthropometric measurements 
•Questionnaire-first visit (Appendix III)
Visit 2
(24-28 weeks) 
(after 3-4 months) 
•Fasting blood sampling 
•OGTT with 75 gm glucose syrup at 1 hour and 2 hours
• Obstetrician clinical examination 
•Anthropometric measurements 
•Questionnaire-second visit (Appendix III)
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2012; Al-Othman et al., 2012b; Takahasi et al., 2013). A pilot study was conducted, to 
test the clarity and efficiency of the questions, on 62 subjects. Table 2.1 summarises 
the measurements and tools used.  
 
Table 2.1 Summary of the sampling and measurements in the study 
 Method or Sample Used 8-12 weeks 24-28 weeks 
Maternal Anthropometrics    
Weight (kg) Digital Pearson Scale (twice)   
Pre-pregnancy weight (kg) Subject recall   
Height (cm) Digital Pearson Scale (twice)   
Waist (cm) Non-stretchable tape (twice)   
Hips (cm) Non-stretchable tape (twice)   
MAC (cm) Non-stretchable tape (twice)   
Skinfold thickness (mm) Caliper   
Blood pressure (mmHg) 
Mercury sphygmomanometer 
(twice) 
  
Socio-Economic Data Questionnaire   
Clinical Measurements    
Family history Questionnaire   
Subject history Questionnaire   
Risk factors Questionnaire   
Pregnancy symptoms Questionnaire   
Pregnancy complications Obstetric assessment   
List of medication Questionnaire   
Dietary Assessment    
FFQ Questionnaire   
Supplement intake Questionnaire   
Other    
Sun exposure Questionnaire   
Physical activity IPAQ   
Biochemical Assessment    
- 25(OH) D, lipid profile, calcium, 
phosphorus, albumin, creatinine, 
alkaline phosphatase, blood 
glucose, insulin 
Serum sample   
- HbA1c Whole blood   
- 25(OH)D, lipid profile, calcium, 
phosphorus, albumin, creatinine, 
alkaline phosphatase, fasting blood 
glucose, fasting insulin 
Fasting serum sample   
- 1- and 2-hour OGTT and 2-hour 
insulin 
1- and 2-hour serum sample   
-HOMA-IR, HOMA-β Matthews equations   
Note: Mid-upper arm circumference (MAC); International Physical Activity Questionnaire (IPAQ); Oral glucose 
tolerance test (OGTT); Homoeostasis Model Assessment of Insulin Resistance (HOMA-IR) and beta cell (HOMA-
β). 
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2.5.1 Anthropometric Measurements 
Anthropometric measurements were taken from the participants during early and mid-
pregnancy. This included weight (kg) and height (cm), for calculating BMI (kg/m2); 
pre-pregnancy weight (kg); pre-pregnancy BMI (kg/m2); GWG (kg); waist (cm) and 
hip circumference (cm), for waist-hip ratio (WHR); mid-arm circumference (MAC); 
triceps, biceps, suprailiac and subscapular (mm) measurements (skinfold thickness), 
and relative fat percentage. In addition, systolic and diastolic blood pressure (mmHg) 
was also recorded.  
 
Weight was documented to the nearest 0.1 kg, using an appropriate international 
standard scale (Digital Pearson Scale, ADAM Equipment Inc., USA), without shoes 
and with lightweight clothing. Height was measured at the early pregnancy visit only. 
This was recorded to the nearest 0.5 cm, using the Digital Pearson Scale, while standing 
upright without shoes. Measurements were taken twice, and the mean readings were 
recorded. Pre-pregnancy BMI was calculated from weight recall, which was 
categorised based on WHO (2000) guidelines. To minimise bias in recalling pre-
pregnancy weight, the study showed a strong correlation between pre-pregnancy BMI 
and BMI at the 1st visit (r = 0.96; p < 0.001). GWG was determined by calculating the 
difference between the women’s weight at the early pregnancy visit, and again at the 
mid-pregnancy visit. Maternal weight gain was then categorised based on the IOM 
GWG guidelines (Table 1.3). The GWG was presented quantitatively, as the total 
weight gain from early to mid-pregnancy, as well as categorically, as excessive versus 
non-excessive weight gain, again based on the IOM GWG guidelines (Rasmussen & 
Yaktine, 2009; Carreno et al., 2012; Brunner et al., 2015). 
 
At both visits, the WHR was assessed, and was defined by the relationship between the 
waist circumference - the narrowest point between the lowest rib and the umbilicus, 
and hip circumference - the level of the greater trochanter, with the legs close together 
(Wang et al., 2003). Waist and hip circumference were assessed using a standardised 
measuring tape, with the subjects in an upright position and wearing lightweight 
clothing. MAC was measured at the centre between the topmost lateral point of the 
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acromion border, and the proximal and lateral border of the head of the radius. 
Measurements of the above circumferences were taken at eye level, and recorded to the 
nearest 0.1 cm.  
 
The mark for both biceps (just above the measuring tape) and triceps (just below the 
measuring tape) were used to measure skinfold thickness (Marfell-Jones et al., 2006). 
Meanwhile, body fat percentages were measured from subcutaneous skinfolds (triceps, 
biceps, suprailiac, and subscapular), using a Harpenden caliper (British Indicators, 
Sussex, England), according to the procedure and equations identified by Durnin and 
Womersly (1974). The skinfold thickness equation has previously been used in many 
studies on pregnant women (Reynolds et al., 2010; Pike et al., 2013). Changes in body 
fat (Δ body fat) were calculated from the differences in quantity of fat between early 
and mid-pregnancy. 
  
Blood pressure (mm of Hg) was measured using a mercury sphygmomanometer, while 
the patient was relaxed and seated. Per the criteria set out by the International Society 
for the Study of Hypertension in Pregnancy, gestational HTN was identified as BP ≥ 
140/90 mmHg (Redman & Russell, 2010). Moreover, metabolic syndrome (yes/no) was 
classified according to the guidelines provided by the USA National Heart, Lung and 
Blood Institute/American Heart Association (NHLBI/AHA) (Grundy et al., 2005), but 
with modifications suitable for the present research sample. Thus, abdominal 
circumference was not included as an indicator of obesity. Metabolic syndrome was 
distinct, with the occurrence of three or more of the following risk factors: BMI prior 
to pregnancy, with > 30 kg/m2; TG ≥ 1.7 mmol/L; HDL-cholesterol < 1.3 mmol/L;  
BP ≥ 130/85 mmHg, and fasting blood glucose ≥ 8.3 mmol/L. 
 
2.5.2 Interview and Physical Activity Questionnaire 
The interview questionnaire was adapted from a previously published epidemiological 
survey in Saudi Arabia that included questions about socio-economic details, past 
medical and treatment history, and sun exposure (Appendix III) (Al-Daghri et al., 
2011; Al-Musharaf et al., 2012; Al-Othman et al., 2012a; Aldesi, 2014). At the early 
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pregnancy visit, all socio-economic and clinical measurements were recorded, 
including the visit date, age of subject, place of birth, gestational age, maternal 
educational status, income, occupation, and area of residence. Clinical data included a 
family medical history, such as the existence of any chronic diseases, age of menarche, 
regularity of menstrual cycle, age at first pregnancy, date of LMP, and estimated date 
of delivery (EDD). Furthermore, as with previous studies (Wuertz et al., 2013; Choi et 
al., 2015; Ates et al., 2016; Bärebring et al., 2016; Lundqvist et al., 2016), the 
participants were asked about risk factors, such as parity (nulliparous or ≥ 1 
multiparous). In addition, they were questioned about previous miscarriage (yes/no), 
number of caesarean sections, and previous pre-eclampsia, along with a historical list 
of medication, namely any anti-hyperlipidaemia and cardiovascular drugs used. The 
season of the sampling was recorded at both visits. For an analysis of season, in relation 
to vitamin D status, the months of the year were divided into two periods: April to 
October was classified as summer, and November to March as winter (Al-Daghri et al., 
2012). The maximum UVB radiation in KSA occurs in July and the minimum values 
occur in December (Mahfoodh et al., 2003). 
 
At both visits, the participants were asked about pregnancy-related symptoms, such as 
nausea, vomiting, morning sickness, tender/swollen breasts, frequent urination, 
headaches, mood swings, abdominal bloating, constipation, acute respiratory or 
gastrointestinal viral or bacterial infections, any hospitalisation or medication 
prescribed, and the presence of any pregnancy-related complications. Furthermore, they 
were asked about sun exposure at both visits, including sun exposure (yes/no) and other 
sun exposure indices, such as exposure to the sun at work (indoor or outdoor work), 
timing of the exposure (noon alone, or with either sunrise or sunset vs. just sunset or 
sunrise), clothing (whole body coverage vs. some parts of the body exposed), and the 
use of sunscreen (yes/no) (Appendix III). Noon time was defined in this study from 10 
am to 2:00 pm. 
 
Physical activity was also assessed at both visits, with a well-known and validated 
questionnaire being applied, namely an Arabic short version of an International 
Physical Activity Questionnaire (IPAQ) (Mohd et al., 2016). The short IPAQ has been 
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validated in various studies, among different populations, including pregnant subjects 
(Craig et al., 2003; Harrison et al., 2011; Takahasi et al., 2013). IPAQ evaluates 
physical activity during periods of leisure, work, and while commuting. It also assesses 
the intensity of activity as: vigorous, moderate, low-intensity physical activity/walking, 
or sitting. Each subject was assisted in recalling her physical activities over the previous 
week. For each type of activity, frequency and duration were recorded in days per week, 
and minutes or hours per day, respectively. This study excluded moderate and high 
activity because few women carried out such activities during pregnancy. The present 
study analysed low-intensity physical activity and minutes spent sitting per week, 
similar to other studies using IPAQ in pregnancy (Sukumar et al., 2015). Low-intensity 
physical activity in minutes per week was applied as a continuous and categorical 
variable, at less than or over 210 minutes/week (Mudd et al., 2013). 
 
2.5.3 Dietary Data Collection and Processing 
The dietary tool applied for measuring the participants’ food intake was the FFQ 
(Appendix III), and has been used previously in Saudi Arabian studies (Al-Musharaf 
et al., 2012; Al-Othman et al., 2012a; Al-Othman et al, 2012b). The subjects were 
interviewed separately, and the data gathered by applying a pre-designed questionnaire 
to measure aspects of food consumption among the expectant mothers, over the course 
of one week. The main purpose of this was to assess calcium, vitamin D, fat, and protein 
intake, as well as any other nutrients that may affect the absorption or excretion of 
vitamin D and calcium. Responses to the dietary questionnaire were facilitated through 
food models, various sized cups and spoons, cans and approximate portions, using hand 
gestures to help the participants recall the amount of food consumed.  
 
The FFQ consisted of eight parts, pertaining to (1) bran, starch, and grains; (2) meat 
and fish; (3) fats and oils; (4) dairy products; (5) fruits and vegetables; (6) traditional 
dishes; (7) sweets and soft drinks; and (8) coffee and tea. Starches and grains mainly 
referred to any bran food that could have reduced calcium absorption (Weaver et al., 
1999; Murray et al., 2000). Fruits and vegetables included those high in calcium, and 
any that may reduce calcium absorption (Heaney et al., 1988). Dairy fats (whole fat, 
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low fat, skimmed milk, or other products), and fat added during cooking may also affect 
calcium absorption (Heaney et al., 1995). Finally, data on supplement intake (yes/no) 
were collected, including multivitamins, folic acid, iron, vitamin D, and cod liver oil.  
 
Nutrient intake was calculated using U.S. Department of Agriculture (USDA) software 
(27th edn, 2014), along with Nutribase software (11th edn, 2014), which utilises food 
macro- and micro-nutrient composition. For traditional Saudi food, an Arabic food 
analysis programme was used (1st version, 2007). The assessment of everyday food 
intake was conducted as total intake of macro- and micro-nutrients, especially vitamin 
D and calcium. Dietary nutrient values were compared with the Dietary reference intake 
(DRI) of micro-nutrients during pregnancy, such as vitamin D and calcium (IOM, 
2010). Additionally, vitamin D and calcium intake were presented continuously and 
categorically as above 600 IU/day and 1000 mg/day of vitamin D and calcium, 
respectively. 
 
2.6 Biochemical Assessment 
Blood samples (10 ml) were collected using sterile vacutainer blood collection 
apparatus. Whole blood, serum, and ethylene diamine tetra-acetic acid (EDTA) plasma 
were collected from the participants. All samples were aliquoted, and stored in a freezer 
at -80oC to facilitate their availability for subsequent chemical analysis. All the lab tests 
were performed on the serum, except haemoglobin A1c (HbA1c), which was performed 
on whole blood. Plasma was stored if needed for further analysis. The samples were 
stored and analysed in the BRP laboratory. 
 
At the early pregnancy visit, random blood samples were collected to measure total 
25(OH)D, serum glucose, insulin, HbA1c, lipid profile, calcium, phosphorus, albumin, 
creatinine, and alkaline phosphatase. At the mid-pregnancy visit, women were fasting 
and each participant underwent OGTT. 1-hour and 2-hour fasting blood samples were 
withdrawn to assess fasting glucose and insulin levels, 1- and 2-hour glucose, 2-hour 
insulin, homeostatic model assessment of insulin resistance (HOMA-IR) and beta cell 
function (HOMA-β). Higher HOMA-IR values indicated greater insulin resistance, 
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while lower HOMA-β values indicated greater beta-cell dysfunction, as validated 
against gold standards (Herzberg-Schafer et al., 2010; Imamura et al., 2013). The 
assessments of other biochemical parameters measured at the 1st visit were also 
repeated.  
 
2.6.1 Laboratory Techniques 
Total 25(OH)D and insulin were measured from the serum, using the Cobas e411 
system (Roche Diagnostics GmbA, Mannheim, Germany). Serum albumin, creatinine, 
calcium, phosphorous, lipids, and glucose were measured using a routine laboratory 
chemical analyser (Konelab, Finland). Meanwhile, HbA1c was evaluated using the 
DCA Vantage Analyzer (Siemens Healthcare, Germany), and bone-specific alkaline 
phosphatase (BAP) was measured using the LIAISON XL immunoassay (DiaSorin, 
Italy). 
 
2.6.2 Vitamin D 
Serum levels of total 25(OH)D were measured using the electrochemiluminescence 
binding assay (ECLIA). The repeatability and intermediate coefficients of variation 
(CV) for the 25(OH)D assay were 4.4% and 6.6%, respectively, with 100% cross-
reactivity to 25(OH) D3, and 92% cross-reactivity to 25(OH) D2. The measurement 
range between 7.50-175 nmol/L and any haemolysis samples were excluded. The BRP 
laboratory is a participating entity in the Vitamin D External Quality Assessment 
Scheme (DEQAS). Since no international consensus exists for vitamin D deficiency 
cut-off points during pregnancy, vitamin D was categorised according to 25(OH)D 
concentrations, as follows: < 25 nmol/L was considered to be a severe deficiency; 25-
49.9 nmol/L was considered to be a deficiency; 50-74.9 nmol/L was considered as 
insufficiency, and ≥ 75 nmol/L was considered as sufficiency (Ross et al., 2011; Flood-
Nichols et al., 2015).   
2.6.2.1 Test Principle  
The test principle used was a competitive protein binding assay test principle, with a 
total duration of 27 minutes. The vitamin D total assay employs vitamin D binding 
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protein to hold both 25(OH) D3 and D2. This assay is directed towards the continuous 
determination of total 25(OH)D in human serum and plasma, to assist with the 
measurement of vitamin D adequacy. Figure 2.3 describes the steps taken on the Cobas 
e411 platform, to measure vitamin D in the total assay, according to the manufacturer’s 
protocol (adapted from Roche Diagnostics, 2012). The results were identified from an 
instrument-specific calibration curve, generated by 2-point calibration and a calibration 
master curve, provided by the reagent barcode. 
 
 
Figure 2.3 Vitamin D total assay (Roche Cobas ® e411). The procedure was conducted 
as follows: first, the sample was incubated with a pre-treatment reagent for nine 
minutes. The natural vitamin D binding protein in the sample was thus denatured to 
release the bound vitamin 25(OH)D. Second, the sample was further incubated with 
recombinant ruthenium-labelled vitamin D binding protein, to form a complex of 
vitamin 25(OH)D and the ruthenylated-vitamin D binding protein. Third, with the 
addition of biotinylated vitamin 25(OH)D, a complex consisting of the ruthenium-
labelled vitamin D binding protein and biotinylated vitamin 25(OH)D was formed. The 
entire complex became bound to the solid phase (through the interaction of biotin and 
streptavidin-coated micro-particles, which were captured on the surface of the 
electrode). Unbound substances were removed. Voltage was applied to the electrode to 
induce chemiluminescent emission, measured with a photomultiplier. 
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2.6.3 Insulin, HOMA-IR and HOMA-β Measurements 
2.6.3.1 Insulin Determination 
Serum and free-insulin concentrations were measured using electrochemiluminescence 
(ECL) assay. The repeatability and intermediate CV for the insulin assay was 2.0% and 
2.6%, respectively, with a test measurement range of between 0.2 and 1000 µU/mL. 
2.6.3.2 Test Principle 
The test principle used, was a one-step sandwich assay test principle, with a total 
duration of 18 minutes. Figure 2.4 demonstrates the procedure for the insulin ECL 
assay. The results were identified through a calibration curve, which was instrument- 
specifically created using a 2-point calibration and master curve, delivered via the 
reagent barcode.  
 
Figure 2.4 Insulin ECL assay test principle (adapted from Roche Diagnostics, 2011). 
The procedure is described in the steps shown in the above Figure. 
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2.6.3.3 HOMA-IR and HOMA-β  
The homoeostasis model of insulin resistance and β-cell function was calculated using 
HOMA-IR and HOMA-β Matthews equations, respectively (Matthews et al., 1985; 
Wallace et al., 2004). This was calculated as follows: 
HOMA-IR = (Fasting insulin µU/mL × Fasting glucose mmol/L)/22.5 
HOMA-β = (20 × Fasting insulin µU/mL)/ (Fasting glucose mmol/L-3.5) 
 
2.6.4 HbA1c 
To measure the level of HbA1c in whole blood, a DCA Vantage Analyzer point-of-care 
(POC) device was used, and was based on the latex immune agglutination method. 
Blood glucose adheres to haemoglobin in red blood cells, to create glycosylated 
haemoglobin, called haemoglobin A1c or HbA1c. HbA1c provides a long-term 
measurement of blood glucose levels in diabetic patients, indicating blood glucose 
control over the preceding three-month period. A drop of blood from the sample was 
applied to a sample cartridge, which was then analysed over a period of five minutes in 
a desktop analyser, to measure the percentage of HbA1c. In addition, latex agglutination 
was inhibited, which is a synthetic polymer containing multiple copies of the 
immunoreactive portion of haemoglobin A1c. The latter causes the agglutination of 
latex, coated with haemoglobin A1c-specific murine monoclonal antibody. This then 
leads to increased light-scattering, measured as a rise in absorption at 531 nm. 
Haemoglobin A1c in whole blood samples compete for binding sites, which are limited 
in number, due to the inhibition of agglutination and decreased light-scattering, 
measured as a decrease in absorption at 531 nm.  
 
2.6.5 Serum Glucose, Lipid, Calcium, Creatinine, Albumin, and 
Phosphorous Assays 
Serum glucose, lipid profile (HDL-cholesterol, total cholesterol, and triglyceride), 
calcium, creatinine, albumin, and phosphorous were measured in a routine laboratory 
analysis (Konelab, Finland). Calibration of the biochemical analyser, for all serum 
samples, was regularly performed prior to the analysis using quality control samples, 
provided by the manufacturers (ThermoFisher Scientific, Espoo, Finland). 
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To assess blood levels of glucose concentration in human serum, the Konelab method 
was used. This employs glucose oxidase and a modified Trinder colour reaction, 
catalysed by the enzyme, peroxidase. Glucose was oxidised to D-gluconate through 
glucose oxidase, with the formation of an equimolar amount of hydrogen peroxide. In 
the presence of peroxidase, 4-aminoantipyrine and phenol were oxidatively coupled by 
hydrogen peroxide to form a quinonimine dye that was red in colour. The intensity of 
the colour in the reaction was measured at 510 nm, and this was proportionate to the 
glucose concentration in the sample. 
 
In addition, triglycerides were hydrolysed by the lipoprotein lipase to glycerol and fatty-
acids. The glycerol was phosphorylated to glycerol-3-phosphate by glycerol kinase, 
which was then oxidised to dihydroxyacetone phosphate and hydrogen peroxide, 
mediated by glycerol-3-phosphateoxide. The hydrogen peroxide reacted with 4-
aminoantipyrine and 4-chlorophenol to form a quinoneimine dye, mediated by 
phosphate oxide. The absorption of the colour formed, was measured at 510 nm and the 
results were automatically calculated using the Konelab Analyser in a calibration curve. 
A triglyceride level ≥ 1.7 mmol/L was considered abnormal (Grundy et al., 2005).  
 
Cholesterol esters were enzymatically hydrolysed by cholesterol esterase to cholesterol 
and free fatty acids. Free cholesterol, including whatever was originally present, was 
then oxidised by cholesterol oxidase to cholest-4-en-3-one and hydrogen peroxide. 
Mediated by peroxidase, the hydrogen peroxide combined with hydroxybenzoic acid 
and 4-aminoantipyrine to form a chromophore (quinoneimine dye), which could be 
quantitated at 500-550 nm (Allain et al., 1974).  
 
The HDL-cholesterol assay was finally undertaken as a homogeneous enzymatic 
colorimetric test in the presence of magnesium sulphate, dextran sulphate, which 
selectively forms water-soluble complexes with LDL, very low-density lipoprotein 
(VLDL), and chylomicrons, which are resistant to polyethylene glycol (PEG)-modified 
enzymes. The cholesterol concentration of HDL-cholesterol was enzymatically 
determined by cholesterol oxidase, coupled with PEG to the amino groups 
(approximately 40%). The results were automatically calculated by the Konelab 
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Analyser, using a calibration curve. Low HDL-cholesterol was subsequently defined as 
< 1.03 mmol/L (Grundy et al., 2005; Lv et al., 2016), and the abnormal total cholesterol-
HDL ratio was defined as > 3.5 (Kannel, 1983). LDL-cholesterol and the total 
cholesterol-to-HDL ratio were calculated using the following equations (Friedewald et 
al., 1972): 
LDL = Total Cholesterol – HDL – (0.16*Triglyceride) 
Total Cholesterol/HDL Ratio = Total Cholesterol/HDL Cholesterol 
 
The albumin assay test principle was based on an albumin reaction with a specific dye, 
bromocresol purple, to form a coloured product. This test was grounded on the 
measurement of the colour intensity developed at 600 nm (Pinnell & Northam, 1978; 
Parviainen et al., 1985). Conversely, A serum calcium assay test principle was applied 
using electrolyte measurements in Konelab Analysers, carried out directly with ion-
selective electrodes, and without any dilution of the sample. Corrected calcium 
concentration (mmol/L) was calculated from the following formula (Kanis & Yates, 
1985): 
Corrected calcium in mmol/L= (Calcium in mmol/L/0.25) + 0.8 x (4-Albumin in gm/L /10) x 0.25 
 
The principle of the phosphorus assay is based on the fact that phosphate forms in the 
acidic medium of a yellow-coloured complex with ammonium molybdate. The 
intensity of this colour was proportionate to the concentration of inorganic phosphate 
in the sample and was measured at 340 nm (Daly & Ertingshausen, 1972). 
 
Meanwhile, the creatinine assay test principle was converted to sarcosine, with the aid 
of creatininase and creatinase. Sarcosine was then converted to glycine, formaldehyde, 
and hydrogen peroxide in the presence of oxygen, using sarcosine oxidase. The 
liberated hydrogen peroxide reacted with 4-aminophenazone and 2, 4, 6-triiodo-3-
hydroxybenzoic acid to form a quinoneimine chromogen in a reaction catalysed by 
peroxidase. The colour intensity was directly proportionate to the concentration of 
creatinine present, and could be measured photometrically at 540 nm. 
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2.6.6 The Bone-Specific Alkaline Phosphatase Assay (BAP) 
Bone-specific alkaline phosphatase was measured using the LIAISON XL (DiaSorin, 
Italy) immunoassay, which is a direct two-site sandwich assay, utilising two affinity-
purified mouse monoclonal antibodies for the capture and detection of alkaline 
phosphatase.  
Figure 2.5 Summary of data collection at both visits. Data collected in the study 
included an interview questionnaire, anthropometric measurements and biochemical 
parameter. 
 
2.7 Data Analysis 
Data were analysed using SPSS version 21.0 statistical software (SPSS, Chicago, IL, 
USA). The normality of all quantitative variables was tested before performing the 
analysis, using Shapiro-Wilk Test. Quantitative normally distributed variables were 
  
 
 
 
 
 
 
 
 
 
 
First visit: Non-fasting 
Second visit: Subjects fasting >10 hours 
Interview Questionnaire Anthropometric Data Biochemical Data 
 Socio-demographic data 
 Medical history 
 Dietary-FFQ  
 Supplement intake  
 Sun exposure 
 Physical activity - IPAQ 
 
 Current Weight (kg)            
 Height (cm) (for BMI) 
 Pre-pregnancy weight (kg)  
 Gestational weight gain (GWG) (kg) 
 Waist (cm)          
 Hip (cm) (for WHR) 
 Mid-arm circumference (cm) 
 Skinfold thickness (Fat %) 
 BP (mmHg). 
First visit 
Lipid profile, glucose, insulin, 
HbA1c, 25(OH)D, calcium, albumin, 
creatinine, phosphorus, alkaline 
phosphatase.   
 
Second visit 
Lipid profile, fasting glucose, 
glucose tolerance test, fasting 
insulin, 2-hour insulin, HOMA-IR, 
HOMA-β, HbA1c, 25(OH)D, calcium, 
albumin, creatinine, phosphorus, 
alkaline phosphatase. 
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reported using mean and standard deviations, while quantitative non-normally 
distributed variables were reported using medians (1st and 3rd quartiles). Frequencies 
and percentages were applied in the reporting of categorical variables. For subsequent 
meaningful statistical analysis, 25(OH)D was categorised using the common clinical  
cut-off of deficient (25(OH)D < 50 nmol/L) and adequate (25(OH)D ≥ 50 nmol/L) 
levels, based on the recommendations of the Endocrine Society (Farrant et al., 2008; 
Dawson-Hughes et al., 2010; Holick et al., 2011; Cho et al., 2013; Parildar et al., 2013; 
Wuertz et al., 2013). Pearson’s chi-square test was used to determine the association 
between categorical variables, while group differences were distinguished via an 
independent sample t-test and Mann-Whitney U test. These tests were conducted for 
normally and non-normally distributed variables, respectively. Adjustment for age and 
BMI as covariates between the groups was carried out through analysis of covariance 
(ANCOVA). 
 
The Wilcoxon Signed Rank Test was used to compare median vitamin D levels from 
early to mid-pregnancy, and adjustments were made for mid-pregnancy gestational age, 
multivitamin intake, physical activity, estimated vitamin D intake, sun exposure, and 
season, using repeated measures ANCOVA. The difference across two visits was 
evaluated using a paired sample t-test and Wilcoxon signed rank test for normally and 
non-normally distributed variables, respectively. Analysis of variance (ANOVA) was 
then undertaken to compare normally distributed variables, categorised into more than 
two groups. For non-normally distributed data, an independent sample Kruskal Wallis 
Test was applied. 
 
Finally, the Pearson’s and Spearman’s rank correlation coefficients were determined to 
assess the linear relationship between quantitative variables for normally and non-
normally distributed variables, respectively. Logistical regression was used to identify 
the risk factors associated with categorical outcome variables. A p-value of < 0.05 and 
95% CI was finally applied to report statistical significance and the precision of the 
estimates.
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Prevalence of Vitamin D Deficiency in Early 
Pregnancy and its Predictors
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3.1 Introduction 
The main sources of vitamin D are either endogenous production or from the diet.  The 
ubiquitous distribution of vitamin D receptors on a wide range of tissues, indicates  
multi-faceted and crucial role of this vitamin (John et al., 2007). 25(OH)D deficiency 
appears to be a global health hazard with approximately on billion sufferers all over 
the world Holick and Chen (2008). Hypovitaminosis D has been implicated in a wide 
variety of conditions such as osteoporosis, rickets, cardiovascular diseases, 
autoimmune diseases, cancer, type 2 diabetes mellitus, and  adverse maternal and 
foetal outcomes  (Aghajafari et al., 2013). 
 
Between 80-100% of Saudi women during their reproductive phase of life have 
suboptimal levels of vitamin D (Al-Mogbel, 2012; Hussain et al., 2014; Fouda et al., 
2016). Higher prevalence of vitamin D deficiency among Saudi women appears to a 
predisposition for further deterioration of vitamin D status particularly among pregnant 
females because of  the increased nutritional demands of growing foetus (Urrutia & 
Thorp, 2012). This is evident from the fact that  in Saudi Arabia, Kuwait, the UAE, 
and Iran, 10-80% of mothers and 40-80% of their neonates at the time of delivery have 
have been shown to have suboptimal serum levels of 25(OH)D (Molla et al., 2005; 
Ainy et al., 2006; Kazemi et al., 2009; Aly et al., 2013). Nevertheless, the rate of 
hypovitaminosis D varies, depending on the location, ethnicity, assay used for 
assessment, and definition of deficiency itself (Figure 3.1 shows the prevalence of 
vitamin D deficiency worldwide). 
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Figure 3.1 Prevalence of hypovitaminosis D in pregnant or lactating women, 
worldwide (adapted from Palacios & Gonzalez, 2014). 
 
 
Aetiology of hypovitaminosis D during pregnancy is multi-factorial. Factors and  
limited exposure to the sunlight, less vitamin D and calcium intake, ethnicity, age, 
socio-economic status, cigarette smoking, alcohol intake, repeated pregnancies, 
obesity, fat malabsorption syndrome, medication, increased vitamin D catabolism, and 
chronic liver or kidney disorders have been implicated in hypovitaminosis D (Holick 
& Chen, 2008; Andersen et al., 2013; Flood-Nichols et al., 2015; Karras et al., 2016). 
Additionally, genetic polymorphisms and gene mutations, such as the CYP2R1 
mutation, may aggravate vitamin D deficiency (Touvier et al., 2015; Thacher & 
Levine, 2016). Furthermore, an increase in nutritional demands during pregnancy is a 
major factor contributing to vitamin D deficiency, so pregnancy itself can be a 
potential risk factor (Garabedian & Ben–Mekhbi, 1999; Holmes et al., 2009; Choi et 
al., 2015). 
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Vitamin D deficiency during pregnancy has been investigated in a limited number of 
studies on a relatively smaller number of participants in the Gulf states (Molla et al., 
2005; Al Kalbani et al., 2011; Al-Faris, 2016).  
 
To date, almost all the studies assessing vitamin D deficiency during pregnancy in the 
Gulf states have been performed on a relatively small number of participants (Molla 
et al., 2005; Al Kalbani et al., 2011; Al-Faris, 2016). Moreover, the vast majority of 
these studies assessed 25(OH)D status in the latter stages of pregnancy, but failed to 
investigate lifestyle factors. However, an assessment of suboptimal vitamin D levels 
in the initial stages of pregnancy offers an opportunity for early detection, which may 
be critical for avoiding adverse maternal and foetal complications. The aim of the 
present study is, therefore, to assess the prevalence of vitamin D deficiency during 
early pregnancy, and to identify factors predisposing pregnant women to such 
deficiency. 
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3.2 Research Design and Methods 
3.2.1 Study Population 
A total of 578 Saudi women, with a mean age of 28.8 ± 5.4 years (range 18-39 years), 
were recruited in their first trimester (8-12 weeks). Inclusion and exclusion criteria 
were given in Chapter 2. 
 
3.2.2 Assessment of Circulating 25(OH)D and Biochemical Parameters 
Venous whole blood was collected from the cubital fossa of non-fasting participants 
(10 mL), to assess levels of 25(OH)D, calcium, phosphorus, creatinine, and alkaline 
phosphatase, along with blood glucose, insulin, and the lipid profile. Random serum 
glucose, calcium, creatinine, albumin, phosphorus, and lipid profiles (HDL-
cholesterol, total cholesterol and triglyceride) were measured using routine laboratory 
analysis (Konelab, Finland). Alkaline phosphatase was measured using the LIAISON 
XL immunoassay (DiaSorin, Italy), while HbA1c was measured using the DCA 
Vantage analyzer (Siemens Healthcare, Germany). Total 25(OH)D and serum insulin 
were measured in an ECLIA and ECL assay, respectively (Cobas e 411; Roche 
Diagnostics GmbA, Mannheim, Germany). The cut-off points used were described in 
Chapter 2. 
 
3.2.3 Determinants of Circulating 25(OH)D Levels 
Anthropometrics were collected as described in Chapter 2. Using a FFQ (Appendix 
III), quantitative aspects of food consumption over a period of seven days were 
recorded to assess calcium, vitamin D, and protein intake, along with any other nutrients 
that would possibly affect the absorption or excretion of vitamin D (Al-Musharaf et al., 
2012; Al-Othman et al., 2012b). Nutrient intake was calculated using specialised 
programs as shown in Chapter 2. The pregnant subjects were then questioned about 
their dietary intake of multivitamins (yes/no). Moreover, physical activity was assessed 
by a short version of the Arabic IPAQ (Hernandez-Cordero et al., 2008; Bertolotto et 
al., 2010; Harizopoulou et al., 2010; Ebrahimi et al., 2015). Low-intensity physical 
activity/walking and sedentary time were determined using the guidelines for data 
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processing and IPAQ analysis (IPAQ Research Committee, 2005). Low-intensity 
physical activity in minutes per week was then presented as a continuous and 
categorical variable of equal or greater than, 210 minutes/week (Mudd et al., 2013). 
 
3.2.4 Data Analysis 
The sample size was estimated for adequate statistical power. It was determined 246 
pregnant women were required, assuming a prevalence of 80% vitamin D deficiency 
(Azhar, 2009), at a 5% level of significance and with ± 5% level of precision (width 
of 95% confidence interval). However, the study enrolled 578 pregnant women to 
account for possible attrition.  
 
For subsequent meaningful statistical analysis, vitamin D levels were categorised into 
deficient (< 50 nmol/L) and non-deficient groups (≥ 50 nmol/L) (Farrant et al., 2008; 
Dawson-Hughes et al., 2010; Holick et al., 2011; Cho et al., 2013; Parildar et al., 2013; 
Wuertz et al., 2013). Pearson’s chi-square test was applied to determine the association 
between the categorical variables (deficient vs. non-deficient). Comparisons between 
groups were then made through an independent sample t-test and the Mann-Whitney 
U test for normally and non-normally distributed variables, respectively. Adjustment 
for age and BMI as covariates between the groups were done using ANCOVA. 
Pearson’s and Spearman’s rank correlation coefficients were also determined to assess 
the linear relationship between quantitative variables for normally and non-normally  
distributed variables, respectively. Moreover, logistic regression enabled the outcome 
variables for risk factors associated with vitamin D deficiency to be identified. Two 
models were applied to adjust for possible confounders: Model 1 - Age, BMI, and sun 
exposure, and Model 2 - Model 1 + parity, season, vitamin D intake, multi-vitamin 
intake, physical activity, education, employment, living in North Riyadh, and extent 
of skin coverage with clothing. All three ORs were reported (unadjusted, adjusted for 
Model 1 and Model 2), and a p-value of < 0.05 was considered statistically significant.  
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3.3 Results 
3.3.1 General Characteristics of Subjects During Early Pregnancy 
3.3.1.1 Socio-economic Status 
As mentioned in Chapter 2, of the 773 pregnant women originally recruited, 578 
attended the first visit of their gestation. The mean maternal age was 28.8 ± 5.4 (range 
18-39) years old. Of the total women in the study, 320 (57.3%) were university 
graduates or post-graduates, 183 (32.7%) were employed, and 62 (12%) earned an 
income >10,000 Saudi Riyals (Figure 3.2). The majority (28.4%) of these women 
lived in West Riyadh, with comparable percentages noted in the South (21.9%), East 
(20.5%) and North (19%) of the city (Figure 3.3 D). Educational status, monthly 
income, profession, and area of residence in Riyadh is presented for the participants in 
general (Figure 3.3 A-D).  
 
 
 
Figure 3.2 Educational Status, monthly income and employment amongst the general 
participants. In the above figure, values are shown in percentages. 
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Figure 3.3 (A) Education, (B) Monthly income, (C) Profession of the participants, and 
(D) Area of residence. In the above figure, values are shown in percentages.  
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3.3.1.2 Obstetric Data and Family History 
Of the total women, 195 had a nulliparous pregnancy (37.3%), whereas 362 (62.7%) 
were multiparous, 129 (30.5%) had previously had a caesarean section, and 120 
(29.6%) had experienced miscarriage. Thirty eight (8.8%) had experienced gestational 
diabetes and 164 (38.2%) had a family history of GDM, while 347 (72.6%) had a 
family history of diabetes (Figure 3.4 presents obstetric data on the women, as well as 
their family history). 
 
 
 
Figure 3.4 Obstetric and family history for the overall sample. Data presented as 
frequencies and percentages. Multiparity was defined ≥ 1 births. All other variable are 
categorical and presented as ‘yes/no ’. 
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3.3.1.3 Anthropometric and Biochemical Characteristics 
The anthropometric and biochemical characteristics of the study population are shown 
in Table 3.1. The mean pre-pregnancy BMI, and BMI in early pregnancy were 27.0 ± 
6.0 and 28.0 ± 6.3 kg/m2, respectively. In early pregnancy, 183 (31.9%) of the pregnant 
women were overweight, and 195 (34%) were obese. Additionally, pre-pregnancy 
BMI was strongly correlated with BMI during early pregnancy (Figure 3.5 A). In 
addition, BMI in early pregnancy was moderately correlated with percentage body fat 
(Figure 3.5 B). Pregnant women with high blood pressure numbered 23 (4.3%), and 
279 (48.3%) in the cohort had low HDL-cholesterol < 1.03 mmol/L (Figure 3.6). 
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Table 3.1 Anthropometric and biochemical characteristics during early 
pregnancy 
Anthropometric Parameters Total N = 578 
Age (Years) 28.8 ± 5.4 
Gestational age (weeks) 12.0 ± 3.0 
Pre-pregnancy BMI (kg/m2) 27.0 ± 6.0 
BMI at 1st visit (kg/m2) 28.0 ± 6.3 
Waist circumference (cm) 91.5 ± 13.6 
Hip circumference (cm) 107.9 ± 12.0 
Waist-hip ratio 0.8 ± 0.1 
Systolic BP (mmHg) 113.9 ± 12.7 
Diastolic BP (mmHg) 67.9 ± 9.6 
Body fat (%) 34.3 ± 5.6 
Biochemical Parameters  
Vitamin D (nmol/l) # 28.7 (19.7 - 43.8) 
Corrected calcium (mmol/l) 2.2 ± 0.2 
Phosphorus (mmol/l) 1.2 ± 0.4 
Alkaline phosphatase (mmol/l) 9.7 ± 3.3 
Creatinine (µmol/l) 55.8 ± 18.2 
Glucose (mmol/l) # 4.8 (4.4 - 5.3) 
Insulin (uU/mL) # 8.5 (4.8 - 18.4) 
HbA1c (%) 5.1 ± 0.5 
Total cholesterol (mmol/l) 5.2 ± 1.0 
HDL-cholesterol (mmol/l) 1.3 ± 0.3 
Total cholesterol/HDL Ratio 4.0 ± 1.0 
LDL-Cholesterol (mmol/l) 3.2 ± 0.8 
Triglycerides (mmol/l) 1.4 ± 0.6 
Note: Data presented as mean and standard deviation for normal variables, the median, first and third 
quartiles are presented for non-normally distributed variables. # Indicates non-normally distributed variables. 
The Assumption of Normality was tested using the Shapiro-Wilk Test. 
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Figure 3.5 Correlation of BMI during early pregnancy with (A) Pre-pregnancy BMI, 
and (B) Percentage body fat during early pregnancy; ‘r’ represents Pearson’s correlation 
coefficient. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Presence of metabolic disorders during early pregnancy. The values show 
the percentage of women with different metabolic disorders in early pregnancy. 
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3.3.1.4 Lifestyle Factors 
The percentage of blood samples collected from the pregnant women during the 
summer amounted to 39.4%, with 60.6% being collected in winter. Exposure to the sun 
was reported by 154 (26.6%) of the women (yes/no), while 165 (28.5%) were exposed 
to the sun noon time alone, plus either sunset or sunrise, or both. The number of women 
whose work took place exclusively indoors totalled 91.9% (n = 531). Regarding their 
clothing, 186 (32.2%) reported that their entire body was covered and only 6.2% of the 
participants used sunscreen lotion for protection (Figure 3.7 displays general 
percentages of sun exposure indices in early pregnancy). 
 
 
 
 
Figure 3.7 Sun exposure indices in early pregnancy. The values are presented in 
percentages.  
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Estimated vitamin D and calcium intake amongst the women during early pregnancy 
was 89.9 IU/day (63.5-169.0) and 117.7 mg/day (60.2-370.3), respectively 
(Figure 3.8). These data indicate that in 2.6% of the cases, vitamin D intake was above 
the DRI, and in 4.5% of the cases, calcium intake was also above the DRI. A quarter 
(25%) of the women reported the use of multivitamin supplements in early pregnancy. 
Also used here was the IPAQ median for sedentary activity of 1,200 minutes/week 
(600-1800), with low intensity physical activity/walking for 210 minutes/week (70-
600) (Figure 3.9). 
 
 
Figure 3.8 Estimated vitamin D and calcium intake in early pregnancy. The values 
show the median intake of vitamin D and calcium from food. 
 
 
 
Figure 3.9 Physical activity (PA) in early pregnancy. The values show the median 
sedentary and physical activity in minutes per week. 
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3.3.2 Vitamin D Deficiency in Early Pregnancy 
The median (interquartile range) 25(OH)D concentration in the pregnant women 
studied here was 28.7 nmol/L (19.7 - 43.8), which was considered to be deficient. A 
total of 41.7% (241/578) of participants were severely vitamin D deficient (< 25 
nmol/L), while 39.3% (227/578) were deficient (25-49.9 nmol/L); 13.7% (79/578), 
insufficient (50-74.9 nmol/L), and 5.4% (31/578) presented with sufficient vitamin D 
levels (≥ 75 nmol/L) (Figure 3.10). Therefore, only a relatively small number of the 
women (n = 31) achieved sufficient vitamin D levels. The population sample was 
subsequently categorised into either deficient (< 50 nmol/L) or non-deficient (≥ 50 
nmol/L) groups for meaningful statistical analysis (Farrant et al., 2008; Dawson-
Hughes et al., 2010; Holick et al., 2011; Cho et al., 2013; Parildar et al., 2013; Wuertz 
et al., 2013). The proportion of vitamin D deficiency  (< 50 nmol/L) in early pregnancy 
amounted to 81% (468/578). 
 
 
Figure 3.10 Vitamin D status in early pregnancy 
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3.3.2.1 Socio-economic Status in Relation to Vitamin D Status 
Proportionally more women were non-deficient in vitamin D if educated to graduate or 
postgraduate level, compared to the deficient group (71.3% vs. 54%, p < 0.001). 
Similarly, the pregnant women who were non-deficient in vitamin D were more likely 
to be employed than those in the deficient group (43.5% vs. 30.2%, p = 0.008). 
Moreover, a significantly higher percentage of pregnant women who were non-
deficient in vitamin D lived in North Riyadh (30.6%), compared to 16.2% in the 
deficient group (p = 0.001), while around 18.4% of the pregnant women who were non-
deficient in vitamin D lived in West Riyadh, compared to 30.8%  from the deficient 
group (p = 0.014). However, no differences were observed in income between the 
groups. Furthermore, the pregnant women living in North Riyadh were significantly 
more educated, at least to graduate level (p = 0.001), in comparison with their 
counterparts living in West Riyadh (p = 0.002) (Figure 3.11 compares data on 
education, and area of residence for the deficient and non-deficient groups of pregnant 
women). 
 
3.3.2.2 Obstetric and Family History in Relation to Vitamin D Status 
Obstetric parameters, such as parity, incidence of caesarean section, and miscarriage, 
as well as family history of diabetes and obesity, failed to reveal any differences 
between the groups. However, the rate of nulliparous pregnancy was higher in the non-
deficient group compared with the deficient group, although this was not statistically 
significant (45.9% vs. 35.3%, p = 0.127).  
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Figure 3.11 (A) Educational status and employment, and (B) Area of residence 
according to vitamin D status in early pregnancy. The values show the percentage of 
university graduates and postgraduates, employed women, and women living in 
different areas of Riyadh, amongst the vitamin D-deficient and non-deficient subjects. 
P-values: * denotes p < 0.05, ** denotes p < 0.01 and *** denotes p < 0.001, using a 
Pearson’s chi-square test. 
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3.3.2.3 Anthropometric and Biochemical Characteristics Against Vitamin D Status 
The anthropometric and biochemical characteristics of the deficient and non-deficient 
groups of pregnant women investigated here are shown in Table 3.2. Age (in years) 
did not show a significant difference between the deficient and non-deficient groups 
(p = 0.192). However, gestational age (in weeks) was significantly higher in the 
deficient group, compared to the non-deficient group, even after adjustment for BMI 
and age (p = 0.043). Pre-pregnancy BMI, BMI in early pregnancy, WHR, and blood 
pressure also failed to reveal any differences between the two groups, although body 
fat percentage was significantly higher in the non-deficient group, even after adjusting 
for age and BMI (35.4 ± 5.1 vs. 34.1 ± 5.6, p = 0.042). In addition, maternal vitamin 
D levels showed a significant positive correlation with body fat percentage (r = 0.13, 
p = 0.003). 
 
The biochemical profile of the pregnant women showed a vitamin D level of 64.5 
nmol/L (57.0-76.6) in the non-deficient group, compared with 24.4 nmol/L (18.0 – 
33.76) in the deficient group. HDL-cholesterol was significantly lower in the deficient 
group (p = 0.026), after adjusting for age and BMI. Furthermore, the total 
cholesterol/HDL ratio was significantly higher in the deficient group (p < 0.001). 
Maternal vitamin D levels, therefore, showed a significant positive correlation with 
HDL-cholesterol (r = 0.19, p < 0.001), whereas a significant negative correlation was 
observed in the vitamin D and total cholesterol/HDL ratio, random glucose, and 
HbA1c (r = -0.15, p < 0.001; r = - 0.11, p = 0.008 ; r = -0.13,  p= 0.001) (Figure 3.12). 
 
 
 
 
 
 
 
 
71 
 
Table 3.2 Anthropometrics and biochemical characteristics per vitamin D status 
in early pregnancy 
 Non-Deficient 
(N=110) 
Deficient 
(N = 468) 
P-value P-value* 
Anthropometric 
Parameters 
    
Age (Years) 29.4 ± 5.2 28.6 ± 5.5 0.192 --- 
Gestational age (weeks) 11.5 ± 2.9 12.1 ± 3.0 0.066 0.043 
Pre-pregnancy BMI (kg/m2)  27.1 ± 6.2 27.0 ± 5.9 0.944 0.065 
BMI at 1st visit (kg/m2) 28.3 ± 6.3 28.0 ± 6.3 0.575 --- 
Waist circumference (cm) 93.1 ± 12.4 91.1 ± 13.8 0.178 0.102 
Hips circumference (cm) 108.8 ± 11.6 107.7 ± 12.1 0.371 0.389 
Waist-hip Ratio 0.9 ± 0.1 0.8 ± 0.1 0.336 0.247 
Systolic BP (mm Hg) 114.3 ± 13.3 113.8 ± 12.6 0.703 0.801 
Diastolic BP (mm Hg) 67.1 ± 9.8 68.0 ± 9.6 0.376 0.248 
Body fat (%) 35.4 ± 5.1 34.1 ± 5.6 0.03 0.042 
Biochemical Parameters     
Vitamin D (nmol/l) # 64.5 (57.0 – 76.6) 
24.4  
(18.0 – 33.76) 
< 0.001 <0.001 
Corrected calcium (mmol/l) 2.3 ± 0.2 2.2 ± 0.2 0.442 0.508 
Phosphorus (mmol/l) 1.2 ± 0.5 1.1 ± 0.4 0.127 0.053 
Alkaline Phosphatase (mmol/l) 9.3 ± 2.9 9.7 ± 3.4 0.266 0.168 
Creatinine (µmol/l) 55.4 ± 17.9 55.9 ± 18.3 0.806 0.914 
Glucose (mmol/l) # 4.7  (4.4 - 5.2) 4.8 (4.4 - 5.3) 0.627 0.708 
Insulin (uU/mL) # 7.9 (4.6 - 17.7) 8.7 (4.9 - 18.4) 0.427 0.446 
HbA1c (%) 5.1 ± 0.5 5.1 ± 0.5 0.490 0.380 
Total cholesterol (mmol/l) 5.2 ± 0.8 5.2 ± 1.0 0.748 0.911 
HDL-cholesterol (mmol/l) 1.4 ± 0.3 1.3 ± 0.4 0.035 0.026 
Cholesterol-HDL Ratio 3.8 ± 0.7 4.1 ± 1.1 < 0.001 0.001 
LDL-cholesterol (mmol/l) 3.1 ± 0.6 3.2 ± 0.8 0.681 0.622 
Triglycerides (mmol/l) 1.4 ± 0.6 1.4 ± 0.6 0.941 0.728 
Note: Data presented as a mean and standard deviation for normal variables, while median, first and third quartiles 
are presented for non-normally distributed variables. # indicates non-normally distributed variables; the p-value for 
mean differences was obtained from an independent sample t-test for normal variables, and a Mann-Whitney U test 
for non-normally distributed variables, while * indicates p-values adjusted for age and BMI on the 1st visit through 
an ANCOVA. 
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Calcium and phosphorus appeared higher in the non-deficient compared with the 
deficient group after adjustments, although this difference was not significant (p = 
0.054 and p = 0.053, respectively). Alkaline phosphatase levels were higher in the 
deficient than in the non-deficient group, but again was not significant (p = 0.168). 
Maternal vitamin D levels showed a significant positive correlation with calcium, 
phosphorus, and creatinine (r = 0.09, p = 0.036; r = 0.10, p = 0.026; r = 0.10, p = 0.025), 
respectively. The presence of metabolic disorders according to vitamin D status is 
displayed in Figure 3.13. 
 
 
 
Figure 3.12 Baseline correlations between Log vitamin D (nmol/L) versus (A) glucose, 
(B) HbA1c, and (C) calcium in early pregnancy. 
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Figure 3.13 Presence of metabolic disorders according to vitamin D status. P-values:  
* denotes p < 0.05. The values show the percentage of women with different metabolic 
disorders in early pregnancy, in both vitamin D deficient women and women without 
deficiency. P-values: * denotes p < 0.05 according to Pearson’s chi-square test. 
 
3.3.2.4 Lifestyle Factors in Relation to Vitamin D Status 
Exposure to the sun at noon alone, and exposure at noon and sunset or sunrise, was 
significantly higher amongst the non-deficient subjects, in comparison with their 
deficient counterparts (64.5% vs. 20.1%, p < 0.001). Similarly, the number of women 
undertaking most of their work indoors was higher amongst the deficient participants, 
compared to the non-deficient subjects (97.6% vs. 67.3%, p < 0.001). Moreover, the 
number of subjects covering their whole body with clothing was significantly higher in 
the deficient group, compared to the non-deficient participants (38.9% vs. 3.6%, p < 
0.001). The percentage of participants who exposed themselves to the sun (32.7%) was 
higher in the non-deficient group, compared to the deficient group (25.2%), although 
this difference was not statistically significant (p = 0.109). In addition, 10% of the non-
deficient group used sunscreen, compared to 5.3% in the deficient group, but this was 
not statistically significant (p = 0.069). The season in which the sun exposure took place 
(summer/winter) did not demonstrate any differences between the groups. The samples 
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collected in summer amounted to 38.9% in the deficient group, compared to 41.5% in 
the non-deficient group, whereas in winter, 61.6% of the samples were collected for the 
deficient participants, compared to 58.5% for the non-deficient group (p = 0.623). 
 
 
 
Figure 3.14 Sun exposure during early pregnancy in relation to vitamin D status during 
this period. The values show the percentage of women with different sun exposure 
indices, in both vitamin D-deficient and non-deficient women. Noon time indicates the 
time between 10 am -2 pm. P-values: *** refers to p < 0.001 from Pearson’s chi-square 
test. 
 
The current study observed that the vitamin D and calcium intake, estimated in early 
pregnancy, did not reveal any statistically significant differences between the deficient 
and non-deficient groups (Figure 3.15). This was also true for multivitamin intake 
reported in early pregnancy (non-deficient at 28.6% vs. deficient at 24.1%). 
Interestingly, the median number of minutes for women engaged in low-intensity 
physical activity/walking (minutes/week) was significantly higher in the non-deficient 
than in the deficient group, even after adjusting for age and BMI (600 vs. 180 
minutes/week, p < 0.001). In fact, maternal vitamin D levels indicated a significant 
positive correlation with low intensity physical activity (minutes/week: r = 0.32, p < 
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0.001). However, the median sedentary time spent (minutes/week) showed no 
differences between the deficient and non-deficient groups (1200 vs. 900 
minutes/week, p = 0.669) (Figure 3.15). 
 
 
Figure 3.15 Estimated vitamin D and calcium intake, according to vitamin D status in 
early pregnancy. The values show the median intake of vitamin D and calcium from 
food, in both vitamin D-deficient and non-deficient women. The test used was the 
Mann-Whitney U test. 
 
 
Figure 3.16 Physical activity in relation to vitamin D status during early pregnancy. 
The values show median sedentary and physical activity in minutes per week for both 
the vitamin D-deficient and non-deficient groups using the Mann-Whitney U test. P-
values: *** denotes p < 0.001 after adjusting for age and BMI, with ANCOVA. 
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3.3.3 Predictors of Vitamin D Deficiency in Early Pregnancy 
Significant independent variables for vitamin D deficiency were assessed using 
multivariate logistic regression analysis, and adjusted for confounding factors. 
Significant independent variables that increased the risk of vitamin D deficiency 
included working exclusively indoors (OR 25.37, 95% CI 5.49-117.28, p < 0.001), 
whole body coverage with clothing (OR 17.81, 95% CI 2.29-138.50, p < 0.001), 
multiparity (OR 3.97, 95% CI 1.66-9.48, p = 0.002), total cholesterol/HDL ratio 
(>3.5) (OR 3.30, 95% CI 1.38-7.90, p = 0.007), low HDL-cholesterol (OR 2.81, 95% 
CI  1.22-6.42, p = 0.015), and living in West Riyadh (OR 2.00, 95% CI 1.14-3.53, p = 
0.011) (Table 3.3). 
 
The variables that appeared to confer some protection against vitamin D defciency in 
early pregnancy were low-intensity physical activity/walking (≥ 210 minutes/week) 
(OR 0.20, 95% CI 0.09-0.47, p < 0.001), sun exposure at noon alone, or with additional 
exposure at sunrise or sunset (OR 0.24, 95% CI 0.10-0.57, p = 0.001), being a university 
graduate or higher (OR 0.32, 95% CI 0.12-0.86, p = 0.023), residence in North Riyadh 
(OR 0.35, 95% CI 0. 15-0.79, p = 0.012), and age (OR 0.91, 95% CI 0.83-1.00, p = 
0.051) (Table 3.3). 
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        Unadjusted         Model 1          Model 2 
 Parameters OR (95% CI) P-value OR (95% CI) * P-value* OR (95% CI) ** P-value** 
Age 0.97 (0.94 – 1.01) 0.192 0.98 (0.94 – 1.02) 0.311 0.91 (0.83 – 1.00) 0.051 
Gestational age 1.07 (0.99 – 1.15) 0.066 1.07 (1.00 – 1.15) 0.059 0.99 (0.86 – 1.13) 0.881 
Multiparity 1.56 (1.00 – 2.43) 0.051 2.02 (1.21 – 3.36) 0.007 3.97 (1.66 – 9.48) 0.002 
Pre-pregnancy BMI (kg/m2) 1.00 (0.96 – 1.03) 0.944 1.00 (0.97 – 1.04) 0.867 0.99 (0.92 – 1.06) 0.729 
Obesity by 1st visit 0.86 (0.55 - 1.35) 0.517 1.22 (0.57 – 2.61) 0.604 0.95 (0.41 – 2.19) 0.907 
University graduate or postgraduate 0.47 (0.30 - 0.75) 0.001 0.42 (0.26 - 0.68) <0.001 0.32 (0.12 - 0.86) 0.023 
Employment 0.56 (0.36 - 86) 0.008 0.56 (0.36 - 0.88) 0.011 0.61 (0.27 – 1.34) 0.605 
Living in North Riyadh 0.44 (0.27 - 0.73) 0.001 0.46 (0.27 - 0.77) 0.003 0.35 (0.15 - 0.79) 0.012 
Living in West Riyadh 1.41 (1.07 - 1.85) 0.014 1.38 (1.05 - 1.83) 0.024 2.00 (1.14 - 3.53) 0.016 
HbA1c at 1st visit 1.14 (0.78 - 1.68) 0.490 1.25 (0.83 - 1.88) 0.278 1.34 (0.62 - 2.90) 0.462 
Random glucose (mmol/l) at 1st visit 1.02 (0.85 - 1.23) 0.627 1.03 (0.85 - 1.26) 0.750 0.84 (0.61 - 1.17) 0.297 
TG (≥ 1.7 mmol/l) 1.06 (0.67 – 1.69) 0.800 1.11 (0.68 – 1.80) 0.687 0.62 (0.24 – 1.59) 0.618 
Total cholesterol/HDL ratio (>3.5) 1.37 (0.89 – 2.11) 0.158 1.50 (0.96 – 2.35) 0.076 3.30 (1.38 – 7.90) 0.007 
Low HDL-cholesterol  
(< 1.03 mmol/l) 
1.66 (1.09 - 2.54) 0.019 1.74 (1.12 - 2.69) 0.014 2.81 (1.22 – 6.42) 0.015 
Hypertension (HTN) 0.86 (0.31 – 2.36) 0.770 0.90 (0.32 – 2.55) 0.843 5.07 (0.23 – 110.38) 0.302 
Blood sample collection (Summer) 1.11 (0.73 - 1.71) 0.623 1.05 (0.67 - 1.64) 0.847 1.18 (0.50 - 2.74) 0.698 
Sun exposure 0.69 (0.44 - 1.09) 0.109 0.67 (0.42 - 1.06) 0.083 1.20 (0.50 - 2.89) 0.688 
Time of exposure (at noon) 0.14 (0.09 - 0.22) <0.001 0.14 (0.09 - 0.23) <0.001 0.24 (0.10 - 0.57) 0.001 
Nature of work (indoors) 20.21 (9.85 - 41.46) <0.001 20.62 (9.72 - 43.78) <0.001 25.37 (5.49 – 117.28) <0.001 
Coverage with clothing (whole body) 16.86 (6.11 - 46.55) <0.001 16.47 (5.92 – 45.80) <0.001 17.81 (2.29 – 138.50)  0.006 
Vitamin D intake  
(> 600 IU/day) 
0.35 (0.11 - 1.12) 0.064 0.42 (0.13 - 1.40) 0.158 0.35 (0.07 - 1.93) 0.230 
Calcium Intake  
(> 1000 mg/day) 
0.62 (0.23 - 1.64) 0.329 0.74 (0.27 - 2.01) 0.560 0.86 (0.14 - 5.14) 0.870 
Use of multivitamin supplements 0.80 (0.46 - 1.39) 0.421 0.78 (0.43 - 1.40) 0.400 0.62 (0.25 - 1.54) 0.299 
Low intensity physical activity  
(≥210 minutes/week) 
0.28 (0.17 - 0.47) <0.001 0.31 (0.18 – 0.51) <0.001 0.20 (0.09 - 0.47) <0.001 
Note: Odds ratio (OR) and 95% CI for OR were obtained using logistic regression analysis, taking vitamin D deficiency (< 50nmol/L) as a dependent variable against potential risk factors, and as an 
independent risk. Model 1 is for age, BMI, and sun exposure.  Model  2 is Model 1+ parity, summer season, vitamin D intake, multivitamin intake, physical activity, education, employment, living in North, 
and coverage with clothing. Categorical variables (e.g. education, employment, HTN, sun exposure, and multivitamin supplementation) are  presented as ‘yes/no’; other categorical values include area of 
residence in Riyadh (North or West Riyadh vs. all other areas); season blood sample collection (summer vs. winter); time of sun exposure (noon alone plus either sunset or sunrise, or both  vs. sunrise or 
sunset or both); working indoors vs. working indoors + outdoors, and whole body vs. partial coverage with clothing. 
Table 3.3 Predictors of vitamin D deficiency among pregnant women in early pregnancy 
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3.4 Discussion 
This is the largest study ever conducted in Saudi Arabia to assess hypovitaminosis D in 
the early stages of pregnancy, as well as its predictors. It was observed that 81% of the 
pregnant women studied were deficient in 25(OH)D. Younger women, multiparous 
subjects, women with a lower level of education, housewives (as opposed to employees 
outside the home), and living in West Riyadh were all factors noted to be linked with 
lower vitamin D levels in early pregnancy. In addition, women who were less frequently 
exposed to the sun due to coverage of their whole body with clothing, and those who 
spent most of their working lives indoors were more likely to suffer from 
hypovitaminosis D in early pregnancy. However, a higher amount of physical activity, 
life in North Riyadh, and sun exposure at noon were associated with higher 25(OH)D 
concentrations. 
 
Vitamin D deficiency or insufficiency would not usually be expected in a sunny country 
like Saudi Arabia (latitude 25°N) (Sedrani et al., 1983), however, numerous studies 
have reported a high prevalence of hypovitaminosis D in the Saudi population, across 
different ages (Al-Musharaf et al., 2012; Alsuwaida et al., 2013; Al-Zoughool et al., 
2015). Nevertheless, only a limited number of studies, using relatively small sample 
sizes, have studied hypovitaminosis D in pregnant Saudi women to date (Serenius et 
al., 1984; Taha et al., 1984; Azhar, 2009; Al-Ajlan et al., 2015; Al-Faris, 2016; Al-
Shaikh et al., 2016). Moreover, most of these studies measured vitamin D levels during 
the third trimester, or at the time of delivery, while only two studies assessed 25(OH)D 
status during early gestation (Al-Ajlan et al., 2015; Al-Faris, 2016). For example, Al-
Ajlan et al. (2015) studied 515 pregnant women in their first trimester, and found that 
26.2 % were deficient (< 25 nmol/L), 68.0 % were insufficient (25–50 nmol/L), and 
only 3.5 % had sufficient (50–75 nmol/L) levels of vitamin D. Al-Faris (2016) 
investigated vitamin D status in 160 pregnant women from Riyadh, and reported that 
50% women were vitamin D-deficient (< 50 nmol/L) and 43.8% had insufficient levels 
(50-74 nmol/L) of vitamin D.  
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Apart from Saudi Arabia, however, vitamin D deficiency in early pregnancy has also 
been reported in the UAE (78%), Oman (98%), India (62%), Korea (91.8%), Spain 
(18%), the UK (57%), and Canada (39%), indicating that inadequate vitamin D levels 
during gestation is a global concern (Narchi et al., 2010; Al Kalbani et al., 2011; 
Makgoba et al., 2011; Dasgupta et al., 2012; Wei et al., 2012; Choi et al., 2015; 
Rodriguez et al., 2016). The rates detected in the existing study are comparable to those 
revealed for other Gulf and Asian countries. 
 
A large variety of risk factors for suboptimal vitamin D levels, such as latitude, season, 
clothing, sunscreen use, skin pigmentation, atmospheric components, and air pollution 
are directly or indirectly linked to sunlight exposure (Holick, 2007; Christakos et al., 
2010; Wacker & Holick, 2013). In the present study, the season (winter/summer) did 
not imply any significant differences in vitamin D levels, between the deficient and 
non-deficient pregnant women. However, this was anticipated, because although the 
season would indicate the amount of available sunlight, coverage of the whole body 
with clothing, and a large proportion of domestic or other work being performed 
indoors in Saudi Arabia, mean that exposure indices are largely unaffected by season 
amongst the Saudi population. Moreover, Saudis generally avoid the hot sun in summer. 
Therefore, inadequate exposure to sunlight, measured using several different indices, 
was shown to be a major risk factor for suboptimal vitamin D levels in the current study. 
In addition, the timing of the sun exposure in this study (noon) was also critical for 
determining the vitamin D levels, and this corresponded with previous data, where 
subjects were found to spend time outside in summer during the peak vitamin D 
production time of 10 am – midday. In contrast, this production time peaks at around 
11 am in winter (Alshahrani et al., 2013). Therefore, despite abundant sunlight in Saudi 
Arabia, lifestyle patterns and traditional dress, covering the whole body, significantly 
decreases sun exposure. This was evident in the present study, where the pregnant 
subjects, who covered their whole body, had significantly lower levels of vitamin D.  
 
Saudi women use dark veils to cover their whole body because of cultural and religious 
beliefs. Limiting sun exposure through the use of these veils has been implicated as a 
major risk factor for vitamin D deficiency (Azhar, 2009; Al-Ghamdi et al., 2012; Al-
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Mogbel, 2012). In fact, Muslim women all over the world, who resort to full body 
coverage, due to their religious beliefs, are consequently at risk of developing vitamin 
D deficiency (Ates et al., 2016; Karras et al., 2016). In Saudi Arabia and elsewhere, 
people have also adopted sun avoidance behaviour, due to modern lifestyles based on 
indoor work, such as in office work. This is especially true in Saudi Arabia, which has 
a very hot climate for a large part of the year. The present study, supported by others, 
indicates that pregnant women working indoors are at greater risk of having low vitamin 
D levels (Xiang et al., 2013).  
 
This study indicates that vitamin D levels vary in pregnant women, according to their 
educational status, with a lower level of education increasing the risk of vitamin D 
deficiency. This observation has been reported in a number of other studies 
documenting higher vitamin D levels among more educated pregnant women (Johnson 
et al., 2011; Burris et al., 2012a; Vandevijvere et al., 2012; van den Berg et al., 2013; 
Fenina et al., 2016; Sharma et al., 2016). Compared to other areas, pregnant women 
residing in North Riyadh were found to have a higher vitamin D status. This is most 
likely because North Riyadh is known for being a more affluent part of the city, with 
more highly educated inhabitants. However, as there were no differences in income 
observed between the 25(OH)D-deficient and sufficient groups, this was attributed 
more to the subjects’ educational level. In contrast to this, low socio-economic status 
has been connected to vitamin D deficiency (Aly et al., 2013). Furthermore, in support 
of this current study, previous research has reported that women who have had two or 
more previous births are more likely to have lower 25(OH)D3 concentrations, compared 
to women who have had just one previous birth (Aly et al., 2013; Andersen et al., 2013). 
 
Dietary intake of vitamin D (2.6%) and calcium (4.6%) intake were shown to be low in 
this study, as with other studies (Jensen et al., 2012; Al-Faris, 2016; Ayadi et al., 2016). 
Approximately one quarter (25%) of the pregnant women in the existing study were 
taking multivitamins in their first trimester, which is similar to other studies from 
different countries, whereby a  range of 7.5%-63.1% of the subjects have been found to 
use multivitamin supplementation (Vandevijvere et al., 2012; Charatcharoenwitthaya 
et al., 2013; Al-Faris, 2016; Ates et al., 2016). Collectively, these data suggest that 
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vitamin D intake during pregnancy, whether from food or supplements, is inadequate 
across the world  (Scholl & Chen, 2009; McGowan et al., 2011; Burris et al., 2012b; 
Vercruyssen et al., 2012; Karras et al., 2014). This is because dietary sources of vitamin 
D tend to be limited and comprise less than 10% of the daily vitamin D requirement as 
well as current food fortification is inadequate in Saudi Arabia (Holick et al., 2012; 
Kanan et al., 2013). In addition, Riyadh is a landlocked city, with no access to the sea 
or rivers, so consumption of vitamin D rich fish is usually infrequent (Al-Mogbel, 
2012). Moreover, Saudi society has experienced a dramatic change in its dietary and 
lifestyle patterns, with a shift towards a more unhealthy dietary habits (Al-Turki, 2008; 
Al-Ghamdi et al., 2012; Al-Faris et al., 2015).  
 
The relationship between 25(OH)D and obesity in pregnancy is inconsistent. This 
present study failed to find any evidence of an association between vitamin D levels 
and pre-pregnancy or early pregnancy obesity. These observations are consistent with 
findings from similar studies (Choi et al., 2015; Flood-Nichols et al., 2015; Al-Faris, 
2016; Ates et al., 2016; Rodriguez et al., 2016). Moreover, the mean BMI observed in 
early pregnancy (27 kg/m2) was comparable to another study conducted by Ates et al. 
(2016) (25 kg/m2), where the mean BMI did not reach obesity level. This could explain 
the absence of any differences in vitamin D deficiency/sufficiency in this regard. 
However, there is still some evidence suggesting that obesity may be associated with 
low vitamin D levels (Vandevijvere et al., 2012; Andersen et al., 2013; Karras et al., 
2016). Furthermore, compared to the deficient group, the non-deficient group of 
pregnant women had a higher fat percentage in the present study, even after adjusting 
for age and BMI. Nevertheless, this was a marginal difference and requires further 
confirmation through other studies. Fat status during pregnancy may be misleading and 
difficult to interpret because of the continuous changes in fat status that occurs 
throughout pregnancy. This is supported by the more marked trend towards pre-
pregnancy obesity in the vitamin D-deficient group in this study; a trend that 
disappeared in early pregnancy, perhaps due to normal physiological changes. 
  
Pregnant women engaging in low-intensity physical activity were also noted to have 
higher vitamin D levels, compared to those in the deficient group. Physical activity 
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amounting to at least 30 minutes per day in early pregnancy was determined as 
independently protecting against vitamin D deficiency. This may be attributed to 
greater mobilisation of vitamin D from burned fat deposits through increased physical 
activity (Riedt et al., 2005; Tzotzas et al., 2010). Pregnant women involved in daily 
outdoor activity during the early stages of pregnancy were more likely to have adequate 
vitamin D levels (Al-Faris, 2016). Jensen and colleagues (1980) have also proposed 
that pregnant women performing an outdoor physical activity are more likely to have a 
satisfactory 25(OH)D status. The elevated vitamin D levels among pregnant women 
involved in outdoor activity could also be due to greater sunlight exposure, thus 
triggering vitamin D synthesis (Kluczynski et al., 2011), and as indicated above, it is 
highly likely that the exercise itself may contribute to the maintenance of vitamin D 
status (Scragg et al., 1995). 
 
To expand on the above, other related explanations include effects independent of sun 
exposure possibly impacting on vitamin D levels in relation to physical activity 
(AlMulhim et al., 2015; Rodriguez et al., 2016). This current study is the first of its kind 
to assess the impact of adjusted sun exposure and physical activity on vitamin D levels 
among pregnant women. However, other studies investigating the association between 
physical activity and vitamin D levels, even after adjusting for sun exposure in non-
pregnant females, have revealed similar findings (Scragg & Camargo, 2008; Brock et 
al., 2010; Kluczynski et al., 2011; Touvier et al., 2015; Wanner et al., 2015). It is 
possible that a reduction in ionised calcium during exercise stimulates parathyroid 
hormone release, thus activating 1,25(OH)2D3 (Maïmoun & Sultan, 2009). In addition, 
increased lipolysis following exercise-induced weight loss may also mobilise vitamin 
D from adipose tissues, resulting in elevated serum levels of vitamin D (Riedt et al., 
2005; Zittermann et al., 2009; Tzotzas et al., 2010). 
 
Among the lipid profile parameters, HDL-cholesterol was significantly lower in the 
deficient group, resulting in an increased total cholesterol/HDL ratio, compared to their 
non-deficient counterparts. Moreover, low HDL-cholesterol levels were 2.81 times 
more likely to be associated with vitamin D deficiency, while the total cholesterol/HDL 
ratio indicated a 3.30 times higher risk of vitamin D deficiency in early pregnancy. 
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These findings indicate that women with low vitamin D levels are at higher risk of 
cardiovascular diseases (Boucher, 1998; Barter  et al., 2007). Among non-pregnant 
women, low HDL-cholesterol has been reported as an independent risk factor of 
vitamin D deficiency (Forrest & Stuhldreher, 2011). Another study looked at 13,039 
adults and showed that higher 25(OH)D levels were associated with higher HDL-
cholesterol and a lower total cholesterol/HDL ratio, after considering factors such 
as diabetes, physical activity, BMI, and waist circumference (Faridi et al., 2016). The 
mechanism of this association is not clear, but vitamin D may indirectly influence lipid 
metabolism mediated by insulin resistance and inflammation (Guasch et al., 2012). 
Matsuura and colleagues (2006) proposed that vitamin D may regulate macrophage 
function of reverse cholesterol transport, and the number of large HDL particles may 
be elevated, by taking over cholesterol through macrophages. Zhou and colleagues 
(2008) revealed that vitamin D possibly improves free fatty acid-induced insulin 
resistance. Meanwhile, Kang et al. (2012) suggest that vitamin D could stimulate 
cytokine gene expression in macrophage, and perform many systemic anti-
inflammatory actions. Most recently, Slominski et al. (2015) reported that novel 
vitamin D3-hydroxyderivatives are non-calcemic, unlike 1,25(OH)2D3, thus potentially 
promoting anti-inflammatory activity. To date, however, few studies have explored 
vitamin D status with lipid profiles during early pregnancy, and longitudinal studies are 
lacking. Therefore, the present study has narrowed this gap in the literature, by being 
among the first studies to show that low HDL-cholesterol levels, and total 
cholesterol/HDL ratios, highly increase the risk of vitamin D deficiency in early 
pregnancy. 
 
Finally, vitamin D exhibited a negative correlation with random blood glucose and 
HbA1c in this study, suggesting that the two parameters may be linked with serum 
vitamin D levels, although this was not statistically significant in multivariate analysis. 
A negative correlation between vitamin D and HbA1c during the first trimester of 
pregnancy has been reported previously (Jafarzadeh et al., 2015).  
 
In conclusion, the Saudi pregnant women studied in this instance had a high prevalence 
of vitamin D deficiency (81%) in their first trimester. Whole body coverage with 
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clothing, lower levels of physical activity, living in West Riyadh, and multiparity were 
found to be the key factors predisposing pregnant women to vitamin D deficiency. 
Vitamin D deficiency was also noted to be associated with adverse HDL-cholesterol 
status, although this finding requires replication. There appears to be a need to increase 
awareness among health professionals and the public in general for avoiding vitamin D 
deficiency, specifically among women and those of childbearing age. Thus, to improve 
vitamin D status, lifestyle recommendations, such as a combination of increased 
physical activity, exposure to the sun at noon, consumption of foods rich in vitamin D, 
and vitamin D supplementation, may all help to raise vitamin D levels. Specific 
recommendations and policies should be implemented in the KSA to detect and prevent 
vitamin D deficiency in general, but particularly during pregnancy, in order to avoid 
the associated adverse maternal and neonatal complications. 
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Longitudinal Changes in Vitamin D Status During 
Pregnancy: Comparison Between Early and Mid-
Term Pregnancy
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4.1 Introduction 
Pregnancy itself is particularly associated with substantial changes in vitamin D and 
calcium metabolism, which are key to foetal bone development. The need to prioritise 
foetal needs requires the mother to increase her vitamin D intake during pregnancy, as 
well as during lactation (Brannon & Picciano, 2011; Ross et al., 2011). Understandably, 
the foetus is entirely dependent on the mother for its supply of both calcium and vitamin 
D during pregnancy (Lapillonne, 2010). However, despite vitamin D levels having 
already been determined for nutritional requirements during gestation, these levels 
seem debatable. In particular, vitamin D deficiency cut-off points for pregnant women 
have been adapted from studies performed on non-pregnant populations (Dror & Allen, 
2010; Flood-Nichols et al., 2015). At present, in the non-pregnant population, a 
circulating level of at least 50 nmol/L is considered adequate to avoid bone dysfunction, 
although ideally 75 nmol/L of vitamin D is considered sufficient (Bodnar & Simhan, 
2010; Holick et al., 2011; Ross et al., 2011).  
 
Despite knowledge of the vitamin D levels possibly required in pregnancy, the 
prevalence of vitamin D deficiency remains high, during early pregnancy (Dasgupta et 
al., 2012), mid-term pregnancy (Xiao et al., 2015), and late pregnancy (Al-Shaikh et 
al., 2016), although a limited amount of research has addressed the determinants of 
25(OH)D deficiency during mid-pregnancy. Studies assessing 25(OH)D levels among 
pregnant women in mid-late pregnancy have reported a 48-80% prevalence of vitamin 
D deficiency (Sahu et al., 2009; Perez-Ferre et al., 2012; Bener et al., 2013; Gernand et 
al., 2013; Choi et al., 2015; Xiao et al., 2015). In one Middle Eastern study from Qatar, 
which assessed mid-pregnancy, this deficiency has been attributed to inadequate sun 
exposure, physical inactivity, and a lack of dietary vitamin D (Bener et al., 2013). 
Additionally, low socio-economic status has been linked with vitamin D deficiency 
during early-mid pregnancy in one study (Shand et al., 2010). 
 
However, it should be stressed here that not all studies have provided consistent 
evidence on the changing level of 25(OH)D as pregnancy progresses. Some studies 
suggest that 25(OH)D levels decline during pregnancy (Ardawi et al., 1997; Zhang et 
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al., 2014), while other data indicate that vitamin D levels are elevated during pregnancy 
(Sanchez et al., 1997; Bärebring et al., 2016), and some have revealed no change 
(Reddy et al., 1983; Seely et al., 1997; Marwaha et al., 2011). These apparent conflicts 
may be due to various influences on the populations studied.  
 
To elaborate on the above, vitamin D levels during pregnancy can be influenced by the 
seasonal and lifestyle factors prevailing at the time. Factors which can adversely disturb 
25(OH)D status during pregnancy, include ethnicity, less than optimal sun exposure, 
clothing style, and low dietary or supplemented vitamin D intake (Bärebring et al., 
2016). On the other hand, pregnancy-related factors influencing vitamin D status could 
include haemodilution, hormonal changes, increased maternal and foetal demand, 
increased body fat, and reduced outdoor activity (Bodnar et al., 2007b; Christesen et 
al., 2012). Alterations in metabolic profile during pregnancy, due to changes in 
oestrogen, progesterone, and insulin homoeostasis have also been linked to reduced 
vitamin D levels (Kalkhoff, 1982). The relationship between adverse metabolic profiles 
and reduced vitamin D levels have been observed in non-pregnant and pregnant female 
populations alike (Ford et al., 2005; Maghbooli et al., 2008). Finally, it has been shown 
that the active trans-placental transport of calcium to the developing foetus may 
influence vitamin D levels (Jones et al., 2000). Therefore, the overall conclusion is that 
adequate vitamin D has a favourable influence on the course of a pregnancy, maternal 
and neonatal calcium homoeostasis, and bone maturation and mineralisation (Jones et 
al., 2000; Walicka & Marcinowska-Suchowierska, 2008).  
 
Studies measuring vitamin D during pregnancy have been primarily concerned with the 
association between adverse maternal and foetal outcomes. However, measuring 
vitamin D just once, and in a single trimester will not necessarily reflect vitamin D 
levels across an entire pregnancy. Nevertheless, it would appear that vitamin D levels 
recorded at different time points during the first half of gestation may give a better 
indication and prediction of 25(OH)D status across the entire term. This is due to a 
higher demand for nutrients by the foetus, since over 90% of foetal growth takes place 
at end of pregnancy (Engelking & Rebar, 2012). Furthermore, data on the determinants 
of 25(OH)D deficiency from the first to the third trimester are limited (Moon et al., 
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2015; Bärebring et al., 2016), and no studies have evaluated determinants for vitamin 
D deficiency from early to mid-gestation. Additionally, there are no available data on 
vitamin D levels in pregnancy, followed up after controlling for different lifestyle 
factors. Moreover, in Saudi Arabia to date, no study has measured 25(OH) levels mid-
pregnancy, or 25(OH)D status prospectively in a large Saudi cohort of pregnant women. 
This Chapter presents novel insights in a first study comparing vitamin D levels in early 
and mid-gestation in Saudi Arabia, as well as the maternal risk factors potentially 
influencing this relationship.   
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4.2 Research Design and Methods 
This prospective study followed 383 pregnant women from first to the second visit. 
However, 45 of the subjects were excluded, as they reported taking vitamin D 
supplementation by mid-pregnancy and 41 were excluded, due to their questionnaires 
being incomplete. The corresponding analysis was, therefore, conducted on 297 
pregnant Saudi women.  
 
4.2.1 Data Collection 
Clinical assessments were conducted on two occasions. Baseline, non-fasting, blood 
samples were obtained during the first visit at 8-12 weeks of gestation. The second visit 
was scheduled for the second trimester, at 24-28 weeks, and the women were asked to 
fast for at least 10 hours. Anthropometric and biochemical assessments, as well as 
questionnaire-based interviews, were conducted at both time points. GWG  and changes 
in body fat were calculated as explained in Chapter 2. As described earlier, the 
interview questionnaires included a FFQ, questions on sun exposure, and a physical 
activity questionnaire (IPAQ) (Al-Daghri et al., 2011; Harrison et al., 2011; Al-
Musharaf et al., 2012; Al-Othman et al., 2012b; Takahasi et al., 2013). 
 
4.2.2 Laboratory Analysis 
During the first visit, random blood samples were collected to measure total 25(OH) D, 
calcium, phosphorus, albumin, creatinine, and alkaline phosphatase along with 
glycaemic and lipid profile. For mid-pregnancy measurements, the biochemical 
parameters assessed during the first visit were repeated. The analysis of previous labs 
were detailed in Chapter 2. Metabolic syndrome was assessed in the second visit and 
classified based on criteria suggested by the US NHLBI/AHA (Grundy et al., 2005). 
 
4.2.3 Data Analysis 
Data were analysed using SPSS version 21.0 statistical software (SPSS, Chicago, IL, 
USA). Pearson’s chi-square test was conducted to identify any association between 
categorical variables (deficient and non-deficient). To determine differences between 
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the groups, an independent sample t-test and Mann-Whitney U Test was used for 
normal and abnormal variables, respectively. Adjustment for age and BMI between the 
groups was done using ANCOVA. Comparison of median vitamin D levels from early 
to mid-pregnancy was done using the Wilcoxon signed rank test, and adjustment for 
mid-pregnancy gestational age, multivitamin intake, physical activity, estimated 
vitamin D intake, sun exposure, and season, was done using repeated measures 
ANCOVA. The difference between two visits was then measured using a paired sample 
t-test and Wilcoxon signed rank test for normal and abnormal variables, respectively.  
 
Pearson’s and Spearman’s rank correlation coefficients were also determined to assess 
the linear relationship between quantitative variables for normally and non-normally  
distributed variables, respectively. Logistic regression was used to identify the risk 
factors associated with vitamin D deficiency by mid-pregnancy. This method used the 
presence or absence of vitamin D deficiency as a dichotomous variable. Possible 
confounding factors, such as age, BMI, sun exposure, GWG, parity, season, vitamin D 
intake, multivitamins, physical activity, education, employment, residence in North 
Riyadh, and coverage with clothing, were included in the analysis. A p-value of < 0.05 
and 95% confidence intervals were applied to report the statistical significance, and 
precision of the estimates. 
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4.3 Results 
4.3.1 Comparison Between Attendees at the Early and Mid-Pregnancy 
Visits and Absentees from the Mid-Pregnancy Visit 
Of the 578 pregnant women who had previously attended an early pregnancy visit, 383 
later attended a mid-pregnancy visit, as described in the CONSORT diagram in Chapter 
2 (Figure 2.1). The subjects who attended the mid-pregnancy visit displayed a trend 
towards higher education (59.7% vs. 52.7%, p = 0.116), and higher income (13.4% vs. 
9.3%, p = 0.180), compared to the subjects who failed to attend the visit, although this 
was not statistically significant. The percentage of subjects living in West Riyadh was 
significantly higher amongst the women who failed to attend the visit, compared to 
those who did (33.9% vs. 25.7%, p = 0.049). However, no difference was observed in 
employment between the women attending mid-pregnancy and those failing to attend. 
Moreover, the subjects who failed to attend the visit had a significantly higher rate of 
previous miscarriage (38.6% vs. 26.6%, p = 0.022), and family history of obesity 
(25.6% vs. 14.1%, p = 0.011), compared to those who attended. A family history of 
diabetes appeared to be slightly more common amongst the subjects who did not attend, 
compared to those who did, although this was not statistically significant (78.6% vs. 
70.1%, p = 0.059). 
 
The mothers who did not attend the mid-pregnancy visit were significantly younger 
than those who attended (28.1 ± 5.6 vs. 29.1 ± 5.3 years old, p = 0.041), but no 
differences were observed in the anthropometrics of either group. The expectant 
mothers who did not attend the mid-pregnancy visit had significantly higher corrected 
serum calcium (2.3 ± 0.2 vs. 2.2 ± 0.2 mmol/L, p = 0.014), and phosphorus levels (1.2 
± 0.4 vs. 1.1 ± 0.4 mmol/L, p = 0.036), and their median vitamin D concentration (29.7 
vs. 27.7 nmol/L) was higher than that of the women who attended, but this was not 
statistically significant (p = 0.171) (Table 4.1). The median estimated dietary intake of 
vitamin D and calcium amongst the subjects, who did not attend, was significantly 
lower than that of the subjects who completed the study (85.1 vs. 105.4 IU/day, p < 
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0.001 and 102.9 vs. 128.9 mg/day, p < 0.001, respectively). However, no difference 
was detected in their physical activity or sun exposure variables.  
Table 4.1 Maternal characteristics in early pregnancy, relative to attendance or 
non-attendance of the mid-pregnancy visit 
 
Attending  
(N=383,  
as per initial 
inclusion) 
Non-attending  
 
(N=195) 
P-value *P-value 
Anthropometric 
Parameters  
    
Age (in years) 29.1 ± 5.3 28.1 ± 5.6 0.041 --- 
Pre-pregnancy BMI (kg/m2)  27.0 ± 6.0 27.0 ± 5.9 0.878 0.087 
BMI (kg/m2)  28.1 ± 6.3 27.8 ± 6.2 0.588 --- 
Waist-hip ratio (WHR)  0.9 ± 0.1 0.8 ± 0.1 0.190 0.273 
Systolic BP  113.8 ± 13.2 114.2 ± 11.6 0.737 0.687 
Diastolic BP  67.4 ± 9.5 68.9 ± 9.8 0.080 0.061 
Body fat %  34.1 ± 5.6 34.8 ± 5.5 0.186 0.065 
Biochemical Parameters      
Glucose (mmol/L) # 4.8 (4.4 - 5.3) 4.8 (4.3 - 5.4) 0.661 0.902 
Insulin (uU/mL) # 8.2 (4.6 - 18.3) 8.7 (5.0 - 18.4) 0.861 0.775 
HbA1c (%) 5.1 ± 0.5 5.1 ± 0.6 0.925 0.744 
Total cholesterol (mmol/L)  5.2 ± 1.0 5.1 ± 1.1 0.399 0.827 
HDL-cholesterol (mmol/L)  1.3 ± 0.4 1.3 ± 0.3 0.717 0.855 
Cholesterol-HDL ratio  4.0 ± 1.1 4.0 ± 1.0 0.566 0.899 
LDL-cholesterol (mmol/L)  3.2 ± 0.7 3.1 ± 0.8 0.357 0.716 
Triglycerides (mmol/L)  1.4 ± 0.6 1.4 ± 0.6 0.500 0.946 
Vitamin D (nmol/L) # 27.7 (18.8 - 43.6) 29.7 (21.3 - 44.9) 0.171 0.154 
Corrected calcium (mmol/L)  2.2 ± 0.2 2.3 ± 0.2 0.002 0.014 
Phosphorus (mmol/L) 1.1 ± 0.4 1.2 ± 0.4 0.021 0.036 
 
Note: Data are presented as mean and standard deviation for normal variables, while the median, first, and third 
quartiles are presented for non-normally distributed variables. # indicates non-normally distributed variables; the p-
value for mean differences was obtained through an independent sample t-test for normal variables, and a Mann-
Whitney U Test for non-normally distributed variables. * indicates p-values adjusted for age and BMI at the first 
visit using ANCOVA. 
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4.3.2 General Characteristics of Subjects at Mid-pregnancy  
4.3.2.1 Anthropometric and Biochemical Characteristics 
In total, 297 pregnant Saudi women successfully attended their second visit. Their mean 
age was 28.9 ± 5.3 years, and the mean gestational age was 26.3 ± 3.2 weeks. 
Anthropometric and biochemical parameters during mid-pregnancy are shown in 
Table 4.2. Mean BMI mid-pregnancy was 30 ± 6.0 kg/m2, comprising 33.8% (100/297) 
were overweight and 43.9% (130/297) were obese. Moreover, 66% (196/297) of the 
subjects displayed hypertriglyceridemia, and 29.6% (88/297) had low HDL-
cholesterol. GDM was also diagnosed in 33.3% (99/297) of the subjects, based on the 
IADPSG (Figure 4.1), which will be discussed in more detail in Chapter 5. Finally, 
about 18% of the subjects presented with metabolic syndrome, by mid-pregnancy. 
 
 
Figure 4.1 Prevalence of metabolic disorders during mid-pregnancy. Data are 
presented as frequencies and percentages. 
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4.3.2.2 Lifestyle Factors 
The percentage of blood samples collected from the pregnant women during the 
summer season totalled 51.1%, while 48.9% were collected during the winter. Sun 
exposure was reported by 22.3% of the participants, and 30.2 % were exposed to the 
sun at noon time. The subjects who worked exclusively indoors comprised 92.9% of 
the overall sample. With regard to covering the body with clothing, 30.9% reported full 
body coverage, whilst only 5.4% of the participants used sunscreen lotion for UV 
protection.  
 
Estimated vitamin D and calcium intake at mid-pregnancy was noted in the subjects as 
149.5 IU/day (67.1-342.7) and 222.8 mg/day (64.3-673.5), respectively. These figures 
indicate that 2.7% of the subjects were ingesting more than the daily recommended 
amount for vitamin D, and 12.2% for calcium. In addition, 55% (111/297) reported 
taking multivitamin supplements by mid-pregnancy. The median sedentary time and 
low-intensity physical activity/walking reported by the subjects in mid-pregnancy 
amounted to 948 minutes/week (600-1500), and 230 minutes/week (75-600), 
respectively. 
 
4.3.3 Vitamin D Status at Mid-pregnancy  
The categorisation of 25(OH)D levels mid-gestation resulted in 36.7% (109/297) of 
participants having severe vitamin D deficiency; 40.7% (121/297) with vitamin D 
deficiency; 16.2% with vitamin D insufficiency; and 6.4% (19/297) with sufficiency 
(Figure 4.2). The median circulating 25(OH)D level in the subjects, consisted of 30.5 
nmol/L (20.0-48.8).  
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Figure 4.2 Vitamin D status at mid-pregnancy 
 
4.3.3.1 Anthropometric and Biochemical Characteristics in Relation to Vitamin D 
Status 
By mid-pregnancy, no significant differences were observed in BMI, GWG, body fat 
percentage, or blood pressure, between the deficient and non-deficient groups 
(Table 4.2). The median 25(OH)D levels in the deficient group was 25.8 nmol/L (17.4-
35.1), compared with 61.6 nmol/L  (55.4-78.4) in the non-deficient group. Phosphorus 
levels were lower (p = 0.049), and alkaline phosphatase levels were significantly higher 
(p < 0.001) in the vitamin D deficient group, compared to the non-deficient group. In 
addition, 25(OH)D levels at mid-pregnancy positively correlated with phosphorus (r = 
0.22, p > 0.001) and negatively correlated with alkaline phosphatase (r = -0.31, p < 
0.001). Conversely, TG was significantly higher in the deficient group, compared to the 
non-deficient group, even after adjusting for age and BMI (p = 0.004). GDM markers 
and insulin are presented in Chapter 6. The presence of characteristics indicating 
metabolic syndrome and GDM are shown in Figure 4.3, and these will be discussed in 
detail in Chapter 6. 
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Table 4.2 Anthropometrics and biochemical characteristics, in relation to vitamin 
D status at mid-pregnancy 
Parameter 
All  
(N=297) 
Non-Deficient  
(N = 67) 
Deficient  
(N = 230) 
P-
value 
P-
value* 
Anthropometric Parameters     
Maternal age (years) 28.9 ± 5.3 29.2 ± 5.0 28.8 ± 5.5 0.634 --- 
Gestational age (in Weeks) 26.3 ± 3.2 25.6 ± 4.0 26.5 ± 2.9 0.040 0.046 
Pre-pregnancy BMI (kg/m2)  27.0 ± 6.0 26.9 ± 5.5 26.9 ± 6.1 0.918 0.798 
BMI (kg/m2) at 2nd visit  30 ± 6.0 30.1 ± 5.4 30.0 ± 6.2 0.882 0.942 
Gestational weight gain (GWG) 
(kg) 
7.2 ± 4.3 7.3 ± 4.0 7.1 ± 4.4 0.762 0.675 
Waist circumference (cm) 104.9 ± 12.9 104.5 ± 13.0 105.1 ± 12.9 0.736 0.793 
Hip circumference (cm) 113.4 ± 11.3 114.5 ± 11.2 113.1 ± 11.3 0.372 0.235 
Waist-hip ratio  0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.073 0.095 
Systolic BP (mm Hg) 112 ± 12.5 111.1 ± 13.1 112.2 ± 12.3 0.530 0.623 
Diastolic BP (mm Hg) 67.9 ± 10.6 67.5 ± 12.6 68.0 ± 10.0 0.790 0.715 
Body fat (%)  37.2 ± 3.3 37.3 ± 3.3 37.1 ± 3.3 0.620 0.600 
Δ Body fat (%) 10.2 ± 25.1 9.7 ± 16.9 10.3 ± 27.1 0.846 0.920 
Biochemical Parameters      
Vitamin D (nmol/L) # 
30.5 
 (20.0 – 48.8) 
61.6  
(55.4 – 78.4) 
25.8  
(17.4 – 35.1) 
<0.001 <0.001 
Corrected calcium (mmol/L)  2.2 ± 0.2 2.2 ± 0.2 2.2 ± 0.2 0.707 0.686 
Phosphorus (mmol/L)  1.3 ± 0.5 1.4 ± 0.5 1.3 ± 0.4 0.061 0.049 
Alkaline phosphatase (mmol/L)  10.6 ± 4 8.6 ± 2.3 11.2 ± 4.2 <0.001 <0.001 
Creatinine (µmol/L)  58.4 ± 16.9 58.4 ± 17.7 58.3 ± 16.8 0.983 0.991 
Total cholesterol (mmol/L)  4.6 ± 1.8 6.5 ± 1.2 6.7 ± 1.4 0.239 0.220 
HDL-cholesterol (mmol/L)  1.6 ± 0.5 1.6 ± 0.5 1.6 ± 0.5 0.577 0.490 
Total cholesterol-HDL Ratio  4.6 ± 1.8 4.3 ± 1.5 4.7 ± 1.9 0.090 0.107 
LDL-cholesterol (mmol/L)  4.1 ± 1.1 4.0 ± 1.0 4.1 ± 1.1 0.562 0.476 
Triglycerides (mmol/L)  2.1 ± 0.7 1.9 ± 0.6 2.1 ± 0.8 0.001 0.004 
Note:  Data presented as a mean and standard deviation for normal variables, while median, first and third quartiles 
are presented for non-normally distributed variables. # indicates non-normally distributed variables; the p-value for 
mean differences was obtained from an independent sample t-test for normal variables, and a Mann-Whitney U test 
for non-normally distributed variables, while * indicates p-values adjusted for age and BMI on the 1st visit through 
an ANCOVA.
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Figure 4.3 Presence of metabolic disorders in relation to vitamin D status. The values 
show the percentage of women with different metabolic disorders at mid-pregnancy, in 
both the vitamin D-deficient and non-deficient groups. P-values: * denotes p < 0.05, 
using the Pearson’s chi-square test. 
 
4.3.3.2 Influence of Lifestyle on Vitamin D Status 
The subjects with no 25(OH)D deficiency were found to experience a higher rate of sun 
exposure, compared with the deficient group (33.8% vs. 19%, p = 0.011). Therefore, a 
greater percentage of the participants who spent most of their working lives indoors 
were found to be deficient, compared to their non-deficient counterparts (95.7% vs. 
83.3%, p < 0.001). It was similarly significant that more subjects who covered their 
entire body with clothing were found to be deficient compared with the non-deficient 
group (35.5% vs. 15.1%, p = 0.005). Moreover, the percentage of women exposed to 
the sun at noon (44.8%) was significantly higher in the non-deficient group, compared 
to the 26% in the deficient group (p = 0.006). The use of sunscreen was represented by 
7.5% of the non-deficient group, compared with 4.8% of the deficient group, but this 
was not statistically significant (p = 0.392). Seasonal variations in sun exposure were 
statistically not different between the groups (p = 0.962), with 51.2% of the samples 
collected during the summer being vitamin D-deficient, compared with 50.8% being 
classed as non-deficient. Whereas in winter, 48.4% were noted as deficient, compared  
97 
 
with 49.2% in the non- deficient group. Data on sun exposure variables are presented 
in Figure 4.4. 
 
 
Figure 4.4 Comparison of the extent of sunlight exposure between the deficient and 
non-deficient groups, during the second trimester of pregnancy. The values show the 
percentage of women with different sun exposure indices, in both the vitamin D-
deficient and non-deficient groups. P-values: ** denotes p < 0.01 and *** denotes p < 
0.001, using the Pearson’s chi-square test. 
 
 
Estimated vitamin D and calcium intake failed to show any differences between the 
deficient and non-deficient groups (Figure 4.5). Interestingly, multivitamin intake was 
significantly lower in the 25(OH)D-deficient women (45.5%) by mid-pregnancy, 
compared with the non-deficient group (64.8%) (p = 0.014) (Figure 4.5). 
 
 
 
 
 
  
 
98 
 
 
Figure 4.5 Estimated vitamin D and calcium intake, according to vitamin D status mid-
pregnancy. The values show the median intake of vitamin D and calcium from food 
among both the vitamin D-deficient and non-deficient women at mid-pregnancy, after 
adjusting for age and BMI. The Mann-Whitney U Test was used. 
 
 
Figure 4.6 Intake of multivitamin supplements in relation to vitamin D status at mid-
pregnancy. The values show the percentage of multivitamin usage for both deficient 
and non-deficient women in mid-pregnancy. P-values:  * denotes p < 0.05. Pearson chi-
square test was used. 
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Regarding physical activity, the median number of minutes for women in the non-
deficient vitamin D group who engaged in more low-intensity physical activity/walking 
than was reported by the deficient group, even after adjusting for age and BMI (840 vs. 
180 minutes/week, p < 0.001). Vitamin D levels at mid-pregnancy positively correlated 
with low-intensity physical activity (r = 0.43, p < 0.001). Furthermore, the women 
found to be deficient in 25(OH)D, demonstrated a higher trend for remaining sedentary, 
compared with the non-deficient women, but this was not statistically significant (1200 
vs. 900 minutes/week, p = 0.113) (Figure 4.7). 
Figure 4.7 Comparison of physical activity between the deficient and non-deficient 
vitamin D groups at mid-pregnancy. The values the median sedentary and physical 
activity in minutes per week for both the vitamin D-deficient and non-deficient women 
mid-pregnancy, after adjusting for age and BMI. P-values:  *** denotes p < 0.001. The 
Mann-Whitney U Test was used. 
 
 
4.3.4 Predictors of Vitamin D Deficiency at Mid-pregnancy 
Multivariate logistic regression analysis was used to explore significant predictors of 
vitamin D deficiency. After adjusting for possible confounding factors, the presence of 
vitamin D deficiency in early pregnancy (OR 4.35 95% CI 1.09-17.36, p = 0.037), and 
working indoors (OR 13.23 95% CI 1.38-126.52, p = 0.025) were found to be predictors 
of vitamin D at mid-pregnancy. In addition, the use of multivitamin supplementation at 
mid-pregnancy (OR 0.33 95% CI 0.12-0.97, p = 0.043), and a greater amount of low-
intensity physical activity at mid-pregnancy (OR 0.15 95% CI 0.05-0.45, p = 0.001), 
were found to confer some degree of protection against vitamin D deficiency, during 
this period. 
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Table 4.3 Predictors of vitamin D deficiency among the subjects’ mid-pregnancy 
 
 Unadjusted Model 1 Model 2 
Parameters OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value 
Age (years) 0.99 (0.94 – 1.04) 0.633 1.00 (0.94 – 1.05) 0.849 0.99 (0.88 – 1.12) 0.948 
Gestational age (weeks) 1.08 (1.00 – 1.17) 0.058 1.07 (0.98 – 1.16) 0.115 0.96 (0.76 – 1.21) 0.697 
Pre-pregnancy BMI (kg/m2) 1.00 (0.95 – 1.04) 0.918 1.00 (0.95 – 1.05) 0.969 1.07 (0.96 – 1.19) 0.211 
Obesity at 2nd visit  0.88 (0.51 - 1.53) 0.660 0.71 (0.28 – 1.81) 0.471 0.46 (0.08 – 2.67) 0.383 
Gestational weight gain (GWG) (excessive) 0.83 (0.47 - 1.45) 0.506 0.84 (0.46 - 1.54) 0.565 1.50 (0.40 – 5.53) 0.547 
Body fat % 0.98 (0.90 - 1.07) 0.620 0.95 (0.87 - 1.05) 0.318 0.97 (0.84 - 1.13) 0.736 
Δ Body fat (%) 1.00 (0.99 – 1.01) 0.846 1.00 (0.99 – 1.01) 0.967 1.00 (0.97 – 1.04) 0.939 
Blood sample collection (summer) at 2nd visit  1.01 (0.57 - 1.79) 0.962 0.91 (0.50 - 1.64) 0.762 0.81 (0.28 – 2.34) 0.698 
Sun exposure by 1st visit  0.55 (0.30 – 1.01) 0.053 0.54 (0.29 – 1.00) 0.050 0.71 (0.24 – 2.11) 0.533 
Sun exposure by 2nd visit  0.46 (0.25 - 0.85) 0.011 0.44 (0.24 - 0.81) 0.008 0.92 (0.29 – 2.9) 0.884 
Time of exposure (noon) by 2nd visit 0.43 (0.24 - 0.79) 0.007 0.43 (0.23 – 0.82) 0.010 0.39 (0.12 - 1.23) 0.109 
Nature of Work (Indoor) by 2nd visit  4.40 (1.78 - 10.89) 0.001 4.37 (1.62 – 11.80) 0.004 13.23 (1.38 – 126.52) 0.025 
Coverage with clothing (whole body) by 2nd visit 3.10 (1.38 - 6.97) 0.006 2.54 (1.09 – 5.90) 0.030 2.50 (0.70 – 8.90) 0.156 
Coverage with clothing (whole body) by 1st visit  2.53 (1.30 – 4.90) 0.006 2.09 (1.06 – 4.14) 0.034 1.62 (0.59 – 4.41) 0.585 
HbA1c at 2nd visit  2.10 (1.10 - 3.99) 0.023 2.09 (1.05 - 4.17) 0.036 2.36 (0.67 - 8.34) 0.181 
Fasting glucose (mmol/l) at 2nd visit 1.45 (1.01 - 2.08) 0.026 1.48 (1.01 – 2.18) 0.046 0.78 (0.43 - 1.41) 0.783 
Vitamin D Deficiency at 1st visit  3.53 (1.85 - 6.72) < 0.001 3.40 (1.72 – 6.73) < 0.001 4.35 (1.09 - 17.36) 0.037 
Cholesterol-HDL ratio at 2nd visit > 3.5  1.16 (0.64 – 2.09) 0.625 1.43 (0.77 – 2.67) 0.261 1.49 (0.44 – 5.07) 0.526 
Low HDL at 2nd visit (>1.03mmol/l)  1.61 (0.85 – 3.05) 0.142 1.98 (0.99 – 3.96) 0.052 2.69 (0.69 – 10.54) 0.156 
Hypertriglyceridemia at 2nd visit  1.42 (0.81 - 2.49) 0.218 1.50 (0.83 - 2.71) 0.185 0.55 (0.19 - 1.60) 0.270 
Metabolic syndrome at 2nd visit  1.54 (0.70 - 3.37) 0.280 1.77 (0.73 - 4.32) 0.207 2.68 (0.42 – 17.19) 0.298 
Gestational diabetes mellitus (GDM) 2.00 (1.06 – 3.76) 0.033 1.93 (0.99 – 3.75) 0.054 1.04 (0.32 – 3.33) 0.953 
Hypertension (HTN) at 2nd visit  1.28 (0.27 – 6.07) 0.759 0.92 (0.19 – 4.50) 0.914 2.39 (0.14 – 40.52) 0.546 
Vitamin D intake by 1st visit (> 600 IU/day)  0.29 (0.06 – 1.46) 0.133 0.35 (0.07 – 1.86) 0.216 0.28 (0.001 – 99.96) 0.672 
Vitamin D intake by 2nd visit (> 600 IU/day)  0.74 (0.14 - 3.91) 0.720 0.87 (0.16 - 4.80) 0.874 0.18 (0.02 - 1.83) 0.146 
Calcium intake by 2nd visit ( > 1000 mg/day)  0.48 (0.20 - 1.11) 0.080 0.54 (0.22 - 1.30) 0.169 0.29 (0.07 - 1.16) 0.079 
Use of multivitamins by 1st visit  2.00 (0.90 – 4.37) 0.088 1.66 (0.74 – 3.71) 0.221 1.74 (0.33 – 9.18) 0.513 
Use of Multivitamins by 2nd visit  0.45 (0.24 - 0.86) 0.015 0.44 (0.23 - 0.85) 0.014 0.33 (0.12 - 0.97) 0.043 
Low intensity PA (≥ 210 minutes/week) by 1st visit  0.89 (0.51 – 1.54) 0.670 0.92 (0.51 – 1.66) 0.788 0.65 (0.26 – 1.60) 0.344 
Low Intensity PA (≥ 210 minutes/week) by 2nd visit  0.20 (0.10 – 0.39) < 0.001 0.18 (0.09 – 0.37) < 0.001 0.15 (0.05 – 0.45) 0.001 
Note: Data are presented as frequency (%) for categorical variables, while mean (SD) and median (1st quartile-3rd quartile) are presented for normally distributed and non-normally distributed 
quantitative variables, respectively. Odds ratio (OR) and 95% CI for OR were obtained using logistic regression analysis, taking vitamin D deficiency (< 50 nmol/L) as a dependent variable 
against potential independent risk factors; Model 1 is for age, BMI, and sun exposure. Model 2 is adjustment 1+ gestational weight gain, parity, season (summer), vitamin D and multivitamin 
intake, physical activity, education, employment, place of residence (north Riyadh), and coverage with clothing. The categorical variables, including GDM, HTN, sun exposure and 
multivitamin supplementation are  presented as ‘yes/no’. Other categorical values, such as blood sample collection in summer vs. winter; time of sun exposure (noon alone plus either sunset 
or sunrise, or both  vs. sunrise or sunset or both), working indoors vs. both indoors and outdoors, and whole body coverage vs. partial coverage with clothing. 
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4.3.5 Alterations in Vitamin D Status During Pregnancy 
During early gestation, 83% (247/297) of the subjects displayed vitamin D 
deficiency, which reduced to 77% (230/297) by mid-pregnancy. This highlights the 
fact that participant's vitamin D levels slightly increased from early to mid-
pregnancy, revealing that the increase in vitamin D from early to mid-pregnancy 
[26.9 (18.2-42.0) vs. 30.5 (20.0-48.8) nmol/L, p = 0.038] remained significant, even 
after adjusting for mid-pregnancy multivitamin intake, physical activity, estimated 
vitamin D-intake, sun exposure, season, and gestational age (p < 0.001) 
(Figure 4.8). Vitamin D levels at mid-pregnancy also positively correlated with 
vitamin D during early pregnancy (r = 0.40, p < 0.001) (Figure 4.9). Furthermore, 
vitamin D levels significantly decreased from early to mid-pregnancy in the non-
deficient group, but significantly increased in the deficient group (Figure 3.10). 
 
 
Figure 4.8  25(OH)D status from early to mid-pregnancy. The values show the 
median vitamin D from early to mid-pregnancy, using the Wilcoxon signed rank 
test. P-value: * denotes p < 0.05. 
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Figure 4.9 Correlation between vitamin D (nmol/L) at mid-pregnancy vs. vitamin 
D (nmol/L) in early pregnancy. 
 
 
 
 
 
           
Figure 4.10 Median vitamin D concentrations (nmol/L) in early and mid-
pregnancy, in both deficient and non deficient groups, according to the Wilcoxon 
signed rank test. P-value: *** denotes p < 0.001.  
 
 
  
103 
 
4.3.6 Comparison Between Variables During Early and Mid-term 
Pregnancy   
As expected, body fat percentages significantly increased from early to mid-
pregnancy (p < 0.001). Interestingly, the data revealed that the increase in body fat 
percentage was greater from early to mid-pregnancy (33.4 ± 5.8% to 37.0 ± 3.2%, 
p < 0.001) in the vitamin D-deficient women, compared with the non-deficient 
group (35.7 ± 5.7% to 38 ± 3.4%, p = 0.002) (Table 4.4). 
 
In the biochemical profile,  the total cholesterol (5.2 ± 1 to 6.6 ± 1.4 mmol/L, p < 
0.001), HDL-cholesterol (1.3 ± 0.4 to 1.6 ± 0.5 mmol/L, p < 0.001), LDL-
cholesterol (3.2 ± 0.7 to 4.0 ± 1.1 mmol/l, p < 0.001), and the total cholesterol/HDL 
ratio (4.1 ± 1.1 to 4.6 ± 1.8 mmol/L, p < 0.001), all significantly increased from 
early to mid-pregnancy, in both groups (Table 4.4). Phosphorus (1.2 ± 0.4 to 1.3 ± 
0.5 mmol/L, p < 0.001), and alkaline phosphatase (9.7 ± 2.9 to 10.4 ± 4.0 mmol/L, 
p < 0.01) also increased significantly from early to mid-pregnancy, among all the 
participants. However, phosphorus and alkaline only increased significantly in the 
deficient group, but did not show any difference in the non-deficient group 
(Table 4.4). Moreover, corrected calcium levels did not show any statistical 
difference from early to mid-pregnancy (2.2 ± 0.2 to 2.2 ± 0.2 mmol/L, p = 0.345).  
 
Sun exposure variables did not change from early to mid-pregnancy. Estimated 
vitamin D [108.5 (63.1-265.5) to 149.5 (67.1-344.5), p < 0.001], and calcium intake 
[163.4 (65.6-596.4) to 212.4 (64.2-673.5), p < 0.001] showed a significant increase 
from early to mid-pregnancy, across the entire sample. Moreover, estimated vitamin 
D and calcium intake significantly increased in the deficient group from early to 
mid-pregnancy, while the non-deficient group did not display any significant 
differences (Table 4.4). Multivitamin intake increased from 19.4% in early 
pregnancy to 47.4% mid-pregnancy (p < 0.001), which was significant in both the 
deficient and non-deficient groups, although this significance was more pronounced 
in the deficient group (p < 0.001) than among the non-deficient group (p = 0.021) 
(Table 4.4). 
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Sedentary time and low-intensity physical activity/walking did not differ between 
the two groups from early to mid-pregnancy [205 minutes/week (75-600) vs. 230 
minutes/week (75-637.5), p = 0.162] and [900 (600-1500) vs. 948.2 (600-1500), p 
= 0.135], respectively. Meanwhile, low-intensity physical activity significantly 
decreased in the non-deficient group (p = 0.01), but significantly increased in the 
deficient group (p = 0.002). However, sedentary time in minutes/week increased 
significantly in the non-deficient group (p = 0.038), but only showed an increasing 
trend among the deficient women, although this was not statistically significant (p 
= 0.466) (Table 4.4). 
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Table 4.4 Comparison of early to mid-pregnancy based on vitamin D status 
 Parameters 
Non-Deficient (N=50) Deficient (N=247) 
Visit 1 Visit 2 P-value Visit 1 Visit 2 P-value 
Systolic BP  116.8 ± 13.2 111.2 ± 15.6 0.014 113.9 ± 13.6 112 ± 12 0.039 
Diastolic BP  69.4 ± 11.2 70.1 ± 12.3 0.698 67.6 ± 9.5 67.2 ± 10 0.603 
Body fat (%) 35.7 ± 5.7 38 ± 3.4 0.002 33.4 ± 5.8 37.0 ± 3.2 < 0.001 
Biochemical Parameters       
Vitamin D (nmol/L) # 65.5 (56.9 – 76.0) 45.3 (29.0 – 64.8) < 0.001 24.2 (17.2 – 33.9) 29.0 (18.8 – 44.9) < 0.001 
Total cholesterol (mmol/L)  5.2 ± 0.8 6.6 ± 1.3 < 0.001 5.2 ± 1 6.6 ± 1.4 < 0.001 
HDL-cholesterol (mmol/L)  1.4 ± 0.3 1.6 ± 0.6 0.036 1.3 ± 0.4 1.6 ± 0.5 < 0.001 
Cholesterol-HDL ratio  3.7 ± 0.7 4.7 ± 2 0.002 4.1 ± 1.2 4.6 ± 1.8 < 0.001 
LDL-Cholesterol (mmol/L)  3.1 ± 0.6 4.1 ± 1 < 0.001 3.2 ± 0.8 4.0 ± 1.1 < 0.001 
Corrected calcium (mmol/L)  2.2 ± 0.2 2.3 ± 0.2 0.668 2.2 ± 0.2 2.2 ± 0.2 0.402 
Phosphorus (mmol/L)  1.3 ± 0.5 1.4 ± 0.4 0.410 1.1 ± 0.4 1.3 ± 0.5 < 0.001 
Creatinine (µmol/L)  60.5 ± 18.7 63.3 ± 15.9 0.480 56.9 ± 17.6 56.5 ± 17.1 0.837 
Glucose (mmol/L) # 4.8 (4.3 – 5.2) 4.3 (3.9 – 4.6) < 0.001 4.8 (4.4 – 5.4) 4.5 (4.0 – 5.1) < 0.001 
Insulin (uU/mL) # 10.5 (4.8 – 20.3) 9.7 (5.3 – 13.5) 0.372 8.3 (4.6 – 18.6) 7.6 (5.0 – 12.1) 0.009 
Alkaline Phosphate  9.7 ± 1.9 9.9 ± 4.4 0.866 9.6 ± 3.09 10.5 ± 3.9 0.005 
Diet       
Vitamin D intake (IU)/day # 91.0 (58.2 - 331.2) 163.0 (58.7 - 373.8) 0.119 108.5 (64.7 - 251.5) 147.2 (67.5 - 331.2) <0.001 
Calcium intake (mg)/day # 137.2 (57.7 - 613.0) 162.2 (57.4 - 650.9) 0.334 163.4 (66.2 - 596.4) 222.8 (65.6 - 686.7) <0.001 
Multivitamin intake 7 (22.6) 15(48.4) 0.021 23 (15.8) 66 (45.2) <0.001 
Physical Activity       
Sitting (minutes/week) #  600.0 (450 – 1500) 911.3 (600 – 1500) 0.038 900.0 (600 – 1500) 1147.4 (600 – 15000) 0.466 
Low intensity (minutes/week) #  840.0 (311.3 – 1500) 435.0 (103.7 – 1000) 0.014 180.0 (62.5 – 420.0) 210.0 (70 – 594.4) 0.002 
Note: Data are presented as the mean and standard deviation for normal variables, while median, first and third quartiles are presented for non-normally distributed 
variables. # indicates non-normal variables; the p-value for mean differences was obtained using a paired sample t-test for normally distributed variables, and a 
Wilcoxon signed rank test for non-normally distributed variables.  
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4.4 Discussion 
In the present study, it must be borne in mind that approximately one-third of the sample 
failed to attend the mid-pregnancy visit. Those who did not attend were significantly 
younger, with a better metabolic profile and higher vitamin D levels. However, they 
also demonstrated significantly less calcium and vitamin D intake, reflecting an 
unhealthy diet. Moreover, the participants who withdrew before the second visit were 
more likely to reside in West Riyadh, which is associated with a lower level of 
education, compared to other parts of the city. In addition, a family history of obesity 
and diabetes was noted for the participants who failed to attend the second visit, and 
they were more likely to have had a previous miscarriage. However, the overall better 
state of health amongst these women withdrawing from the study meant that the figures 
derived at mid-pregnancy were not over-estimated. 
 
The present finding demonstrates that the prevalence of 25(OH)D deficiency (< 50 
nmol/L) in the second trimester of pregnancy amounted to about three quarters (77.4%) 
of the women studied. A higher percentage (86.4%) of vitamin D deficiency in late 
pregnancy has also been reported in KSA (Al-Shaikh et al., 2016). The above study, 
along with the findings from the current study, observed an alarmingly high prevalence 
of vitamin D deficiency in Saudi Arabia. However, these observations may not 
represent the actual status of vitamin D deficiency across the entire Kingdom, because 
they were made exclusively in Riyadh, which is located in the centre of the country. 
Notwithstanding the above, other studies, have similarly stated a prevalence of vitamin 
D deficiency at mid-pregnancy, amounting to 78.7% in China and 74% in India (Sahu 
et al., 2009; Xiao et al., 2015). The situation in the USA appears to be slightly better, 
with 34.8% of pregnant women found to suffer from hypovitaminosis D (< 37.5 
nmol/L) (Gernand et al., 2013). Similarly, in Qatar, 48.4% of pregnant women studied 
were noted as being deficient in vitamin D, although the above study also reported that 
32.5% of the participants consumed vitamin D supplements (Bener et al., 2013). 
Nevertheless, vitamin D deficiency still appears to be especially high among pregnant 
Saudi women, even if this is a general global issue, particularly among pregnant 
women.  
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Despite the fact that the majority of the pregnant women in the present study were 
determined to be deficient in vitamin D by their second trimester, concentrations of the 
vitamin were significantly higher than in the first trimester. Similar observations of a 
progressive increase in blood vitamin D status have previously been reported, with 
significantly higher 25(OH)D status during the second trimester, compared to the first 
trimester of pregnancy (Charatcharoenwitthaya et al., 2013). Other studies have also 
reported that serum vitamin D levels can demonstrate an insignificant increase from the 
first to the second trimester (Park et al., 2014; Choi et al., 2015; Lundqvist et al., 2016). 
However, compared to the first trimester, a significant increase in vitamin D levels 
during the third trimester is in keeping with the results of the present study; suggesting 
a progressive increase in serum vitamin D levels as the pregnancy advances (Bodnar et 
al., 2007b; Ginde et al., 2010; Vandevijvere et al., 2012; Charatcharoenwitthaya et al., 
2013; Choi et al., 2015; Bärebring et al., 2016; Lundqvist et al., 2016). A decreasing 
trend, or absence of any change, in serum vitamin D levels with advancing pregnancy 
have also been reported in a number of other papers (Ritchie et al., 1998; Marwaha et 
al., 2011; Fernández-Alonso et al., 2012; Zhang et al., 2014; Jafarzadeh et al., 2015; 
Moon et al., 2015). Although, it is crucial to note that no study has observed static 
trends in vitamin D concentration during pregnancy, if corrected for seasonal and 
lifestyle factors. For example, a recent study corrected for seasonal factors revealed that 
vitamin D levels tend to increase as pregnancy progresses (Bärebring et al., 2016). 
Moreover, higher baseline concentrations of vitamin D in early pregnancy are better 
predictors of higher concentrations during the later stages of gestation (Ginde et al., 
2010; Charatcharoenwitthaya et al., 2013; Lundqvist et al., 2016). 
 
Similar to the results described in Chapter 3, seasonal factors were not found to impact 
vitamin D levels, although sun exposure indices were associated with vitamin D levels 
at mid-pregnancy. Other studies conducted during mid-pregnancy have yielded 
findings to support the above (Bener et al., 2013; Parildar et al., 2013; Xiang et al., 
2013). Additionally, estimated vitamin D and calcium intake failed to display any 
significant difference in mid-pregnancy vitamin D concentrations.  In general, vitamin  
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D, calcium, and multivitamin intake in the present study were found to significantly 
increase as the pregnancies progressed. This may be explained by improved appetite 
and food cravings during mid-pregnancy, after the first-trimester pregnancy symptoms 
have diminished (Bayley et al., 2002). Food cravings naturally appear late during early 
gestation, and peak mid-gestation, before weakening as gestation progresses to full term 
(Bayley et al., 2002).   
 
In the present study, by mid-pregnancy, multivitamin supplementation was found to 
confirm a slight increase in vitamin D levels, and hence, could be indicated as having a 
partial role in enhancing vitamin D levels from early to mid-pregnancy. Numerous 
studies conducted in the past have reported the impact of multivitamins on vitamin D 
levels (Bodnar et al., 2007b; Ginde et al., 2010; Charatcharoenwitthaya et al., 2013). 
For example, an intake of 400 IU of multivitamins daily, may be inadequate for 
increasing vitamin D concentrations in expectant mothers to ≥ 50 nmol/L,  especially 
among high-risk women, such as ethnic minorities and women living at northern 
latitudes, and for winter pregnancies (Cockburn et al., 1980; Hollis & Wagner, 2004; 
Ginde et al., 2010). This multivitamin concentration may help to prevent 
hypovitaminosis D in women with adequate levels of vitamin D, but would be 
inadequate for resolving insufficiency, if used in isolation (50-75 nmol/L) 
(Charatcharoenwitthaya et al., 2013). Thus, vitamin D supplementation in higher doses 
is essential for pregnant women, especially Saudi women, where the majority are 
already vitamin D-deficient. A daily supplement of 4000 IU/day of vitamin D is 
considered to be safe, and reasonably adequate for avoiding vitamin D deficiency in 
pregnancy (Hollis et al., 2011). 
 
Also comparable to Chapter 3, neither BMI nor fat percentage correlated with serum 
vitamin D levels in the second half of pregnancy, which is supported by other 
observations made previously (Clifton-Bligh et al., 2008; Farrant et al., 2008; 
Soheilykhah et al., 2010; Lau et al., 2011; Josefson et al., 2013; Karras et al., 2013; 
Karlsson et al., 2015; Simões et al., 2016). Conversely, an inverse correlation between 
BMI and vitamin D levels during the second half of gestation has also been reported  
(Bodnar et al., 2007b; Soheilykhah et al., 2010; Zuhur et al., 2013; Arnold et al., 2015).  
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However, similar to the current findings, no such correlations were reported alongside 
adiposity (body fat content) in the literature. In addition, as with obesity and adiposity, 
a null relationship was observed for GWG and vitamin D concentration. However, there 
are controversial and insufficient data to suggest that maternal obesity/adiposity 
reduces maternal vitamin D concentrations, especially during mid- and late pregnancy 
(Simões et al., 2016). Possible explanations for the absence of an association between 
adiposity and maternal vitamin D concentration in previous studies include: (1) no 
difference between the mean BMI, fat percentage, and GWG in the deficient and non-
deficient groups, (2) changes in vitamin D metabolism during pregnancy (Salle et al., 
2000; Song et al., 2013), (3) the failure to determine any vitamin D protein ligands 
(Brannon & Picciano, 2011), and (4) increased total body water content 
(haemodilution), observed during pregnancy. However, the mechanisms involved have 
yet to be elucidated.  
 
Also, similar to Chapter 3, physical activity in mid-pregnancy was found to positively 
correlate with serum vitamin D levels, and also emerged as an independent determinant 
for predicting 25(OH)D concentration at mid-pregnancy. A positive correlation 
between physical activity and 25(OH)D concentration during gestation has been 
described in the past (Wuertz et al., 2013; Moon et al., 2015; Simões et al., 2016). In 
the present study, physical activity was indeed found to restore vitamin D levels to an 
extent, but this fell short of optimal restoration, although this could be due to incidental 
sun exposure, experienced as individuals participate in physical activity. However, 
there are suggestions that physical activity per se has an independent effect on vitamin 
D levels, a suggestion that is implicated here, as the increase in vitamin D concentration 
was still significant, even after adjusting for sun exposure. However, this has rarely 
been investigated during pregnancy in any detail.  
 
During the second trimester, cardiometabolic profiles were associated with vitamin D 
deficiency, with pronounced significance in TG levels. This confirms the role of 
vitamin D deficiency in increasing the incidence of metabolic disorders (Boucher, 
1998; Barter  et al., 2007), but there is limited information regarding the link between  
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25(OH)D concentration and lipid profiles during pregnancy. A cross-sectional study 
investigating non-pregnant Canadian female adults, with a high risk of T2DM and 
obesity, has nevertheless shown that TG decreased as much as 0.14 mmol/L per 1 
nmol/L increase in vitamin D (Mansuri et al., 2015). It has been suggested that 
25(OH)D may facilitate the removal of lipoprotein particles, by increasing the gene 
expression of lipoprotein lipase (Vu et al., 1996). Moreover, hyperparathyroidism, 
secondary to hypovitaminosis D could also decrease the peripheral removal of TG (Cho 
et al., 2005; Kwon & Lim, 2016). 
 
In the current study, 25(OH)D deficiency in early pregnancy represented an 
independent risk factor for vitamin D deficiency at mid-pregnancy, after adjusting for 
confounding factors. In addition, vitamin D deficiency in early pregnancy has been 
proposed as an independent predictor of 25(OH)D inadequacy in the third trimester of 
pregnancy (Charatcharoenwitthaya et al., 2013; Choi et al., 2015). 
 
The reason for the slight increase in vitamin D observed from early to mid-pregnancy 
is partly due to physical activity, as well as vitamin D and multivitamin intake. Other 
variables include sun exposure, obesity, season (summer), and body fat percentage; did 
not reveal any association with changes in vitamin D levels from early to mid-
pregnancy, at either of the visits. Moreover, it is possible that vitamin D-binding 
proteins, or genetic factors, play a role in vitamin D increases (Wang et al., 2010).  
 
It was also evident that vitamin D levels behaved differently in the deficient and non-
deficient groups. In the deficient group, 25(OH)D increased from early to mid-
pregnancy, while in the non-deficient group, vitamin D levels appeared to decrease 
from early to mid-pregnancy. It can, therefore, be concluded in this study that the 
deficient group was most influential on the overall population sample, thus showing a 
trend towards an increase. In this regard, it is possible that the vitamin D-deficient 
subjects, after being informed of their vitamin D status, increased their multivitamin 
intake, consumed more vitamin D rich food, and engaged in more physical activity, 
compared to their non-deficient counterparts.  
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In conclusion, the strongest predictors of vitamin D status in pregnancy emerged as 
multivitamin supplementation, working indoors, and physical activity. Some of the 
disagreement arising between other published literature and the present data may be 
attributed to different study conditions, methods of vitamin D analysis, varying sample 
size and demographics, different latitudes and duration of UV exposure, seasonal 
factors, and lifestyle habits. Other reasons for the changing serum vitamin D 
concentrations seen in pregnancy, could include altered liver 25-hydroxylase activity, 
changes in intact PTH levels, increased foetal metabolic activity (Cushard et al., 1972; 
Sanchez et al., 1997), and the influence of placenta-derived hormones (Kovacs & 
Kronenberg, 1997; Tobias & Cooper, 2004). Therefore, further research is essential for 
exploring these factors in Saudi Arabia. 
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5.1 Introduction 
The prevalence of obesity and T2DM is high throughout the world, but particularly in 
Middle Eastern countries (Al-Daghri et al., 2010; Bahijri et al., 2016). For example, it 
has been reported that as many as 34.6 million people in the Middle East were 
diagnosed with T2DM in 2013, and this is expected to rise to 67.9 million people by 
2035; an increment of 96% (Guariguata et al., 2014). According to the International 
Diabetes Federation (IDF), the prevalence of adult T2DM in Saudi Arabia is estimated 
at 17.4% (IDF, 2015). This is particularly concerning, due to the emerging trends of 
further disease, beyond T2DM, and the importance of identifying high-risk groups 
early. Having GDM has been recognised as the strongest predictor of T2DM, with a 7-
8 times higher risk of T2DM later in life (Kim et al., 2002; Yang et al., 2009). 
 
The prevalence of GDM ranges from 1-14% of all pregnancies, depending on the 
diagnostic criteria applied, and the ethnic group involved (ADA, 2004; Jang, 2011; Kim 
et al., 2012). Data on the overall prevalence of GDM in Saudi Arabia remains limited. 
Nevertheless, in 2015, one study performed in the Saudi Arabian city named Al-Madina 
reported a prevalence of 39.4% for GDM, using the IADPSG diagnostic criteria 
(Alfadhli et al., 2015). 
  
GDM is associated with multiple adverse maternal and neonatal complications (Kjos & 
Buchanan, 1999; Reece, 2010). For instance, it is known to cause almost 7% of 
pregnancy-related complications, including hypertension and pre-eclampsia, as well as 
leading to caesarean section, infection, and polyhydramnios (Kjos & Buchanan, 1999; 
Di Cianni et al., 2003; Gasim, 2012; Chen et al., 2015). Additionally, GDM is related 
to long and short term foetal complications (Kjos & Buchanan, 1999; Erem et al., 2003; 
Gasim, 2012; Alfadhli et al., 2015). Furthermore, mothers with GDM tend to suffer a 
financial burden that can be around 25% higher, and bear 44-49% greater costs for 
inpatient care, in comparison with a normal pregnancy (Kolu et al., 2012). Therefore, 
the timely identification of factors predisposing pregnant women to GDM, not only 
appears to be cost effective, but may even be critical for avoiding associated morbidity.  
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A number of pre-pregnancy, or pregnancy-related risk factors, associated with GDM 
have been identified beyond simple obesity. The pre-pregnancy factors include age 
(over 35 years old), ethnicity, multiparity, changes in weight between pregnancies, 
cigarette smoking, family history of T2DM or GDM, previous GDM, history of foetal 
death, previous macrosomia, and previous caesarean section (Nohira et al., 2006; 
Russell et al., 2008; Dode & Santos, 2009; Reece et al., 2009; Al-Rowaily & 
Abolfotouh, 2010; Nankervis et al., 2012). Polycystic ovary syndrome has also been 
implicated in the later development of IGT and GDM (Noctor & Dunne, 2015). 
Furthermore, at least 10 genes with specific polymorphisms have been linked with an 
elevated risk of GDM, particularly the TCF7L2 gene (Zhang et al., 2013). Additionally, 
high levels of serum γ-glutamyl transferase in the years prior to pregnancy have been 
identified as an intrinsic factor for the development of GDM (Osorio, 2014). 
 
Pregnancy-related factors of increased risk of GDM, such as  high random and fasting 
glucose levels during pregnancy (Kim et al., 2002), an abnormal OGTT result (Jang, 
2011; Noctor & Dunne, 2015), and high HbA1c during early pregnancy, have also been 
associated with future risk of GDM (Hughes et al., 2014). Furthermore, inadequate 
insulin secretion following OGTT is implicated in the development of abnormal 
glucose tolerance, and GDM risk (Buchanan et al., 1998). Moreover, excessive GWG 
(Hantoushzadeh et al., 2016), unhealthy dietary habits, and physical inactivity are 
considered to be potential risk factors for the development of GDM (Dode & Santos, 
2009; Erem et al., 2015), while lipid profile abnormalities in early pregnancy are also 
associated with GDM future development (Enquobahrie et al., 2005; Li et al., 2015).  
 
The aim of the present study was to estimate the prevalence of GDM among pregnant 
Saudi women, using the IADSPG criteria. Although the risk factors of GDM in Saudi 
communities may vary from those of other populations, it is important to understand 
the key influences, and also the impact of gestational age, on classical and non-classical 
factors influencing the onset of GDM. 
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5.2 Study Design and Methods 
5.2.1 Study Design and Population 
This was a prospective observational study of 297 pregnant women with a mean age 
28.9 ± 5.3 years, followed from the first to the second trimester of pregnancy. The 
inclusion and exclusion criteria were applied as explained in Chapter 2. 
 
5.2.2 Data Collection 
Socio-economic data were obtained from all the women at their first visit, using a 
questionnaire to retrieve details of their clinical and obstetric history. Also, 
anthropometric and lifestyle factors were collected and analysed, such as physical 
activity, using the short version of IPAQ (Hernandez-Cordero et al., 2008; Bertolotto 
et al., 2010; Harizopoulou et al., 2010). The cut-off points for the above variables are 
presented in Chapter 2. 
 
During the first visit, random blood samples were collected to measure blood glucose, 
insulin, HbA1c, and lipid profile. During mid-pregnancy (at 24-28 weeks of gestation), 
subjects were asked to fast for at least 10 hours, and GDM screening was performed. A 
fasting blood sample was then withdrawn and each participant was subsequently made 
to drink 75 gm of glucose within five minutes. Blood samples were collected after 60 
and 120 minutes, for the assessment of glucose and insulin levels. IADPSG guidelines 
were also applied to diagnose GDM as described in chapter 2. HOMA-IR and HOMA-
β were also calculated using HOMA-IR and HOMA-β Matthews equations, 
respectively (Matthews et al., 1985; Wallace et al., 2004).  
 
An assessment of other biochemical parameters performed at the first visit was also 
repeated, including HbA1c and lipid profile. Finally, metabolic syndrome was 
classified according to the criteria proposed by the US NHLBI/AHA, with adaptations 
appropriate for the present study population (Grundy et al., 2005). Metabolic syndrome 
is defined in Chapter 2. 
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5.2.3 Data Analysis 
Data were analysed using SPSS version 21.0 statistical software (SPSS, Chicago, IL, 
USA). Pearson’s chi-square test was applied to observe the association between 
categorical variables (GDM vs. non-GDM). To determine GDM and non-GDM 
differences, an independent sample t-test and Mann-Whitney U Test were implemented 
for normally and non-normally distributed variables, respectively. ANCOVA was 
applied to compare groups using age and BMI as covariates. To compare non-normally 
distributed variables, categorised into more than two groups, an independent sample 
Kruskal Wallis Test was conducted. Pearson’s and Spearman’s rank correlation 
coefficients were also determined to assess the linear relationship between quantitative 
variables for normally and non-normally distributed variables, respectively, with a p-
value of < 0.05 indicating statistical significance. 
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5.3 Results 
5.3.1 Prevalence of GDM 
The present study included 297 consecutive pregnant women, 33% of whom (98/279) 
were diagnosed with GDM, based on IADPSG (Figure 5.1). According to their fasting 
blood glucose, 65.7% (195/297) of the sample were diagnosed with GDM, and 34.3% 
(101.8/297) were diagnosed using a 1-hour or 2-hour glucose tolerance test. 
 
 
 
Figure 5.1 The prevalence of GDM according to IADPSG. The values show the 
percentage of women with, and without, GDM by mid-pregnancy. 
 
 
 
5.3.2 General Characteristics of Subjects with and without GDM 
5.3.2.1 Socio-economic Status in Relation to GDM  
There were no significant socio-economic differences observed between women with 
and without GDM, in terms of their education, income status, employment, or place of 
residence. A lower proportion of the women were university graduates in the GDM 
group, compared to the non-GDM group, but this was not statistically significant 
(29.8% vs.70.2%, p = 0.107) (Figure 5.2).  
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Figure 5.2 Educational status of women, in relation to GDM status. The values show 
the percentage of women with university degrees among the GDM and non-GDM 
subjects. P-values were obtained using Pearson’s chi-square test.  
 
 
5.3.2.2 Obstetric and Family History in Relation to GDM 
In the GDM group, the women were significantly more likely to have experienced 
GDM in the past, and have a family history of diabetes, compared with the women who 
were not currently suffering from GDM (p < 0.001 and p = 0.045, respectively). 
Multiparity and irregular menstrual cycle were also more common among the women 
suffering from GDM, compared to their counterparts without GDM, but this was not 
statistically significant (p = 0.067 and p = 0.097, respectively). Data on obstetric 
parameters and family history are presented in Figure 5.3. 
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Figure 5.3 Obstetric parameters and patient history, in relation to GDM status. The 
values show the percentage of women with obstetric risk factors, and a family history 
of diabetes in the GDM and non-GDM groups. P-values: * denotes p < 0.05 and *** 
denotes p < 0.001 using Pearson’s chi-square test. 
 
  
5.3.2.3 Anthropometric Characteristics in Relation to GDM 
Pre-pregnancy, early, and mid-pregnancy BMIs were significantly higher in the GDM 
group, compared to their counterparts without GDM, but this significance disappeared 
after adjusting for age. Additionally, waist circumference in early and mid-pregnancy 
was significantly higher amongst the GDM subjects, compared with the non-GDM 
subjects, but the difference was insignificant after adjusting for age and BMI. No 
significant differences were observed in WHR, body fat, or Δ body fat percentage 
during either visit.  The anthropometric characteristics of both the GDM and non-GDM 
groups are shown in Table 5.1. Furthermore, maternal fasting glucose showed a 
positive correlation with pre-pregnancy BMI (r = 0.18, p = 0.002), and BMI in early (r 
= 0.18, p = 0.002), and mid-pregnancy (r = 0.16, p = 0.007), along with gestational age 
(r = 0.16, p = 0.006).  
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Table 5.1 Anthropometric characteristics for both visits, in relation to GDM status  
Parameters 
Non GDM 
(N = 198) 
GDM 
(N = 99) 
P-values P-values * 
            Booking Visit 
Age (years)      28.5 ± 5.3  29.6 ± 5.4   0.098 --- 
Gestational age (weeks) 12.1 ± 2.9 12.4 ± 3.3 0.391 0.399 
Pre-pregnancy BMI (kg/m2)   26.1 ± 6.0 28.3 ± 5.7 0.003 0.111 
BMI (kg/m2) at visit 1 27.3 ± 6.4 29.2 ± 5.5 0.010 --- 
Waist circumference (cm) 91.0 ± 12.9 94.3 ± 12.9 0.040 0.402 
Hip circumference (cm) 107.1 ± 12.2 109.4 ± 10.6 0.108 0.738 
Waist-hip ratio (WHR)  0.9 ± 0.1 0.9 ± 0.1 0.198 0.253 
Systolic BP (mmHg) 114.6 ± 13.8 113.1 ± 12.8 0.359 0.115 
Diastolic BP (mmHg) 68.0 ± 9.9 66.9 ± 9.5 0.359 0.196 
Body fat (%) 33.5 ± 6.4 34.3 ± 4.6 0.292 0.906 
      OGTT Visit 
Gestational age (weeks) 26.4 ± 3.0 26.1 ± 3.6 0.463 0.476 
BMI (kg/m2) at visit 2 29.5 ± 6.4 31.1 ± 5.2 0.035 0.228 
Gestational weight gain (GWG) (kg) 7.5 ± 4.2 6.5 ± 4.3 0.054 0.211 
Waist circumference (cm) 103.8 ± 13.0 107.1 ± 12.5 0.041 0.358 
Hip circumference (cm) 112.7 ± 11.5 114.9 ± 10.7 0.126 0.263 
Waist-hip ratio (WHR)  0.9 ± 0.1 0.9 ± 0.1 0.094 0.053 
Systolic BP (mmHg) 111.2 ± 12.1 113.4 ± 13.0 0.163 0.718 
Diastolic BP (mmHg) 67.2 ± 10.2 69.3 ± 11.2 0.106 0.249 
Body fat (%)  37.1 ± 3.5 37.3 ± 2.9 0.711 0.686 
Δ Body fat (%) 10.1 ± 28.9 10.3 ± 14.9 0.952 0.437 
Note: Data are presented as the mean and standard deviation for normal variables. The p-value for mean differences 
was obtained using an independent sample t-test for normally distributed variables. * indicates p-values adjusted for 
age and BMI, at the first visit. 
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For GWG, either in total kilograms (Table 5.1) or, according to the IOM 
(excessive/non-excessive), no difference was found between the groups (Figure 5.4). 
Interestingly, a negative correlation was detected between total GWG and fasting 
glucose (r = -0.16, p = 0.006) (Figure 5.5). What is more, total GWG was found to be 
significantly lower among women who had been obese pre-pregnancy, in comparison 
to their underweight, normal, and overweight counterparts (p < 0.001) (Appendix VI).  
 
Figure 5.4 GWG parameters, based on IOM mid-pregnancy, in relation to GDM status.  
The values show the percentage of women with excessive and non-excessive weight 
gain by mid-pregnancy, in both the GDM and non-GDM groups. Pearson’s chi-square 
test was used. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Correlation between log of fasting glucose (mmol/L) and GWG, between 
early and mid-pregnancy. 
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5.3.2.4 Biochemical Characteristics in Relation to GDM 
The biochemical parameters in both early and mid-pregnancy are shown in Table 5.2. 
Maternal fasting glucose in the OGTT exhibited a positive correlation with random 
glucose (r = 0.15, p = 0.012), random insulin (r = 0.13, p = 0.028), 1- and 2-hour glucose 
tolerance (r = 0.25, p < 0.001 and r = 0.22, p < 0.001), HbA1c at both visits (r = 0.24, 
p < 0.001 and r = 0.29, p < 0.001), fasting insulin (r = 0.38, p < 0.001), 2-hour insulin 
(r = 0.14, p = 0.056), and HOMA-IR (r = 0.54, p < 0.001). Furthermore, maternal fasting 
glucose showed a negative correlation with HOMA-β (r = -0.37, p < 0.001). 
 
The lipid profile at both visits, except for TG, failed to show any significant difference 
between the GDM groups. TG in mid-pregnancy was significantly higher among the 
GDM sufferers, compared to the non-GDM group, persisting even after adjusting for 
BMI and age. A positive correlation was observed between maternal fasting glucose 
and total cholesterol/HDL ratio in early (r = 0.21, p < 0.001) and mid-pregnancy (r = 
0.19, p < 0.001), and TG in early (r = 0.16, p = 0.005) and mid-pregnancy (r = 0.19, p 
= 0.001). Also, maternal fasting glucose correlated negatively with HDL-cholesterol in 
early (r = -0.15, p = 0.012) and mid-pregnancy (r = -0.20, p = 0.001). These correlations 
presented in early (Figure 5.6) and mid-pregnancy (Figure 5.7). 
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Table 5.2 Biochemical characteristics in early and mid-pregnancy in relation to 
GDM status 
Parameters 
Non-GDM 
(N = 198) 
GDM 
(N = 99) 
P-values P-values* 
        Booking Visit 
Glucose (mmol/L) # 4.6 (4.3 - 5.2) 5.1 (4.6 - 5.8) < 0.001 0.002 
Insulin (uU/mL) # 8.2 (4.2 - 18.3) 9.6 (6.0 - 20.6) 0.059 0.375 
HbA1c (%) 5.0 ± 0.5 5.2 ± 0.5 < 0.001 0.003 
Total cholesterol (mmol/L)  5.2 ± 1.0 5.3 ± 1.0 0.336 0.930 
HDL-cholesterol (mmol/L)  1.4 ± 0.4 1.3 ± 0.4 0.206 0.185 
Cholesterol-HDL ratio  4.0 ± 1.0 4.2 ± 1.2 0.061 0.187 
LDL-cholesterol (mmol/L)  3.1 ± 0.7 3.2 ± 0.8 0.449 0.920 
Triglycerides (mmol/L)  1.4 ± 0.6 1.6 ± 0.6 0.071 0.253 
        OGTT Visit 
Fasting glucose (mmol/L) #            4.2 (3.8 - 4.5) 5.2 (4.7 - 5.7) < 0.001 < 0.001 
1-hr glucose (mmol/L) # 6.8 (5.6 - 8.0) 9.5 (7.9 - 10.7) < 0.001 < 0.001 
2-hr glucose (mmol/L) # 6.0 (5.1 - 7.0) 7.1 (5.9 - 9.5) < 0.001 < 0.001 
Fasting insulin (uU/mL) # 6.2 (4.2 - 10.8) 10.5 (6.7 - 17.8) < 0.001 < 0.001 
2-hr insulin (uU/mL) # 35.3 (24.1 - 53.9) 55.5 (32.7 - 76.8) < 0.001 0.124 
HOMA-IR # 1.2 (0.8 - 2.2) 2.4 (1.6 - 4.6) < 0.001 < 0.001 
HOMA-β # 201.8 (127.5 - 387.4) 168.9 (74.8 - 270.3) 0.002 0.194 
HbA1c (%) 4.8 ± 0.4 5.0 ± 0.5 < 0.001 < 0.001 
Total cholesterol (mmol/L)  6.6 ± 1.3 6.7 ± 1.4 0.656 0.857 
HDL-cholesterol (mmol/L)  1.6 ± 0.5 1.5 ± 0.5 0.154 0.080 
Cholesterol-HDL ratio  4.5 ± 1.7 4.9 ± 2.0 0.057 0.075 
LDL-cholesterol (mmol/L)  4.1 ± 1.1 4.1 ± 1.1 0.748 0.732 
Triglycerides (mmol/L)  2.0 ± 0.7 2.3 ± 0.8 0.001 0.005 
Note: Data presented as the mean and standard deviation for normally distributed variables, while the median, 1st 
and 3rd quartiles are presented for non-normally distributed variables. # indicates non-normally distributed variables; 
the p-value for mean differences was obtained using an independent sample t-test for normal variables, and a Mann-
Whitney U Test for non-normally distributed variables; * indicates p-values, adjusted for age and BMI at the 1st 
visit. 
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Figure 5.6 Correlations between the log of fasting glucose, and (A) Total cholesterol-
HDL ratio, (B) Triglycerides, and (C) HDL–cholesterol in early pregnancy. 
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Figure 5.7 Correlations between the log of fasting glucose, and (A) Total cholesterol-
HDL ratio, (B) Triglycerides, and (C) HDL–cholesterol mid-pregnancy. 
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5.3.2.5 Metabolic Disorders in Relation to GDM Status 
The prevalence of pre-pregnancy obesity, and obesity in early and mid-pregnancy, were 
higher among the subjects with GDM compared with those without GDM (Figure 5.8). 
At mid-pregnancy, the percentage of participants with hypertriglyceridemia or 
metabolic syndrome was also significantly higher among the subjects with GDM, in 
comparison with their non-GDM counterparts (p = 0.024 and p < 0.001, respectively). 
This will be discussed further in Chapter 6. 
 
Figure 5.8 Presence of metabolic disorders in (A) Early, and (B) Mid-pregnancy among 
GDM and non-GDM subjects. The values show the percentage of women with different 
metabolic disorders in early and mid-pregnancy, in both the GDM and non-GDM 
groups. P-values: * denotes p < 0.05, **p < 0.01, and ***p < 0.001, using Pearson’s 
chi-square test. 
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5.3.2.6 Physical Activity in Relation to GDM Status 
In early pregnancy, women without GDM undertook significantly higher low-intensity 
physical activity/walking (in minutes/week), compared with the GDM subjects, even 
after adjustment for age and BMI (p = 0.007). However, the latter variable was not 
statistically significant by mid-pregnancy (p = 0.163) (Figure 5.9). 
 
 
 
Figure 5.9 Physical activity (PA) at both visits, in relation to GDM status.  The values 
show the median sedentary and physical activity in minutes per week among both the 
GDM and non-GDM subjects, after adjusting for age and BMI. ** denotes p < 0.01, 
using the Mann-Whitney U Test. 
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5.4 Discussion 
This study is one of the few studies conducted in Saudi Arabia that assesses the 
prevalence of GDM using IADPSG, along with the associated risk factors in both early 
and mid-pregnancy. In this present chapter, it was determined that 33% of the subjects 
had developed GDM by mid-pregnancy. Moreover, in early pregnancy, higher random 
blood glucose and HbA1c levels were associated with GDM in mid-pregnancy, whereas 
hypertriglyceridemia and metabolic syndrome in mid-pregnancy were higher in the 
GDM group. A maternal lifestyle factor, such as physical activity, was associated with 
conferring protection against GDM. Many of these risk factors are adjustable, so timely 
identification of the determinants, and subsequent intervention could prevent the 
development of GDM, and any associated morbidity. 
 
The prevalence of GDM in Saudi Arabia has been steadily increasing, from 12.5% in 
2000, to 18.7% in 2013, and then 24% in 2015, according to the ADA and WHO 2013 
criteria (Ardawi et al., 2000; Wahabi et al., 2014; Wahabi et al., 2016). A prevalence of 
33% GDM was found in the current study, according to the IADPSG criteria. This 
appears to be high, thus corresponding to the rising trend towards GDM in Saudi 
Arabia. The IADPSG criteria may even have contributed to the observed prevalence of 
GDM in this present study, as this is 2-3 times higher than the previously reported 
prevalence of GDM in the respective context, when the ADA criteria were used (Al-
Rowailly & Abolfotouh, 2010; Wahabi et al., 2014). The reason for the high prevalence 
when using the IADPSG criteria may be due to the inclusion of pregnant women with 
hyperglycaemia in the GDM group (Han et al., 2012; IDF, 2013). In support of the 
findings from the present study, the application of the IADPSG criteria has previously 
determined 39.6% and 36.6% prevalence rates of GDM in Saudi Arabia, and 37.7% in 
the UAE (Agarwal et al., 2010; Al-Rubeaan et al., 2014; Alfadhli et al., 2015).  
 
The difference between the prevalence rates in the present study, and a study conducted 
by Al-Rubeaan et al. (2014) is that the latter used fasting glucose levels alone to screen 
for GDM. This was due to convenience, as it was a home-based study. Alfadli et al. 
(2015) reported a higher incidence of GDM in Western Saudi Arabia, but the present 
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study was conducted in the central region, so regional variation could account for some 
of the differences between the studies. The application of IADPSG to assess GDM in 
other international studies has reported prevalence rates amounting to 30.5% in Norway 
(Jenum et al., 2012), 29.9% in Iran (Shahbazian et al., 2016), and 27% in India (Nayak 
et al., 2013). Prevalence rates as low as 9.3% have been reported in China (Leng et al., 
2015), 12.4 % in Ireland (O’Sullivan et al., 2011), 13% in Australia (Moses et al., 2011), 
and 17.8% in Canada (Ryan, 2011). It is believed that the prevalence of GDM is 
influenced by ethnic variations within a population, as well as genetic, demographic, 
socio-cultural, and socio-economic factors (Yuen & Wong, 2015).  
 
A family history of diabetes, prior history of GDM, and multiparity were well-known 
factors associated with GDM, identified in this and previous studies (Savvidou et al., 
2010; Teh et al., 2011; Khan et al., 2013; Alfadhli et al., 2015; Erem et al., 2015; Chitme 
et al., 2016; Lin et al., 2016; Shahbazian et al., 2016). It is worth noting that the 
percentage of women with a family history of diabetes in the GDM group, in the current 
study, amounted to 78.3%, which is similar to the previously reported 68.2% of 
pregnant Saudi women (Alfadhli et al., 2015). The higher prevalence of a family history 
of diabetes in both Saudi cohorts paralleled the high prevalence of T2DM in Saudi 
Arabia (Al-Nozha et al., 2004; Al-Daghri et al., 2010; Al-Rubeaan et al., 2014). 
Irregular menstrual cycle in this cohort showed a higher trend in GDM subjects, 
compared to non-GDM subjects (p = 0.097). Other studies have previously revealed 
that an irregular menstrual cycle is significantly associated with GDM (Haver et al., 
2003; Bhat et al., 2010).  
 
It is well recognised that pre-pregnancy obesity, or obesity at different gestational 
stages is associated with GDM, and this was supported by the current study, as well as 
previous studies in different countries, including Saudi Arabia (Al-Rowaily & 
Abolfotouh, 2010; El-Gilany & Hammad, 2010; Bener et al., 2013; Al-Rubeaan et al., 
2014; Park et al., 2014; Arnold et al., 2015; Erem et al., 2015; Mao et al., 2015; Lin et 
al., 2016; Shahbazian et al., 2016). However, the present study revealed no difference 
in fat mass markers between the GDM and non-GDM groups, in either early or mid-
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pregnancy. This may be attributed to foetal growth and fluid retention in GDM mothers, 
which may have affected the readings of fat mass in this study. 
 
In the present study, a negative association between fasting glucose and GWG was 
detected. This inverse correlation between pregnancy-related weight gain and GDM 
has previously been reported (Nohr et al., 2008; Heude et al., 2012; Li et al., 2015; 
Hung & Hsieh, 2016). This could be explained by women with a higher BMI gaining 
less weight, because they are more cautious about it. However, even if these women 
gain less weight in pregnancy, their hepatic gluconeogenesis may still be bad, because 
of their pre-pregnancy obesity. In the current study, irrespective of GDM status, total 
GWG in kilograms or GWG according to the IOM (2009), the GDM group also 
demonstrated lower weight gain from early to mid-pregnancy, but this did not reach a 
level of significance. Other earlier studies have also failed to indicate a difference 
(Saldana et al., 2006; Herring et al., 2009; Lacroix et al., 2014; Park et al., 2014; Ruifrok 
et al., 2014). On the contrary, there is evidence to suggest that the increased risk of 
developing GDM during pregnancy is related to excessive weight gain before GDM 
diagnosis (Brunner et al., 2015). Inconsistencies in studies regarding the association of 
GWG and GDM could be due to differences between the cut-off points, continuous and 
other categorical measurements and the time intervals for assessing GWG (Dode & 
Santos, 2009). 
 
In addition to the above, low-intensity physical activity for a minimum of 30 
minutes/day during early pregnancy was found to be linked with GDM in this instance. 
Similar observations have also been reported in numerous studies documenting that 
light-to-moderate intensity physical activity during early pregnancy is linked with a 
lower risk of GDM (Oken et al., 2006; Morkrid et al., 2014; Nasiri-Amiri et al., 2016). 
An assessment of physical activity using the IPAQ-Greek version revealed that 
inactivity among pregnant women during the early stages of pregnancy poses a 
significant risk of GDM, compared to women involved in physical activities 
(Harizopoulou et al., 2010). An example of this could be regular walk during early 
pregnancy, which has been shown to have an inverse relationship with the risk of GDM, 
whereas occupational and physical activity in the home has no impact (Aune et al., 
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2016). However, this current study, along with others, failed to find an association 
between mid-pregnancy physical activity and GDM (Parildar et al., 2013; Chasan-
Taber et al., 2014), which points to the relevance of physical activity during early 
pregnancy, but not during the later stages, when GDM may have already occurred. 
 
Physical activity has been linked to a lowered risk of excessive GWG, insulin 
resistance, and T2DM (Helmrich et al., 1991; Manson et al., 1991; Wang et al., 2002). 
It has also long been known for its role in improving glucose homoeostasis by 
enhancing insulin sensitivity, and this is most likely due to increasing fat-free mass 
(Shulman et al., 1990; Annuzzi et al., 1991; Devlin, 1992). Moreover, physical activity 
has been implicated in the prevention or delay of T2DM onset among non-pregnant 
individuals (Boule et al., 2001; Jeon et al., 2007). It is, therefore, quite likely that 
physical activity has the potential to prevent the development of GDM, and its related 
adverse health outcomes (Morkrid et al., 2014).  
 
In the present study, fasting glucose by mid-pregnancy was diagnostic for GDM in 
65.7% of cases. Therefore, the assessment of fasting glucose appears to be a useful 
option as an initial screening test to diagnose GDM (Agarwal et al., 2010). Moreover, 
the assessment of 1- and 2-hour glucose concentrations during the OGTT was also 
useful for GDM diagnosis, as these tests were diagnostic in over one-third of the GDM 
cases here. The above findings differed from those derived from another Saudi study, 
where 48% GDM cases were diagnosed by fasting glucose, and 52% were diagnosed 
using 1- and 2-hour OGTT glucose levels (Alfadhli et al., 2015).  
 
Random plasma glucose, in early pregnancy, has been proposed as a useful screening 
test for GDM, identifying women at low and high risk of GDM (Jowett et al., 1987; 
Meek et al., 2016). Meek et al. (2016) suggest that performing a random blood glucose 
test, taking into account age and BMI, during the early stages of pregnancy, can 
improve sensitivity, but is of low specificity for GDM diagnosis (Meek et al., 2016). 
The results of one systematic review showed that random blood glucose and OGTT in 
the first trimester were good indicators of GDM (Van Leeuwen et al., 2011), and some 
older reports showed that GDM could be positively diagnosed in early pregnancy 
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(Super et al., 1991; Bartha et al., 2000; Bartha et al., 2003). However, the validity of 
applying the WHO 2013 criteria before 24–28 weeks of gestation has been questioned 
(Zhu et al., 2013).   
 
HbA1c percentages during both visits were within normal limits, however, the mean 
HbA1c level in the GDM group was significantly higher than the non-GDM group, 
even after adjustment for age and BMI. A relatively low percentage of HbA1c (5.2% 
vs. 5%) was detected in the present study, during early pregnancy in the GDM and non 
GDM group, respectively. Yet, HbA1c value of 5.4% among women with GDM has 
also been reported (Kwon et al., 2015). A cut-off value of HbA1c ≥ 6.5% is considered 
to be diagnostic for diabetes in pregnancy (Metzger et al., 2010; WHO, 2013; ADA, 
2014), but this is based on data for non-pregnant subjects. Moreover, first trimester 
HbA1c ≥ 6.1% has been shown to exhibit a strong association with the future 
development of GDM (Anaka et al., 2014). The optimal HbA1c threshold in pregnancy 
is likely to be lower, as HbA1c levels fall in the first trimester (Nielsen et al., 2004; 
Mosca et al., 2006), which could be due to the shorter lifespan of red blood cells during 
pregnancy (Lind & Cheyne, 1979; Lurie & Danon, 1992). For the same reason, a cut-
off of HbA1c ≥ 5.9%, at less than 20 weeks of gestation, has been recommended for 
the diagnosis of GDM (Hughes et al., 2014). The association of HbA1c with GDM in 
mid-pregnancy has already been documented (Wang et al., 2012; Kwon et al., 2015), 
whereas no association of HbA1c during the third trimester of pregnancy has been 
established for GDM (El Lithy et al., 2014).  
 
Furthermore, the cardio-metabolic profile in this study was higher in subjects with 
GDM, compared to the GDM group, including fasting insulin, HOMA-IR, and TG. 
Fasting glucose positively correlated with the total cholesterol/HDL ratio, and 
negatively correlated with HOMA-β and HDL-cholesterol, findings which support 
those of previous studies (Wang et al., 2012; Zhou et al., 2012; Pleskačová et al., 2015; 
Ryckman et al., 2015; Chitme et al., 2016). 
 
Little is currently known about the relationship between metabolic changes during early 
pregnancy and GDM development (Chatzi et al., 2009; Lei et al., 2016). In this study, 
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it was difficult to assess metabolic syndrome during the first visit because of the non-
fasting collection of blood samples in early pregnancy. In mid-pregnancy, however, the 
percentage of metabolic syndrome was significantly higher in the GDM group, 
compared to the non-GDM group. This relationship will be discussed further in the next 
chapter. 
 
In conclusion, the prevalence of GDM was found to be high among the subjects in this 
study, namely pregnant Saudi women. It is crucial to identify the factors predisposing 
pregnant women to GDM, in order to ensure the timely detection of predisposition, and 
subsequently intervene to avoid the development of GDM, and its associated foetal and 
maternal morbidity.  
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Impact of Vitamin D Status on Gestational Diabetes 
Mellitus and Metabolic Risk Among Saudi Women 
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6.1 Introduction 
GDM is associated with insulin dysregulation, metabolic syndrome and multiple 
adverse maternal and neonatal complications (Kjos & Buchanan, 1999; Reece, 2010; 
Vilmi-Kerälä et al., 2015). Metabolic syndrome comprises a combination of glucose 
intolerance, abdominal obesity, dyslipidaemia, and HTN (Eckel et al., 2005). When 
GDM is coupled with a metabolic syndrome phenotype, it can also increase the future 
risk of cardiovascular disease and constitute a significant burden on healthcare 
resources (Alberti et al., 2005; Sullivan et al., 2012). Therefore, as GDM is a modifiable 
disorder, a better understanding of the pathogenesis of metabolic syndrome is critical 
for avoiding associated morbidity, through timely therapeutic intervention.  
 
Several non-traditional risk factors have been implicated in the development of GDM. 
As such, vitamin D is considered to be an important predisposing factor influencing the 
development of GDM, due to its association with insulin resistance, inflammation, and 
dyslipidaemia  (Norman et al., 1980; Boucher et al., 1995). Particularly as low serum 
concentrations of vitamin D have been shown to be associated with a higher risk of 
developing T2DM (Gagnon et al., 2011; Khan et al., 2013) and GDM (Zhang et al., 
2008).  
 
Currently, the majority of studies investigating the association between vitamin D 
deficiency and GDM have been performed during the second or third trimester of 
pregnancy (Farrant et al., 2008; McLeod et al., 2012; Wang et al., 2012; Whitelaw et 
al., 2014). Although, some studies have also investigated the first trimester of 
pregnancy before the development of GDM (Baker et al., 2012; Lacroix et al., 2014; 
Park et al., 2014; Jain et al., 2015). There is, however, growing evidence through 
systematic reviews that vitamin D deficiency is a substantial risk factor for the 
occurrence of GDM (Christesen et al., 2012; Poel et al., 2012; Aghajafari et al., 2013; 
Wei et al., 2013; Burris & Camargo, 2014; Zhang et al., 2015; Lu et al., 2016). Although 
most of the findings linking vitamin D deficiency with GDM are cross-sectional or 
case-control studies, there is a need to conduct targeted prospective longitudinal studies.  
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Beyond association studies, a number of mechanisms have been suggested connecting 
vitamin D deficiency with the development of GDM. The first of these mechanisms is 
considered to act through the direct binding of vitamin D to its receptor on a β-cell, 
which appears to enhance insulin secretion (Johnson et al., 1994). Similarly, the 
expression of 1-α-hydroxylase in a β-cell has been shown to activate 25(OH)D (Bland 
et al., 2004). In addition, vitamin D-dependent changes in calcium flux have been 
shown to trigger  insulin secretion from β-cells in the pancreas  (Eliades & Pittas, 2009; 
Pittas & Dawson-Hughes, 2010). The second mechanism, possibly involved in 
increasing the risk of GDM, also acts through vitamin D, but by enhancing the 
expression of insulin receptors and insulin responsiveness, thus promoting insulin 
sensitivity (Vaidya & Williams, 2012). Beyond the risk of GDM, vitamin D deficiency 
has been associated with systemic inflammation, leading to increased insulin resistance 
and β-cell apoptosis (Alvarez & Ashraf, 2009; Eliades & Pittas, 2009). Collectively, 
the current evidence suggests that vitamin D deficiency predisposes the development 
of hyperglycaemia. Moreover, it has been found that the expression and production of 
CYP24A1 is increased in placental tissue among subjects with GDM, compared with 
normal placental tissue, and serum vitamin D levels have been shown to negatively 
correlate with the expression of CYP24A1 in the placenta (Cho et al., 2013).  
 
It is quite conceivable that factors associated with 25(OH)D deficiency during gestation 
may also lead to the development of GDM. Insulin resistance is frequently observed 
among obese women, which could possibly be related to the increased prevalence of 
vitamin D deficiency in this segment of the population, particularly during pregnancy 
(Baptiste-Roberts et al., 2009) because sequestration of vitamin D could take place in 
adipose tissue, thus lowering systemic levels (Wortsman et al., 2000). However, 
exposure to the sun through activity can reduce this deficiency, insulin resistance, and 
the risk of GDM, which positively correlates to the amount of physical activity 
performed (Zhang et al., 2006). A higher prevalence of hypovitaminosis D among 
Asian, Hispanic, Middle Eastern, and African women has already been established, and 
is, possibly also leading to a higher prevalence of GDM amongst these ethnicities 
(Oleson et al., 2010; Lin et al., 2015).  
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Genetic variations associated with VDR polymorphisms, and the dysregulation of 
vitamin D metabolism, have been linked with susceptibility to different diseases (Levin 
et al., 2012). Additionally, factors such as increased oxidative stress, related to placental 
dysfunction, which alter the expression of VDRs and the binding protein, may 
adversely affect vitamin D homoeostasis, resulting in the development of GDM (Ma et 
al., 2012). As such, it is important to understand the influence of vitamin D deficiency 
during pregnancy within the Saudi population. Therefore, this chapter addresses the 
question of whether vitamin D deficiency is associated with GDM outcomes, and what 
other factors may influence this association. It also considers variables, such as 
glycaemic indices, metabolic syndrome, biomarkers, and lifestyle, which may influence 
vitamin D levels, as well as the consequences of low vitamin D levels.  
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6.2 Research Design and Methods  
A total of 297 healthy Saudi pregnant women, with a mean age of 28.8 ± 5.4 years were 
included in the study. All participants were recruited during the first trimester (812 
weeks) of their pregnancies, after fulfilling previously described inclusion criteria 
(Chapter 2). They were then followed up to the second trimester (24-28 weeks) of 
gestation. Anthropometric data, the interview questionnaire, and blood samples were 
collected from each participant during early and mid-pregnancy.  
 
6.2.1 Biochemical Assessment  
Venous blood samples were collected from each participant at both visits. During the 
first trimester, non-fasting blood samples were obtained for the assessment of baseline 
parameters, including random glucose, insulin, HbA1c, lipid profile, 25(OH)D, 
calcium, phosphorus, albumin, creatinine and alkaline phosphatase. Mid-pregnancy 
fasting blood samples (>10 hours) were drawn from each participant to assess fasting 
blood glucose, fasting insulin, 1- and 2-hour OGTT, 2-hour insulin, HbA1c, complete 
lipid profile, HOMA-IR, HOMA-β, 25(OH)D, calcium, phosphorus, albumin, 
creatinine, and alkaline phosphatase. The laboratory analysis was detailed in chapter 2. 
 
6.2.2 Data Analysis 
Data were analysed using SPSS version 21.0 statistical software (SPSS, Chicago, IL, 
USA). Pearson’s chi-square test was then utilised to observe any correlations between 
categorical variables. In order to determine group differences, an independent sample 
t-test and Mann-Whitney U Test were applied to normally and non-normally distributed 
variables, respectively. Adjustment for age and BMI as covariates between the groups 
was undertaken via ANCOVA, while ANOVA was conducted to compare normally 
distributed variables categorised into more than two groups (tertiles).  
 
Pearson’s and Spearman’s rank correlation coefficients were used to determine any 
linear relationships between quantitative variables for normally and non-normally  
distributed variables, respectively. Logistic regression was also applied to identify the 
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risk factors associated with the categorical outcome variable. This method was selected 
based on the presence or absence of GDM as a dichotomous variable. Five models were 
subsequently generated to adjust for possible confounders, with Model 1: age and BMI 
at visit 1; Model 2: Model 1 + parity, education, employment, residence in  North 
Riyadh, past GDM, family history (obesity, DM and GDM); Model 3: Model 2 + total 
GWG at visit 1 + changes in fat percentage; Model 4: Model 3 + sun exposure at visit 
1+ season at visit 1+ vitamin D intake at visit 1, multivitamin intake at visit 1, and 
Model 5: Model 4 + physical activity at visit 1. All odds ratios were reported 
(unadjusted, adjusted for models 1, 2, 3, 4 and 5). Finally, a p-value of < 0.05 
was considered statistically significant. 
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6.3 Results 
6.3.1 Vitamin D Status and GDM  
The median vitamin D level was lower in the GDM group, compared to the non- GDM 
group, in early [24.4 nmol/L (17.6-37.1) vs. 28.6 nmol/L (19.4-47.9), p = 0.033] and 
mid-pregnancy [27.1 nmol/L (18.4-39.2) vs. 32.8 nmol/L (20.1-50.4), p = 0.014], this 
remained significant after adjusting for age and BMI (Figure 6.1). Additionally, the 
prevalence of vitamin D deficiency in early and mid-pregnancy was higher among the 
GDM subjects than the non-GDM subjects (Figure 6.2). 
 
 
 
 
Figure 6.1 Vitamin D levels in early and mid-pregnancy in GDM and non-GDM 
subjects. The values show the median vitamin D level in both the GDM and non-GDM 
subjects, after adjusting for age and BMI. * denotes p < 0.05 and ** denotes p < 0.01 
using the Mann-Whitney U Test. 
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Figure 6.2 The prevalence of vitamin D deficiency, in (A) Early and (B) Mid-
pregnancy among GDM and non-GDM subjects. The values show the percentage of 
women with vitamin D deficiency in early and mid-pregnancy, in both the GDM and 
non-GDM groups. P-values: * denotes p < 0.05 and *** denotes p < 0.001 using 
Pearson’s chi-square test. 
 
Interestingly, corrected calcium values were significantly lower among the subjects 
with GDM in early pregnancy, compared to their counterparts with no GDM (2.2 
mmol/L ± 0.2 vs. 2.3 mmol/L ± 0.2, p = 0.007), and it remained significant, even after 
adjustment for age and BMI. In addition, alkaline phosphatase was significantly higher 
among the GDM women compared to their non-GDM counterparts, in early (10.6 
mmol/L ± 3.4 vs. 9.3 mmol/L ± 2.8, p = 0.001), and mid-pregnancy (11.6 mmol/L ± 
4.4 vs. 10.1 mmol/L ± 3.6, p = 0.012), which also remained significant after adjustment. 
Fasting glucose positively correlated with alkaline phosphatase at both visits (r = 0.20, 
p = 0.002; r = 0.24, p < 0.001). Finally, fasting glucose negatively correlated with 
phosphorus at mid-pregnancy (r = -0.19, p = 0.003). 
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6.3.1.1 Influence of Lifestyle Related to Vitamin D Characteristics and GDM 
There was no difference in sun exposure variables during early pregnancy, among the 
GDM subjects. At mid-pregnancy, the percentage of women covering their whole body 
was significantly higher in the GDM group than in the non-GDM group (39.7% vs. 
26.6%, p = 0.040). Similarly, the percentage of women exposed to the sun at noon was 
significantly higher among the non-GDM group, compared to the GDM group (36% 
vs. 18.9%, p = 0.004) (Figure 6.3). 
 
 
  
 
Figure 6.3 Sun exposure at mid-pregnancy among the GDM and non-GDM subjects. 
The values show the percentage of women with different sun exposure indices in both 
the GDM and non-GDM groups. P-values: * denotes p < 0.05, and ** denotes p < 0.01, 
using Pearson’s chi-square test. 
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The present study revealed no differences between estimated vitamin D and calcium 
intake, irrespective of GDM status (Figure 6.4). Fasting glucose correlated positively 
with estimated vitamin D and calcium intake in early and mid-pregnancy (Figure 6.5). 
A higher proportion of the subjects without GDM were taking multivitamin 
supplements, compared to the subjects with GDM, at mid-pregnancy (53.9% vs. 
41.9%), but this was not statistically significant (p = 0.095). However, no differences 
were reported for multivitamin supplement intake in early pregnancy. 
 
 
 
Figure 6.4 Vitamin D and calcium intake at both visits, in relation to GDM status. The 
values show the median intake of vitamin D and calcium from food, among both the 
GDM and non-GDM subjects, after adjusting for age and BMI. ‘V1’ and ‘V2’ indicate 
1st and 2nd visit, respectively. ‘Calc.’ indicates calcium. The Mann-Whitney U Test 
was applied. 
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Figure 6.5 Correlations between log of fasting glucose (mmol/L), vitamin D intake 
(IU/day), and calcium intake (mg/day) in (A) Early-pregnancy and (B) Mid-pregnancy. 
 
 
 
6.3.2 Vitamin D and its Association with GDM Markers in Pregnant 
Women 
No differences were observed prospectively between anthropometric data in mid-
pregnancy and vitamin D-deficient and non-deficient women in early pregnancy. 
Although GWG revealed an increase among the subjects who were vitamin D-deficient 
in early pregnancy, and this was greater than that found for the non-deficient subjects, 
the difference was not statistically significant (p = 0.179) (Figure 6.6). Percentage 
change in body fat failed to demonstrate any significant difference between the vitamin 
D-deficient and non-deficient groups (10.6 ± 26.8 vs. 8.2 ± 14.2, p = 0.560). 
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Figure 6.6 Comparison of GWG between vitamin D-deficient and non-deficient 
subjects, during early pregnancy. The values show the percentage of women with 
excessive and non-excessive weight gain by mid-pregnancy, in both the vitamin D-
deficient and non-deficient groups in early pregnancy. Pearson’s chi-square test was 
applied. 
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6.3.2.1 Glycaemic Markers with vitamin D status in Early Pregnancy 
Fasting glucose among the pregnant women, who were deficient in vitamin D [4.5 
mmol/L (4.0 - 5.0)] during early pregnancy, was higher than in the non-deficient 
subjects [4.2 mmol/L (3.9-4.6); p = 0.002]. Negative correlations were found between 
early pregnancy vitamin D levels and fasting glucose levels (r = -0.12, p = 0.046) and 
HbA1c (r = -0.24, p < 0.001). Likewise, HbA1c (%) at mid-pregnancy among the 
vitamin D-deficient subjects (4.9 ± 0.4), during early pregnancy, was higher than for 
the non-deficient subjects (4.8 ± 0.4; p = 0.094). This comparison reached a level of 
significance when HbA1c was compared according to vitamin D tertiles in early 
pregnancy, as illustrated in Figure 6.7. HOMA-β was higher among the non-deficient 
women in early pregnancy [246.9 (147.9-367.0)] compared with the deficient subjects 
[175.9 (102.2-330.9), p = 0.033], but lost significance after adjusting for age and BMI 
(p = 0.103) (Table 6.1). 
 
 
Figure 6.7 HbA1c levels at mid-pregnancy, per vitamin D tertiles of the participants in 
early pregnancy. The values show the mean ± SD of HbA1c, with vitamin D early 
pregnancy tertiles. P-value: ** denotes p < 0.01, obtained via ANOVA. Significance 
for HbA1c was only between tertile 1 and tertile 3.  
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6.3.2.2 Glycaemic Markers with vitamin D status in Mid-pregnancy  
Mid-pregnancy vitamin D levels, fasting glucose, and HbA1c values were significantly 
higher among the vitamin D-deficient subjects, compared to their non-deficient 
counterparts after adjustment (p = 0.049 and p = 0.019, respectively). Negative 
correlations between vitamin D and fasting glucose (r = -0.19, p = 0.001) and HbA1c 
(r = -0.22, p < 0.001) were observed at mid-pregnancy. Fasting insulin and HOMA-IR 
were higher in the vitamin D-deficient group, compared to the non-deficient group (p 
= 0.043 and p = 0.020, respectively). The significance after adjustment for BMI and 
age was borderline (p = 0.054 and p = 0.055). Negative correlations were also observed 
between vitamin D levels and fasting insulin levels (r = -0.11, p = 0.053), and HOMA-
IR (r = -0.17, p = 0.004), at mid-pregnancy (Figure 6.8). Table 6.1 shows a comparison 
between GDM markers at mid-pregnancy, in relation to vitamin D status during early 
and mid-pregnancy.  
 
Figure 6.8 Correlations between the log of vitamin D (nmol/L) at mid-pregnancy, 
versus (A) the log of fasting insulin (Uu/mL) and (B) the Sqrt of HOMA-IR. 
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Table 6.1 Biochemical GDM markers among vitamin D-deficient and non-
deficient women during early and mid-pregnancy 
 
 Vitamin D Status in Early Pregnancy  
Mid-Pregnancy 
Parameters  
Non-Deficient 
(N=67) 
Deficient 
(N=230) 
p-value *p-value 
Fasting glucose (mmol/L) # 4.2 (3.9-4.6) 4.5 (4.0-5.0) 0.011 0.002 
1-hr glucose (mmol/L) # 7.4 (6.3-8.8) 7.5 (5.9-9.1) 0.949 0.984 
2-hr glucose (mmol/L) # 6.1 (5.6-7.3) 6.3 (5.3-7.5) 0.908 0.603 
Fasting insulin (uU/mL) # 9.7 (5.4-13.5) 7.6 (5.0-12.1) 0.168 0.232 
2-hr insulin (uU/mL) # 43.3 (19.9-69.7) 41.0 (25.9-61.7) 0.709 0.313 
HOMA-IR # 1.8 (0.9-2.8) 1.6 (0.9-2.6) 0.717 0.885 
HOMA-β # 246.9 (147.9-367.0) 175.9 (102.2-330.9) 0.033 0.103 
HbA1c (%) 4.8 ± 0.4 4.9 ± 0.4 0.167 0.094 
 Vitamin D Status Mid-pregnancy  
 Non-Deficient 
(N=50) 
Deficient 
(N=247) 
  
Fasting glucose (mmol/L) # 4.3 (3.9-4.6) 4.5 (4.0-5.0) 0.026 0.046 
1-hr glucose (mmol/L) # 8.0 (6.2-8.9) 7.4 (5.9-9.0) 0.734 0.752 
2-hr glucose (mmol/L) # 6.1 (5.2-7.3) 6.3 (5.3-7.5) 0.378 0.316 
Fasting insulin (uU/mL) # 6.4 (4.3-11.6) 8.4 (5.4-14.0) 0.043 0.054 
2-hr insulin (uU/mL) # 43.8 (26.3-64.6) 41.0 (25.3-61.7) 0.682 0.648 
HOMA-IR # 1.2 (0.7-2.3) 1.7 (1.0-3.1) 0.020 0.055 
HOMA-β # 208.7 (118.1-367.0) 193.8 (104.0-337.6) 0.577 0.782 
HbA1c (%) 4.8 ± 0.4 4.9 ± 0.5 0.023 0.019 
Note: Data are presented as mean and standard deviation for normally distributed variables, while the median, 1st 
and 3rd quartiles are presented for non-normally distributed variables. # indicates non-normally distributed variables; 
the p-value for the mean differences were obtained using an independent sample t-test for normally distributed 
variables and the Mann-Whitney U test for non-normally distributed variables; * indicates p-values adjusted for age 
and BMI at 1st visit. 
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6.3.3 Vitamin D Deficiency and the Risk of Obesity, Hypertension, and 
Metabolic Syndrome 
6.3.3.1 Early Pregnancy  
Vitamin D deficiency during early pregnancy did not pose any risk to the lipid profile, 
metabolic syndrome, obesity, or HTN by mid-pregnancy.  
6.3.3.2 Mid-pregnancy  
Vitamin D deficiency at mid-pregnancy was an independent risk factor for metabolic 
syndrome (OR = 5.79, 95% CI 1.48-22.66, p = 0.012). Vitamin D deficiency at mid-
pregnancy increased the risk of low HDL-cholesterol (OR = 2.58, 95%, CI 0.99-6.72, 
p = 0.049), but no risks were posed for obesity or HTN (Table 6.2). 
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Table 6.2 Vitamin D deficiency at mid-pregnancy, and its association with obesity, HTN and metabolic syndrome 
Diseases at  
Mid-Pregnancy 
Unadjusted     Model 1 Model 2 Model 3 Model 4 Model 5 
OR (95% CI) 
P-
value 
OR (95% CI) 
P-
value 
OR (95% CI) 
P-
value 
OR (95% CI) 
P-
value 
OR (95% CI) 
P-
value 
OR (95% CI) 
P-
value 
Vitamin D Deficiency at Mid-pregnancy as a Risk Factor 
Obesity  0.88 (0.51-1.53) 0.660 0.87 (0.50-1.53) 0.633 1.06 (0.53-2.10) 0.871 1.21 (0.59-2.51) 0.602 1.10 (0.51-2.37) 0.800 1.04 (0.48-2.25) 0.926 
HTN  1.28 (0.27-6.07) 0.759 1.14 (0.24-5.54) 0.856 1.04 (0.19-5.73) 0.963 1.56 (0.24-10.27) 0.643 1.21 (0.17-8.78) 0.851 1.45 (0.20-10.73) 0.716 
Low HDL-
cholesterol 
(<1.03 mmol/l) 
1.61 (0.85-3.05) 0.142 1.65 (0.86-3.15) 0.132 2.16 (0.94-4.95) 0.069 2.12 (0.91-4.93) 0.081 2.70 (1.06-6.87) 0.037 2.58 (0.99-6.72) 0.049 
Total cholesterol- 
HDL ratio > 3.5 
1.16 (0.64-2.09) 0.625 1.21 (0.67-2.22) 0.521 2.00 (0.96-4.17) 0.065 2.03 (0.94-4.40) 0.074 2.04 (0.87-4.76) 0.100 1.98 (0.80-4.87) 0.138 
TG ≥ 1.7 (mmol/L) 1.42 (0.81-2.49) 0.218 1.39 (0.78-2.46) 0.262 1.21 (0.62-2.35) 0.576 1.24 (0.62-2.47) 0.548 1.33 (0.64-2.78) 0.448 1.29 (0.61-2.74) 0.504 
Metabolic 
Syndrome 
1.54 (0.70-3.37) 0.280 1.70 (0.73-3.96) 0.216 3.60 (1.04-12.45) 0.043 3.72 (1.07-12.95) 0.039 4.84 (1.29-18.15) 0.019 5.79 (1.48-22.66) 0.012 
Note: Data are presented as slope, odds ratio (OR) and 95% confidence interval (CI) for OR, using logistic regression analysis, taking vitamin D deficiency as a risk factor and disease as depdendent variable 
at visit 1; Model 1: Age and BMI at visit 1; Model 2: Model 1 + parity, education, employment, residence in North Riyadh, past GDM, family history (obesity, DM and GDM). Adjustment 3: Model 2 + total 
GWG based on weight at visit 1 + change in fat %; Model 4: Model 3 + sun exposure by visit 1, season at visit 1, vitamin D intake by visit 1, multivitamin by visit 1; Model 5: Model 4 + physical activity by 
visit 1. HTN indicates Hypertensi 
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6.3.4 Predictors of GDM 
6.3.4.1 Predictors of GDM in Early Pregnancy 
Data for predictors of GDM among the subjects during early pregnancy are shown in 
Table 6.3. Previous history of GDM (OR 11.13 95%, CI 3.10-39.96, p < 0.001), vitamin 
D deficiency (OR 3.97, 95%, CI 1.12-14.15, p < 0.033), high HbA1c (OR 3.06, 95% 
CI 1.32-7.07, p = 0.037), and low HDL-cholesterol (OR 2.11, 95% CI 1.01-4.39, p < 
0.046) during early pregnancy posed a significant risk for the development of GDM.  
 
Blood samples from subjects in early pregnancy that were collected during the summer 
season (OR 2.15, 95% CI 0.99-4.67, p = 0.053) showed an increased risk of GDM, but 
this was not statistically significant. Before adjustments were made, pre-pregnancy 
BMI (OR 1.06, 95% CI 1.02-1.11, p = 0.003), early pregnancy obesity (OR 1.72, 95% 
CI 1.04-2.85, p = 0.033), a family history of diabetes (OR 1.87, 95% CI 1.02-3.44, p = 
0.044), and random blood glucose (OR 1.36, 95% CI 1.08-1.71, p = 0.008), were also 
associated with an increased risk of GDM. Random blood glucose and pre-pregnancy 
BMI remained significant, even after adjusting for age and BMI at the 1st visit. In 
contrast, low-intensity physical activity during early pregnancy was found to provide 
some protection against the development of GDM, even after adjusting for age and BMI 
(OR 0.56, 95% CI 0.33-0.97, p = 0.039).  
6.3.4.2 Associated Factors of GDM at Mid-pregnancy 
Data on the associated factors of GDM among the subjects' mid-pregnancy are 
described in Table 6.3. The presence of metabolic syndrome (OR 57.61, 95%, CI 
12.64-262.64, p < 0.001), obesity (OR 3.59 95%, CI 1.04-12.40, p = 0.043), and high 
HbA1c (OR 2.29, 95% CI 1.01-5.19, p = 0.047) were observed as independent 
variables, associated with an increased risk of developing GDM at mid-pregnancy. 
Although mid-pregnancy hypertriglyceridemia increased the risk of GDM (OR 1.84, 
95% CI 1.08-3.15, p = 0.025), the significance was lost after adjustment. Multivitamin 
supplementation, however, was noted to confer some protection against the 
development of GDM at mid-pregnancy (OR 0.38, 95% CI 0.18-0.81, p = 0.013). 
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Table 6.3 Predictors of GDM among the subjects during (A) Early pregnancy and (B) Mid-pregnancy 
  Unadjusted Model 1 Model 2 Model 3 Model 4 Model 5 
(A) Early Pregnancy 
Parameters 
OR  
(95% CI) 
P-value 
OR  
(95% CI) 
P-value 
OR 
 (95% CI) 
P-value 
OR  
(95% CI) 
P-value 
OR  
(95% CI) 
P-value 
OR  
(95% CI) 
P-value 
Age 1.04 (0.99-1.09) 0.099 1.03 (0.98-1.08) 0.287 1.02 (0.96-1.09) 0.490 1.02 (0.95-1.09) 0.545 1.02 (0.95-1.10) 0.524 1.02 (0.94-1.09) 0.690 
Multiparty 1.65 (0.96-2.81) 0.068 1.37 (0.77-2.44) 0.290 1.23 (0.61-2.48) 0.565 1.28 (0.62-2.63) 0.502 1.22 (0.56-2.63) 0.617 1.31 (0.59-2.89) 0.511 
Pre-pregnancy BMI 
(Kg/m2)  
1.06 (1.02-1.11) 0.003 1.05 (1.01-1.10) 0.021 1.04 (0.98-1.10) 0.191 1.03 (0.97-1.09) 0.308 1.04 (0.98-1.11) 0.219 1.05 (0.98-1.12) 0.141 
Obesity 1.72 (1.04-2.85) 0.033 1.02 (0.43-2.43) 0.970 1.53 (0.78-2.98) 0.216 1.44 (0.71-2.93) 0.317 1.45 (0.69-3.05) 0.324 1.65 (0.77-3.56) 0.201 
University graduate or 
postgraduate 
0.67 (0.41-1.09) 0.108 0.70 (0.42-1.17) 0.173 0.72 (0.36-1.43) 0.346 0.67 (0.33-1.34) 0.254 0.63 (0.30-1.31) 0.215 0.65 (0.31-1.38) 0.265 
Employment 1.05 (0.63-1.76) 0.839 1.01 (0.60-1.72) 0.964 1.21 (0.61-2.43) 0.587 1.37 (0.67-2.79) 0.383 1.55 (0.74-3.27) 0.250 1.71 (0.79-3.69) 0.176 
Previous GDM 14.64 (4.79-44.69) < 0.001 14.93 (4.70-47.42) < 0.001 11.60 (3.36-39.99) < 0.001 11.42 (3.31-39.41) < 0.001 10.56 (3.04-36.61) <0.001 11.13(3.10-39.96) <0.001 
Family history of GDM 1.32 (0.75-2.31) 0.340 1.29 (0.73-2.29) 0.377 0.99 (0.50-1.99) 0.983 0.95 (0.48-1.97) 0.975 0.90 (0.43-1.90) 0.785 0.80 (0.37-1.73) 0.576 
Family history of obesity 0.84 (0.34-2.09) 0.704 0.78 (0.30-2.00) 0.596 0.79 (0.28-2.21) 0.654 0.71 (0.25-2.02) 0.516 0.74 (0.25-2.18) 0.578 0.70 (0.23-2.12) 0.530 
Family history of DM 1.87 (1.02-3.44) 0.044 1.64 (0.88-3.05) 0.123 1.28 (0.64-2.53) 0.487 1.24 (0.61-2.51) 0.547 1.44 (0.68-3.02) 0.341 1.47 (0.67-3.21) 0.332 
HbA1c (%) 2.56 (1.50-4.36) 0.001 2.28 (1.32-3.95) 0.003 2.85 (1.34-6.06) 0.007 2.66 (1.23-5.76) 0.013 2.83 (1.27-6.35) 0.011 3.06 (1.32-7.07) 0.009 
Random glucose 
(mmol/L) 
1.45 (1.17-1.81) 0.001 1.36 (1.08-1.71) 0.008 1.30 (0.97-1.73) 0.083 1.43 (1.03-1.98) 0.031 1.37 (0.98-1.91) 0.068 1.33 (0.93-1.89) 0.116 
TG (≥ 1.7 mmol/L) 1.65 (0.99-2.74) 0.054 1.47 (0.87-2.48) 0.151 1.21 (0.59-2.49) 0.599 1.11 (0.53-2.30) 0.790 1.17 (0.54-2.52) 0.693 1.02 (0.45-2.29) 0.972 
Total cholesterol HDL 
ratio > 3.5 
1.31 (0.78-2.20) 0.317 1.18 (0.69-2.01) 0.547 1.47 (0.73-2.93) 0.279 1.41 (0.69-2.91) 0.351 1.53 (0.72-3.24) 0.269 1.30 (0.60-2.84) 0.511 
Low HDL-cholesterol 
 (< 1.03 mmol/L) 
1.44 (0.89-2.34) 0.140 1.47 (0.90-2.42) 0.125 1.83 (0.97-3.47) 0.063 1.91 (0.99-3.67) 0.055 2.12 (1.04-4.32) 0.040 2.11 (1.01-4.39) 0.046 
HTN 0.35 (0.08-1.60) 0.174 0.22 (0.05-1.10) 0.065 0.26 (0.03-2.49) 0.244 0.26 (0.03-2.50) 0.245 0.23 (0.02-2.23) 0.205 0.26 (0.03-2.62) 0.254 
Vitamin D intake  
(> 600 IU/day) 
0.43 (0.05-3.72) 0.441 0.46 (0.05-4.09) 0.489 0.87 (0.07-11.03) 0.916 0.72 (0.06-9.45) 0.801 0.69 (0.05-9.18) 0.781 0.60 (0.04-8.17) 0.703 
Use of multivitamins 1.53 (0.81-2.89) 0.194 1.36 (0.70-2.65) 0.369 0.86 (0.37-2.05) 0.739 0.94 (0.39-2.25) 0.889 0.86 (0.34-2.17) 0.742 0.91 (0.33-2.48) 0.846 
Low intensity PA  
(≥ 210 mints/wk) 
0.61 (0.36-1.03) 0.064 0.56 (0.33-0.97) 0.039 0.56 (0.27-1.14) 0.110 0.60 (0.28-1.29) 0.192 0.58 (0.26-1.29) 0.183 ---- ---- 
Blood sample collection 
(Summer) 
1.60 (0.97-2.63) 0.064 1.78 (1.07-2.98) 0.027 1.91 (0.99-3.68) 0.054 1.96 (1.00-3.85) 0.049 2.11 (1.02-4.37) 0.045 2.15 (0.99-4.67) 0.053 
Vitamin D deficiency at 
1st visit 
4.43 (1.82-10.79) 0.001 4.63 (1.87-11.46) 0.001 3.71 (1.18-11.65) 0.025 3.94 (1.24-12.46) 0.020 4.40 (1.33-14.54) 0.015 3.97 (1.12-14.15) 0.033 
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  Unadjusted Model 1 Model 2 Model 3 Model 4 Model 5 
(B) Mid-pregnancy 
Parameters 
OR 
 (95% CI) 
P-
value 
OR 
 (95% CI) 
P-
value 
OR  
(95% CI) 
P-
value 
OR 
 (95% CI) 
P-
value 
OR 
 (95% CI) 
P-
value 
OR  
(95% CI) 
P-
value 
Vitamin D deficiency 2nd 
visit 
2.00 (1.06-3.76) 0.033 2.00 (1.05-3.82) 0.034 1.89 (0.88-4.06) 0.101 1.93 (0.89-4.21) 0.097 1.88 (0.85-4.17) 0.122 1.98 (0.89-4.41) 0.096 
Obesity 2nd visit 2.03 (1.25-3.32) 0.005 2.11 (0.94-4.75) 0.070 3.40 (1.19-9.72) 0.022 4.63 (1.50-14.31) 0.008 4.21 (1.29-13.71) 0.017 3.59 (1.04-12.40) 0.043 
GWG (excessive) 0.92 (0.56-1.52) 0.744 0.88 (0.52-1.49) 0.623 0.99 (0.71-1.38) 0.956 1.08 (0.71-1.66) 0.710 1.11 (0.71-1.74) 0.639 1.04 (0.66-1.65) 0.858 
Δ Body fat (%) 1.00 (1.00-1.01) 0.952 1.00 (0.99-1.02) 0.492 0.99 (0.96-1.01) 0.237 0.99 (0.96-1.01) 0.281 0.98 (0.96-1.01) 0.206 0.99 (0.96-1.01) 0.255 
HbA1c (%) 3.13 (1.83-6.00) < 0.001 2.89 (1.58-5.29) 0.001 2.51 (1.19-5.30) 0.016 2.44 (1.15-5.19) 0.020 2.48 (1.12-5.50) 0.026 2.29 (1.01-5.19) 0.047 
TG (≥ 1.7 mmol/l) 1.84 (1.08-3.15) 0.025 1.69 (0.98-2.91) 0.061 1.96 (0.98-3.93) 0.057 1.84 (0.91-3.75) 0.092 1.85 (0.87-3.92) 0.108 1.70 (0.78-3.67) 0.179 
Metabolic syndrome 12.45 (5.9-25.97) < 0.001 14.46 (6.36-32.87) < 0.001 39.61 (11.11-141.31) < 0.001 42.08 (11.44-154.77) < 0.001 41.45 (10.51-163.52) <0.001 57.61 (12.64-262.64) <0.001 
HTN 1.67 (0.50-5.61) 0.409 1.27 (0.34-4.71) 0.720 1.87 (0.39-8.99) 0.436 1.62 (0.33-7.84) 0.551 1.47 (0.29-7.33) 0.642 1.36 (0.26-7.12) 0.713 
Vitamin D intake (>600 
IU/day) 
1.65 (0.36 - 7.57) 0.517 1.82 (0.39-8.49) 0.446 0.59 (0.06-5.63) 0.648 0.56 (0.06-5.39) 0.614 0.52 (0.05-5.32) 0.580 0.44 (0.04-4.53) 0.486 
Calcium intake (>1000 
mg/day) 
1.25 (0.54 - 2.85) 0.604 1.23 (0.53-2.82) 0.632 1.51 (0.62-3.69) 0.366 1.47 (0.59-3.65) 0.405 1.45 (0.54-3.91) 0.465 1.40 (0.52-3.79) 0.512 
Multivitamin 
supplementation 
0.61 (0.34-1.10) 0.099 0.59 (0.33-1.07) 0.084 0.44 (0.22-0.87) 0.019 0.42 (0.21-0.85) 0.015 0.47 (0.23-0.98) 0.043 0.38 (0.18-0.81) 0.013 
Low intensity PA (≥210 
mints/wk) 
0.76 (0.45-1.28) 0.298 0.70 (0.41-1.20) 0.198 0.67 (0.33-1.36) 0.269 0.80 (0.37-1.71) 0.559 0.89 (0.41-1.93) 0.760 1.04 (0.46-2.38) 0.918 
Note: Data are presented as slope, odds ratio (OR), and 95% confidence interval (CI) for OR using logistic regression analysis, and taking GDM as a dependent variable against potential 
risk factors at visit 1; Model 1: Age and BMI at visit 1; Model 2: Model 1 + parity, education, employment, residence in South Riyadh, past GDM, family history (obesity, DM and 
GDM). Model 3: Model 2 + total GWG as at visit 1 + changes in fat %; Model 4: Model 3 + sun exposure by visit 1, season at visit 1, vitamin D intake by visit 1, multivitamin intake 
by visit 1; Model 5: Model 4 + physical activity (PA) by visit 1. 
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6.4 Discussion  
In spite of the high levels of vitamin D deficiency observed in early pregnancy, and at 
delivery in Saudi Arabia, this is the first study conducted in the above context to 
examine changes in levels of vitamin D deficiency, and the influence of these on 
maternal and birth outcomes. In this prospective study, associations between vitamin D 
status and GDM risk have been explored, following adjustment for both vitamin D and 
GDM risk factors. These studies indicate that low vitamin D levels in early and mid-
pregnancy are associated with increased risk of GDM development. Furthermore, the 
fact that vitamin D deficiency is observed to be independently associated with 
metabolic syndrome, and an increased risk of low-HDL cholesterol, suggests that it is 
not only associated with abnormal glycaemia, but also increases cardio-metabolic risk.  
 
This study specifically reveals that vitamin D deficiency in early pregnancy is 
associated with up to 3.97 times greater risk of developing GDM, after adjusting for 
potential confounding factors, including lifestyle factors. In three different studies, low 
vitamin D concentration during the first trimester of pregnancy showed an association 
with a 2.66, 2.21, and 1.9 times higher risk of developing GDM at 24-28 weeks, after 
adjusting for classical risk factors, such as BMI, ethnicity, season, and age (Zhang et 
al., 2008; Parlea et al., 2012; Arnold et al., 2015). As such, the risk posed by low blood 
levels of 25(OH)D among the pregnant women in the present study was significantly 
higher than the previously reported hypovitaminosis D-related risk of developing 
GDM. Moreover, the higher risk of developing GDM associated with vitamin D 
deficiency, in the present study, was determined after adjusting for risk factors for both 
vitamin D deficiency and GDM. This finding is consistent with one Canadian study 
reporting vitamin D deficiency as an important determinant for the development of 
GDM, after adjusting for vitamin D confounding factors, such as the season, sun 
exposure, dietary intake of vitamin D, and PTH levels, along with adjusting for other 
GDM risk factors, such as maternal age, ethnicity, parity, and obesity (Lacroix et al., 
2014). Five independent meta-analyses of observational studies have reported a 38-
61% higher risk of GDM among vitamin D-deficient pregnant women (Poel et al., 2012; 
Aghajafari et al., 2013; Wei et al., 2013; Zhang et al., 2015; Lu et al., 2016). Although 
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there are data suggesting that vitamin D deficiency during early pregnancy is not a 
significant risk factor for developing future GDM (Baker et al., 2012), 73% of the 
participants investigated had sufficient levels of vitamin D. Multivitamin or vitamin D 
supplementation, along with the fact of residing in geographical locations that favour 
an adequate vitamin D status, may have contributed to the observed discrepancy.  
 
In this current study, vitamin D levels during early and mid-pregnancy were found to 
negatively correlate with fasting glucose and HbA1c at mid-pregnancy. This finding is 
consistent with a study by Makgoba et al. (2011), which also reported a negative 
correlation between first-trimester vitamin D and second-trimester GDM markers, 
including fasting glucose and 2-hour OGTT. Furthermore, after adjusting for 
confounding factors, maternal 25(OH)D inadequacy in the second trimester was shown 
to be associated with higher fasting glucose concentrations, but not 2-hour OGTT 
concentrations (Loy et al., 2015). No association was observed between early vitamin 
D deficiency and OGTT values in the present study. This suggests that 2-hour OGTT 
may be less likely to be influenced by vitamin D concentration, although the variability 
of the latter is more apparent than that of fasting glucose. In addition, it has been stated 
that insulin resistance can influence 1- and 2-hour postprandial glucose levels (McLeod 
et al., 2012). As such, it is possible that 25(OH)D may not affect glucose metabolism 
via modulation of insulin sensitivity, but could do so through other mechanisms, such 
as modifying pancreatic β-cell function, or cytokine production (Pittas et al., 2007). 
Furthermore, a negative correlation between vitamin D in the first (Alamolhoda et al., 
2010; Makgoba et al., 2011) and second half of pregnancy (Lau et al., 2011; El Lithy 
et al., 2014), and HbA1c in mid-pregnancy has previously been reported. The noted 
association between vitamin D and HbA1c points to a potential interaction between 
vitamin D and glycaemic control during pregnancy. 
 
A relatively small number of studies have assessed the relationship between vitamin D 
and insulin in pregnancy, but this current study reveals a correlation between mid-
pregnancy vitamin D deficiency and impaired insulin sensitivity, thus confirming the 
earlier studies (Clifton‐Bligh et al., 2008; Farrant et al., 2008; McLeod et al., 2012; 
Wang et al., 2012; Mutlu et al., 2015).  
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It is important to stress that the limited studies carried out have not detected an 
association between GDM or its markers, and vitamin D deficiency (Parildar et al., 
2013; Kramer et al., 2014; Park et al., 2014). This is partly due to the fact that the studies 
that have addressed the topic of GDM, did not explore its markers, so their results have 
been vague with regard to glycaemia (Schneuer et al., 2014; Flood-Nichols et al., 2015; 
Rodriguez et al., 2015). Contradictory findings may also have arisen, due to the small 
number of GDM subjects participating in the studies mentioned above, or to the high 
levels of heterogeneity between the studies themselves. This can be attributed to 
different methodological factors, ethnicity, study design, sample size, trimester of 
pregnancy, or lack of adjustment for confounding factors, including vitamin D 
supplementation and seasonal variation. Moreover, the heterogeneity of dietary factors 
and differences in socio-economic status, as well as low prevalence of vitamin D 
deficiency are further factors potentially impacting the results (Burris et al., 2012; 
Schneuer et al., 2014; Loy et al., 2015). 
 
Interestingly, the current study revealed links between vitamin D related lifestyle 
factors, linking to GDM and its markers. Mid-pregnancy, the percentage of women 
covering the whole of their bodies and those experiencing less exposure to sunlight, 
particularly at noon, was higher among the GDM subjects, compared to those with no 
GDM. This is because sunlight exposure stimulates vitamin D synthesis in the skin 
(Holick, 2004), therefore less exposure to sunlight will result in decreased vitamin D 
production during mid-pregnancy, which may in turn contribute to the development of 
GDM (Maghbooli et al., 2008; Zuhur et al., 2013; Jain et al., 2015). Furthermore, it was 
interesting to note in the current study that seasonal changes (summer vs. winter) in 
early pregnancy showed an increasing trend towards GDM prevalence. This is similar 
to other recent, but limited, research (Moses et al., 2016; Verburg et al., 2016). 
 
Vitamin D and calcium intake during early and mid-pregnancy significantly correlated 
with fasting glucose in this instance. This is reminiscent of a recent study that found a 
positive association between GDM, and higher vitamin D and calcium intake (Meinilä 
et al., 2015). The increase may be explained by the greater consumption of high-fat 
dairy products during pregnancy, and it is a relationship that should be studied further. 
155 
 
Moreover, multivitamin supplementation by mid-pregnancy appears to confer some 
protection against the development of GDM, in the current study. Vitamin D and 
calcium supplementation in pregnant women have a beneficial effect on glycaemia 
(Asemi et al., 2013). Supplementation with vitamins C, E, and B12, have also been 
shown to be associated with a beneficial effect on glycaemic control  (Reunanen et al., 
1998; Song et al., 2011; Sukumar et al., 2015; Tabatabaei-Malazy et al., 2015), and 
have been indicated in decreasing the risk of developing future diabetes. However, it 
remains to be determined whether a single component, or a combination of various 
vitamins and minerals in multivitamin preparations, confers protection against T2DM 
(Ford, 2001). Moreover, details regarding the type, dosage, frequency, and duration of 
vitamin use was unavailable from the participants, in the present study.  
 
Aside from the above, low vitamin D levels positively associated with metabolic 
syndrome and low HDL-cholesterol, independent of several potential confounding 
factors, including obesity, physical activity, age, and parity. Asemi et al. (2013) 
reported that vitamin D supplements could induce a significant reduction in total serum 
cholesterol and LDL-cholesterol concentrations. Moreover, hypovitaminosis D has 
been shown to increase the risk of components of metabolic syndrome in pregnancy, 
such as obesity (Karras et al., 2016), high levels of triglycerides (Rodriguez-Rodriguez 
et al., 2011), low HDL-cholesterol (Makgoba et al., 2011), fasting blood glucose level 
(Loy et al., 2015), and gestational HTN (Bodnar et al., 2007a). A meta-analysis of the 
non-pregnant population demonstrated an inverse correlation between vitamin D levels 
and the risk of metabolic syndrome (Ju et al., 2013).  
 
Confirming the results presented in Chapter 5, the present study confirms that a past 
history of GDM and obesity are strong predictors of future GDM development 
(Kautzky-Willer et al., 2008; Al-Rubeaan et al., 2014; Erem et al., 2015; Qing et al., 
2016). In addition, the present study demonstrates that high HbA1c levels in early 
pregnancy pose a three-fold risk during early pregnancy, and 2.29 times risk during 
mid-pregnancy, for the development of GDM. High HbA1c levels at 18-22 and 32-36 
weeks of pregnancy are associated with 11.4 and 56 times the risk of developing GDM, 
respectively (Odsæter et al., 2016). Although HbA1c as a risk factor for GDM 
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development has not been investigated extensively, a few studies have cited HbA1c as 
a risk factor, but none adjusted for lifestyle factors as independent risk factors. 
However, the present study aimed to address this and did perform adjustments for 
lifestyle factors in order to ascertain their independent risk effects. Although HbA1c 
may be an important predictor of GDM, as a single entity it does not seem to be a robust 
criterion for diagnosing GDM (Agarwal et al., 2005; Rajput et al., 2012; Sevket et al., 
2014; Odsæter et al., 2016). 
 
Furthermore, a few but inconsistent studies have focused on the role of early pregnancy 
lipid profiles and GDM risk (Enquobahrie et al., 2005; Li et al., 2015; Wang et al., 
2016). This current study revealed that within the lipid profile, only low HDL-
cholesterol in early pregnancy appeared to be an independent risk factor of GDM, 
which remained significant after adjusting for confounding factors. This observation is 
consistent with the findings of previous studies reporting low levels of HDL-cholesterol 
in the first trimester; these being associated with a higher risk of future GDM 
development, even after adjusting for confounding factors (Savvidou et al., 2010; 
Makgoba et al., 2011; Li et al., 2015).  
 
T2DM, GDM, and metabolic syndrome all share similar risk factors, particularly 
against the backdrop of similar genetic susceptibilities (Ben‐Haroush et al., 2004). 
Therefore, it is assumed that their pathogenesis is indistinct, with one preceding the 
other, and many components of the metabolic syndrome predicting GDM. It has been 
proposed that GDM is a phase of metabolic syndrome that refers to a combination of 
high insulin levels, insulin resistance, obesity, dyslipidaemia, hypertension, and T2DM, 
or impaired glucose tolerance (Ben‐Haroush et al., 2004). Metabolic syndrome was in 
fact found to incur 57.61 times the risk of developing GDM by mid-pregnancy, which 
could be ascribed to significantly higher components of metabolic syndrome here, 
including obesity, TG, fasting glucose, fasting insulin, and HOMA-IR, in the GDM 
group. However, limited studies have considered metabolic syndrome with GDM risk 
during normal pregnancies (Bartha et al., 2008; Negrato et al., 2008). Metabolic 
syndrome is certainly linked to a worsening of glucose homoeostasis at mid-pregnancy, 
with the subsequent development of GDM (Negrato et al., 2008), and was detected in 
157 
 
45.7% of the pregnant women in the present study, which was significantly higher than 
the 10% prevalence rate reported previously by Bartha et al. (2008). 
 
In conclusion, the current study has verified that hypovitaminosis pertaining to vitamin 
D, during the first trimester of pregnancy is a significant risk factor for developing 
GDM, even after adjusting for lifestyle factors. The findings of this study, therefore, 
put forward additional arguments concerning the effect of vitamin D on alterations to 
lipid profiles and metabolic syndrome, thus emphasising the need for further 
investigation, so that these potentially modifiable complications can be detected in a 
timely manner, leading to better pregnancy outcomes. 
157 
 
 
 
Final Discussion 
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7.1 Discussion 
7.1.1 Vitamin D Status Among Pregnant Saudi Women  
During pregnancy, a number of endogenous and exogenous factors, such as maternal 
blood glucose, insulin, and vitamin D concentration affect maternal and foetal 
homoeostasis (Drever et al., 2010; Lukaszewski et al., 2013; Karras et al., 2014). 
Among the pregnant women included in the present study, 81% were found to have a 
vitamin D deficiency, which is higher than the prevalence rates reported in European 
and Western countries (Makgoba et al., 2011; Wei et al., 2012; Flood-Nichols et al., 
2015). However, vitamin D deficiency rates of up to 98% among Asian pregnant 
women, indicates that these rates exhibit regional and ethnic variations (Narchi et al., 
2010; Al Kalbani et al., 2011; Choi et al., 2015). Vitamin D deficiency among women, 
particularly during pregnancy, may adversely affect pregnancy outcomes (Lu et al., 
2016). This emphasises the need to gain a better understanding of factors predisposing 
pregnant women to vitamin D deficiency, particularly in the initial stages of pregnancy.    
 
7.1.2 Factors Determining Vitamin D Status Among Pregnant Saudi 
Women 
Exposure to sunlight is critical for adequate supplies of vitamin D, as 80% of vitamin 
D is derived from the skin reacting to sunlight (Holick, 2003). Limited exposure to 
sunlight is, therefore, considered an important predictor of vitamin D deficiency 
(Holick, 2004). Avoidance of sun exposure by spending a significant amount of time 
indoors has already been recognised as a major risk factor in the development of 
vitamin D deficiency (Xiang et al., 2013). The pregnant women in the present study 
were observed to experience inadequate sun exposure through being indoors, which 
was linked to extreme climatic conditions and the wearing of traditional clothing that 
covers the whole body. These factors are believed to contribute to vitamin D deficiency 
in the current context. Whole body coverage with traditional dress has been shown to 
pose a 17 times higher risk of vitamin D deficiency, and this reflects what has been 
observed in other Muslim countries (Ates et al., 2016; Karras et al., 2016). 
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Vitamin D intake from food was also found to be low in the sample studied here, with 
only 2.6% of the subjects ingesting more than the daily recommended intake. Since 
food sources provide less than 10% of the human body’s daily vitamin D requirement, 
reliance solely on dietary sources is expected to result in hypovitaminosis D (Holick et 
al., 2012). Moreover, recent unhealthy diet rich in fat and carbohydrates  and changes 
in eating habits in KSA may have contributed to lower dietary intake of vitamin D and 
calcium, especially in younger women (Al-Ghamdi et al., 2012; Al-Faris et al., 2015). 
In addition, successive and unplanned pregnancies in a community with a high 
prevalence of vitamin D deficiency may further aggravate the condition (Aly et al., 
2013; Andersen et al., 2013). Accordingly, multiparity was also associated with vitamin 
D deficiency in the present study; due to depletion of the vitamin D reserves in the body 
especially if there is a lack of vitamin D supplementation or faulted dietary behaviors 
within the pregnancy spacing periods (Jensen et al., 2012). Pregnant housewives with 
low educational status, residing in low income localities were all consequently found 
to be vulnerable to vitamin D deficiency, reflecting a lack of awareness in this particular 
group.  
 
The individuals with no vitamin D deficiency were also found to have a higher body 
fat percentage than the members of the vitamin D-deficient group. This could be 
explained by rapid dynamic changes in lipid metabolism during this period of their 
pregnancies (Lain & Catalano, 2007), thus triggering higher serum 25(OH)D 
concentrations. It is well known that fatty dairy products are rich in vitamin D, so it is 
highly likely that adequate levels of vitamin D were maintained by a higher dietary fat 
and vitamin D content in the non-deficient group. However, assessment of body fat 
during pregnancy, by measuring skinfold thickness is prone to error, due to pregnancy-
related hormonal changes resulting in increased hydration of the connective tissues 
(Robertson, 1969). Despite this, estimation of body fat using skinfold thickness remains 
the best measure of percentage body fat, independent of the changes related to the 
presence of the foetus (Forsum et al., 1989; Widen & Gallagher, 2014).  Nevertheless, 
although fat mass quantification is important for understanding vitamin D status during 
all stages of life, this could be less important in pregnancy compare with other risk 
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factors, including physical activity, which appears to be more relevant to vitamin D 
status (Bener et al., 2013; Simões et al., 2016).  
 
To illustrate this, the physically active women in the present study were found to have 
adequate levels of vitamin D, with physical activity of 30 minutes/day being observed 
to be an independent predictor of 25(OH)D adequacy, even after adjusting for sun 
exposure. This observation is consistent with previously reported findings, suggesting 
that an active lifestyle will support adequate vitamin D levels (Kluczynski et al., 2011; 
Rodriguez et al., 2016). Correspondingly, it has been speculated that the maintenance 
of adequate vitamin D levels is most likely due to its mobilisation from the adipose 
tissues (Tzotzas et al., 2010).    
 
Finally, low HDL-cholesterol levels, and the total cholesterol/HDL ratio have proved 
to be significant risk factors for hypovitaminosis D in early pregnancy. It has previously 
been shown that vitamin D concentration positively correlates with HDL cholesterol, 
even after adjusting for age, BMI, ethnicity, family history of diabetes, and cigarette 
smoking (Makgoba et al., 2011). Therefore, reduced HDL-cholesterol levels are not 
only associated with vitamin D deficiency, but also pose a significant risk for the 
development of cardiovascular disease, particularly among pregnant women (Boucher, 
1998; Barter  et al., 2007).  
 
7.1.3 Vitamin D Status During Pregnancy  
The monitoring of vitamin D levels during pregnancy has been recommended for 
favourable pregnancy outcomes (Moon et al., 2015). It has been proposed that vitamin 
D status during early pregnancy is a reliable predictor of vitamin D concentrations later 
on in pregnancy, thus providing an opportunity to pre-empt, and avoid adverse effects 
of vitamin D deficiency in both the mother and the foetus (Choi et al., 2015). Although 
pregnant women with vitamin D deficiency during early pregnancy were found to 
exhibit an improvement in their vitamin D levels as their pregnancy progressed, they 
failed to achieve adequate levels of vitamin D by mid-pregnancy. Rising vitamin D 
levels with advancing pregnancy may have been attributed to increased production of 
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vitamin D by the growing placenta (Forsum et al., 1989; Widen & Gallagher, 2014). 
Moreover, genetic factors, vitamin D binding proteins, and high levels of oestrogens 
may have also be implicated in these rising concentrations during mid-pregnancy 
(Wang et al., 2010; Hedlund et al., 2013). The fact that 77% of the pregnant women 
displayed vitamin D deficiency at mid-pregnancy, indicates that endogenous sources of 
vitamin D fall short of providing sufficient amounts of vitamin D at such a time, but 
this may be compensated with increased physical activity and intake of vitamin D 
supplements.  
 
7.1.4 Prevalence and Risk Factors of GDM Among Pregnant Saudi 
Women 
Pregnancy has always been known as a diabetogenic state, characterised by overt 
insulin resistance and compensatory hyperinsulinaemia (Ryan, 2011). Coupled with 
high rates of obesity in the general population in Saudi Arabia, the risk of developing 
GDM is undoubtedly increased (Al-Rubeaan et al., 2014; Alfadhli et al., 2015). Similar 
observations were made in the present study, whereby 33% of pregnancies were found 
to be complicated by GDM.  
 
A past history of GDM was associated with an 11 times higher risk of developing GDM 
in the present study, and this was among the strongest predictors of GDM. Other 
classical risk factors linked to GDM in the present study were family history of T2DM, 
pre-pregnancy obesity, obesity during early and mid-pregnancy, and physical 
inactivity. The subjects in the GDM group were obese, and thus cautious against 
gaining weight. Similar findings were derived from previous studies (Li et al., 2015; 
Hung & Hsieh, 2016). The GDM relationship with a higher cardio-metabolic profile 
was evident in this and earlier studies (Ryckman et al., 2015; Chitme et al., 2016). 
 
7.1.5 Novel Predictors of GDM in Pregnant Saudi Women  
The present study revealed some novel predictors of increased GDM risk in early 
pregnancy. For instance, random blood glucose and Hb1Ac levels were higher in the 
GDM women, compared to their counterparts without GDM. In fact, a high percentage 
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of Hb1Ac (the range in this study was from 4% - 6.4%) in early pregnancy appeared to 
increase the risk of GDM three-fold. These two biomarkers have previously been 
proposed as reliable markers for GDM screening (Anaka et al., 2014; Meek et al., 
2016). Furthermore, in the lipid profile, low HDL-cholesterol in early pregnancy 
amongst the Saudi subjects independently proved to be a significant risk factor of GDM 
occurrence. This has similarly been reported previously in the UK and China (Savvidou 
et al., 2010; Makgoba et al., 2011; Li et al., 2015).  
 
Vitamin D exerts a direct effect on pancreatic β-cells and glucose metabolism (Pittas & 
Dawson-Hughes, 2010). In the present study, vitamin D deficiency during early 
pregnancy was observed to be an independent risk factor for GDM, with a four-fold 
higher risk of development by mid-pregnancy. Blood levels of vitamin D were shown 
to exhibit an inverse correlation with HbA1c and fasting glucose in the present study. 
The insulin resistance observed at mid-pregnancy could possibly be due to vitamin D 
deficiency coinciding with the development of GDM. Similar findings have also been 
reported in a number of studies (Clifton-Bligh et al., 2008; Mutlu et al., 2015). 
Consistent with the findings of the present study, Lu and colleagues (2016) reported 
that vitamin D deficiency in early pregnancy increases the risk of GDM by 1.45 times. 
A number of meta-analyses have also confirmed that vitamin D deficiency in early 
pregnancy is a reliable predictor of GDM (Christesen et al., 2012; Poel et al., 2012; 
Aghajafari et al., 2013; Wei et al., 2013; Zhang et al., 2015; Lu et al., 2016).  
 
Previous reviews, however, were based on observational studies and did not address all 
confounders. The majority of such studies were only adjusted for classical confounders, 
such as age, BMI, ethnicity, and family history (Maghbooli et al., 2008; Zhang et al., 
2008; Arnold et al., 2015). In contrast, the current study investigated confounders such 
as physical activity, sun exposure, vitamin D intake, supplementation, season, socio-
economic status, education, area of residence, GWG, history of diabetes, and parity.  
Vitamin D-related lifestyle factors were associated with a significant risk of developing 
GDM, such as sun exposure indices. In addition, multivitamin supplementation was 
found to confer protection against the development of GDM. Adjusting for sun 
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exposure and multivitamin intake was therefore important, because of its clinical 
relevance.   
 
The current study revealed that obesity is associated with GDM, but not with vitamin 
D deficiency. It showed that as a confounder, obesity in early pregnancy did not 
attenuate the significance between vitamin D concentration and GDM risk. This is 
similar to Arnold et al. (2015), who revealed no statistical significance in the interaction 
of pre-pregnancy overweight/obesity status with 25(OH)D levels and GDM risk. These 
data imply that pregnant women, whether of normal weight or obese, need an early 
pregnancy vitamin D level of at least 50 nmol/L to reduce the risk of GDM, but this 
needs to be tested in future RCTs on supplementation. 
 
GWG by mid-pregnancy showed a reduced weight-gaining trend among the GDM 
women in the current study, but GWG did not indicate any differences, with regard to 
vitamin D deficiency. These associations with GWG support previous studies on GDM 
(Hung & Hsieh, 2016) and vitamin D deficiency (Charatcharoenwitthaya et al., 2013; 
Bärebring et al., 2016). Vitamin D deficiency in early gestation increases the risk of 
GDM, and is independent of GWG as a confounder, while vitamin D deficiency at mid-
pregnancy is found to be affected by GWG, and thus loses significance for GDM risk. 
To date, only one study has assessed GWG in relation to vitamin D levels at mid-
pregnancy and GDM risk, and found that adjusting for BMI at mid-pregnancy 
contributes to the loss of significance for GDM risk, while GWG made little difference 
(Burris et al., 2012).  
 
Multiparity, physical inactivity and low HDL-cholesterol were identified as 
independent risk factors of either vitamin D deficiency, GDM, or both.  Adjusting for 
these confounders did not attenuate the significance of vitamin D increasing the risk of 
GDM here. Consistent with the findings of the present study, adjusting for physical 
activity has also been shown not to attenuate the risk posed by vitamin D deficiency for 
the development of GDM (Burris et al., 2012; Lacroix et al., 2014). Similarly, adjusting 
for parity here failed to attenuate the vitamin D-related risk of GDM, an observation 
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that has been reported previously (Maghbooli et al., 2008; Makgoba et al., 2011; Burris 
et al., 2012; Lacroix et al., 2014). 
 
Despite the fact that 47.4% of the current subjects reported consuming multivitamins 
containing vitamin D, 36.7% were severely vitamin D-deficient by mid-pregnancy. 
This is because their supplementation failed to meet the 600 IU/day DRI. Daily 
supplementation with multivitamins and 400-500 IU of vitamin D has proved to be 
ineffective for the treatment of vitamin D deficiency (Lau et al., 2011). However one 
study has shown that in GDM women, the administration of 50,000 IU of vitamin D 
supplements twice in the study, along with 1000 mg calcium daily, effectively reduced 
fasting glucose, serum insulin levels, and HOMA-IR, and showed a significant 
improvement in lipid profile (Asemi et al., 2013). It has been proposed that the 
administration of 2000-4000 IU/day during pregnancy is sufficient for achieving 
adequate vitamin D levels (Hollis et al., 2011; Charatcharoenwitthaya et al., 2013; 
Wagner et al., 2013). Therefore, the administration of 5000 IU of vitamin D on a daily 
basis to women in early pregnancy brings about a significant reduction in future GDM 
development (Shahgheibi et al., 2016). 
 
In the present study, vitamin D deficiency at mid-pregnancy was revealed to be an 
independent risk factor for metabolic syndrome, and this is an observation reported for 
the first time. It has been speculated that GDM could possibly be a component of 
metabolic syndrome, comprising hyperinsulinaemia, insulin resistance, obesity, 
dyslipidaemia, HTN, and T2DM, or impaired glucose tolerance (Ben-Haroush et al., 
2004), meaning that vitamin D, GDM, and metabolic syndrome are interrelated.  
 
7.2 Strengths of the Current Study 
The main strengths of the current study were: 
1. The prospective study design and recruitment of a cohort from three tertiary 
care hospitals in Riyadh, using rigorous selection criteria. Strictly standardised 
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regimes for recruitment and data collection, facilitating individual follow-up 
for about 3-4 months.  
2. All the women included in the study were ethnically homogeneous.  
3. This is the first study in Saudi that links vitamin D deficiency in early 
pregnancy with GDM and metabolic syndrome. 
4. For assessing GWG, the baseline weight was recorded during early pregnancy, 
as opposed to pre-pregnancy, for comparison with weight at mid-pregnancy.  
5. For the first time ever, physical activity was documented as an independent 
risk factor for vitamin D deficiency during pregnancy, independent of sun 
exposure.  
6. The use of an ECLIA permitted the detection of both forms of 25(OH)D. It was 
also highly correlated with the Liquid chromatography–mass spectrometry 
(LC-MS/MS) gold standard, and vitamin D results were included in the 
external quality assurance scheme, DEQAS (Zerwekh, 2008). 
7.3 Limitations of the Current Study 
Some of the caveats have already been mentioned in previous chapters. However, the 
limitations of this study may be outlined as follows: 
1. Significant high loss to follow-up.  
2. Blood samples collected during early pregnancy were non-fasting specimens, 
whereas the samples collected mid-pregnancy were fasting samples. However, 
non-fasting samples were compared with fasting samples at the second visit, 
and fasting is not mandated for booking clinical visits during pregnancy. This 
is convenient for pregnant women, as in other studies (Savvidou et al., 2010; 
Tomedi et al., 2013; Lacroix et al., 2014). In fact, non-fasting TG in early 
pregnancy may be overestimated (Campos et al., 2005).  
3. The FFQ used in the present study was designed to measure vitamin D, 
calcium, and protein intake, but not total energy, carbohydrates, or fats.  
4. The recall bias of the questionnaires, including the FFQ, sun exposure 
questionnaire, and IPAQ, may have resulted in under- or over-reporting during 
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the interview. However, the interviewer was well-trained and used repeated 
questions to ensure the reliability of the answers.  
5. Details of the compliance, dose, and type of multivitamin supplementation 
were not recorded.  
6. Fat mass percentage was measured using skinfold thickness, which is 
vulnerable to error, especially during pregnancy (Forsum et al., 1989). 
However, for each patient, four sites were measured to minimise error. In 
addition, the most common and convenient method of measuring changes in 
body composition during pregnancy is anthropometry (skinfold thickness) 
(Forsum et al., 1989; Widen & Gallagher, 2014).  
7. This study categorised GWG into excessive vs. non-excessive GWG. The non-
excessive GWG included both adequate and inadequate GWG  (i.e. below the 
IOM recommendations), similar to one recent meta-analysis (Brunner et al., 
2015). Thus, the influence might be overestimated, and will partially result in 
potentially lowered GDM risk, associated with lower than recommended 
GWG.  
8. This study used a HOMA equation to calculate insulin resistance and β-cell 
function. These are intended for low sensitivity and only reflect changes in the 
fasting state, compared to other direct methods, such as those derived from 
clamp studies or the minimal model. However, markers of insulin 
resistance/sensitivity based on fasting markers were strongly associated with 
gold-standard measures, and validated in the pregnant population (Kirwan et 
al., 2001). 
7.4 Recommendations  
This thesis highlights the importance of studying low vitamin D concentration, 
prevalent among Saudi pregnant women living in Riyadh. More attention should be 
given to vitamin D concentration in pregnancy, due to its greater impact on health status 
and disease prevention than previously thought. Some strategies could be taken to 
address the current situation:  
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 Exposure to sunlight needs to be increased among women in the present context, 
through greater skin exposure across different parts of the body to the sun at noon, 
so that they can synthesise adequate levels of the vitamin.  
 Awareness needs to be increased among pregnant women, with regards to the 
importance of dietary vitamin D intake from food naturally rich in vitamin D, or 
else food fortified with vitamin D.  
 Enhanced fortification of food with vitamin D may be necessary to compensate for 
reduced vitamin D synthesis via the skin, and a reversal of vitamin D deficiency in 
Saudi Arabia, especially among pregnant women.  
 Dietary supplementation of vitamin D, up to 2000-4000 IU/day should be 
considered for those at risk of vitamin D deficiency, such as pregnant women 
(Hollis et al., 2011). Furthermore, since a large proportion of pregnant women 
suffer from vitamin D deficiency, it would make sense to suggest vitamin D be 
given to all women planning a pregnancy or already pregnant, similar to folic acid. 
 Indoor and outdoor physical activity is advised to help improve vitamin D status. 
An optimum duration of activity, amounting to a minimum of 30 minutes/day 
should be recommended.  
 Effective education programmes should be designed to target Saudi pregnant 
women at the local level, in order to enhance public awareness of this serious 
problem; particularly among women of low socio-economic status. Thus, both 
personal and government action should be taken to address the current situation.  
Understanding the high prevalence of GDM in Saudi women highlights the importance 
of investigating all the determinants and harnessing prevention strategies to reduce its 
incidence. Regarding GDM screening, random plasma glucose and HbA1c levels could 
be used to identify women at high risk of GDM, who would benefit from earlier 
diagnosis, or more intensive lifestyle intervention in early pregnancy. 
 
A vital component in the prevention of both vitamin D deficiency and GDM may 
involve enhancing healthy maternal lifestyle factors, such as reducing weight before 
pregnancy, increasing physical activity, and restricting dietary cholesterol and calorie 
intake. It is in fact advisable for younger women to avoid fad foods high in fat and 
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sugar, as such intake may promote vitamin D deficiency and susceptibility to GDM, 
through an unbalanced diet. Furthermore, multivitamin and vitamin D supplementation 
represent a simple and safe intervention that could lower the risk of diabetes. 
7.5 Future Directions  
 The significantly high prevalence of vitamin D deficiency among pregnant Saudi 
women indicates a need for large scale studies in KSA to assess vitamin D status, 
not only among pregnant women, but also among the general population.  
 It is of paramount importance to assess the impact of lifestyle factors on vitamin D 
status among pregnant women, and the general population in the Saudi context, and 
this could take place by conducting large scale studies. It would include identifying 
the factors limiting sun exposure, with attempts being made to determine optimal 
levels of sun exposure for maintaining adequate levels of vitamin D among the local 
population.  
 Although vitamin D status has been assessed in this study during early and mid-
pregnancy, longitudinal studies are recommended for monitoring vitamin D status 
throughout pregnancy, as well as pregnancy outcomes among the local population.  
 Further studies would clarify the interrelationship between sufficient vitamin D 
supplementation, recommended during pregnancy through RCTs in different 
trimesters, and would thus facilitate the establishment of guidelines for the Saudi 
population. 
 Studies on inflammatory markers with vitamin D from early pregnancy and GDM 
risk are required. Both vitamin D and GDM are known to increase inflammation. 
Whether early pregnancy vitamin D deficiency and inflammation combined 
together increases risk of GDM needs to be explored. 
7.6 Conclusion  
This study is among few Saudi studies that have measured vitamin D in early 
pregnancy, and is in fact the first Saudi study to assess the risk of vitamin D deficiency 
during early and mid-pregnancy, and investigating the effect of such deficiency on the 
prevalence of GDM. At 81% (< 50 nmol/L), the prevalence of vitamin D deficiency 
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among pregnant Saudi women was found to be high, and poses a significant risk for the 
future development of GDM, which has reached 33%, according to IADPSG. 
Suboptimal sun exposure indices, multiparity, high total cholesterol-HDL ratio, low 
HDL-cholesterol, and living in West Riyadh were the main predictors of vitamin D 
deficiency among the pregnant Saudi women studied here. However, variables such as 
physical activity during pregnancy, and higher educational status seemed to confer 
some protection against vitamin D deficiency, whereas, the strongest risk factor for the 
development of GDM was a previous history of GDM. Furthermore, vitamin D 
deficiency in early pregnancy was found to increase the risk of GDM four-fold. 
Therefore, the monitoring of vitamin D status during pregnancy would appear to be a 
key factor in the early detection of vitamin deficiency, so timely therapeutic 
intervention could help avoid unfavourable pregnancy outcomes, complicated by 
GDM, particularly in the Saudi context. 
169 
 
 
APPENDICES 
170 
 
Appendix I- Ethical Approvals 
 
 
171 
 
 
 
  
172 
 
 
 
 
  
173 
 
Appendix II -Consent form 
Did the subject meet all study criteria while recruitment?  
Please check all the criteria 
 
o Age from 1839 years old 
o First trimester between (8-12 weeks) 
o Singleton pregnancy 
o Saudi nationality 
o Not on vitamin D supplementation 
o No previous history of diabetes mellitus (type I or II). 
o No calcium or parathyroid conditions or thyroid disease 
o No history of usage cardiac medication therapy or diuretic. 
o No chronic hypertension.  
o No history of malabsorption. 
o No serious chronic condition (epilepsy, cancer, other malignancy).  
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Appendix III- First and Second visit questionnaires 
First visit questionnaires 
Research code: 
Date of filling of 
the form: 
Date of filling of the 
form: 
Name: 
Tel or Mobile No: 
Place of birth: 
Week of 
gestation…… 
Date of Birth (age): 
Anthropometric Measurements 
:Mother anthropometrics  
 Ht....................cm               Current Wt.................kg                    
 Prepregnancy Wt.................. kg 
 Current BMI…………. kg/ m2  
 Before pregnancy BMI…………. kg/ m2   
 
 Waist:  .........................  cm                               
Hips:  .........................  cm                               
      Waist-hips ratio:  .........................  cm                          
Mid arm Circumference....................... cm                          
     
 Caliper: 
Skin Fold thickness (fat %) .................... 
Triceps...................… 
Biceps....................… 
Suprailiac....................                   
Subscapular.................. 
 
 Blood Pressure:  ....................  
 
Sociodemographic Measurements 
Education Level 
 
Illiterate   Primary    Intermediate       Secondary         
University         Post graduate       
Family Income Per month 
No Income less than 5000 S.R     5000-10000 S.R 
10000-20000 S.R           More than 20000 S. R 
Occupation 
 House wife      Retired      Student       Teacher 
Employee Physician Businesswomen   
 Other (………) 
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Marital status 
 Married            Single 
Divorced           Widow 
Does your husband a relative? 
Yes     No                      
Relative degree     First degree    Second degree 
Living area 
 North Riyadh       West Riyadh 
East Riyadh          South Riyadh      Center Riyadh 
Skin color  North Riyadh      West Riyadh 
East Riyadh         South Riyadh      Center Riyadh 
Clinical Measurements 
Medical history: Family 
 HTN               Hyperlipidemia                           Heart disease                   Osteoporosis 
  Asthma            Cancer                                       Liver Disease                      Kidney Disease 
 Others: …………………………………. 
 Diabetes       1st degree relatives       mother     father      siblings        children    
                         2nd degree relatives      grandparents     uncle(mother) uncle(father)    grandchildren 
              
  GDM          1st degree relatives       mother    sister     daughter 
                         2nd degree relatives      grandmother     aunt(mother)      aunt(father)   grandchildren 
   Obesity      1st degree relatives       mother     father      siblings        children   
                         2nd degree relatives      grandparents    uncle(mother)    uncle(father)  grandchildren              
 
Medical history: Subject 
HTN                      Hyperlipidemia                 Polycystic ovarian syndrome           Osteoporosis 
 Asthma         Anemia                    GDM                                IGT                         Obesity 
Others: …………………………………. 
Age of menarche: …………. 
Menstrual cycle           Regular          Irregular 
Age at first pregnancy: …………. 
LMP (last menstrual period): …… EDD (expected date of delivery) by date: ………    
EDD by scan: ……………… 
Risk Factors: 
-The head circumference of last baby………………… 
-Usage of insulin or its alternatives  Yes     NO 
-Parity (how many times she got pregnant): …………… Number of children…………… 
- Previous caesarean section Yes     No, how many………. 
-Miscarriages if occurs?   Yes          No       If yes, how many times?...............Reasons……………  
-Preeclampsia                 Yes          No        -Gestational HTN         Yes          No 
 
If any occurred in the past:     Poly urea         Glycosuria              Protein urea 
-Pregnancy symptoms:  
Nausea                             vomiting                       morning sickness       headache          mood 
swings  
abdominal bloating           frequent urination       constipation                 tender swallow breast 
-Pregnancy complications:  …………………………………………….. 
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List of medications:  
Please a check on all medications used by the subject 
Anti-Hyperlipidemics 
[    ] Atorvastatin – Lipitor, Torvast 
[    ] Cerivastatin – Lipobaby 
[    ] Fluvastatin – Lescol, Lescol XL 
[    ] Lovastatin – Mevacor, Altocor, Altoprev 
[    ] Mevastatin  [    ] Pitavastatin – Livalo, Pitava 
[    ] Pravastatin – Pravachol, Selektine, Lipostat 
[    ] Rosuvastatin – Crestor 
[    ] Simvastatin – Zocor, Lipex 
[    ] Simvastatin + Ezetimibe – Vytorin 
[    ] Atorvastatin + Amlodipine – Caduet 
[    ] Simvastatin + Niacin – Simcor 
[    ] Cholestyramine [    ] Gemfibrozil 
[    ] Colestipol [    ] Benzafibrate, fenofibrate 
Cardiovascular drugs 
[    ] Aspirin          [    ] Warfarine         [    ] Heparin  
[    ] Clopidogrel     [    ] Amiodarone – 
Amiodarone, Cordarone 
[    ] Disopyramide – Rythmodan 
[    ] Flecainide acetate – Apo – Flecainide 
 
[    ] Mexiletine – Novo – Mexiletine 
[    ] Procainamide – Procan 
[    ] Propafenone – Rhythrnol, Nu, Apo, Gen, PMS 
[    ] Digoxin 
[    ] Clonidine 
[    ] Methyldopa 
[    ] Diazoxide 
[    ] Hydralazine 
[    ] Isosarbide dinitrate 
[    ] Nitroglycerin 
[    ] Prazosin, Terazosin, Dozazosin 
[    ] Atenolol, Acebutolol, Bisoprolol, Labetalol, 
Metaoprolol, Nadolol, Oxprenolol, Pndolol, 
Propranolol, Sotalol, Timolol 
[    ]  Amlodipine, Felodipine, Nifedipine 
[    ] Diltiazem, Verapamil 
[    ] Captopril, Benazepril, Enalapril, Cilazapril, 
Perindopril, Quinapril, Ramipril, Lisinopril 
[    ] Candesartan, Irbesartan, Losartan, Telmisartan, 
Valsartan,  
[    ] Spironolactone   [    ] Hydrochlorothiazide 
[    ] Furosemide        [    ] Pentoxyphylline 
Other (Please specify) 
1._________________________________ 
2._________________________________ 
3._________________________________ 
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Second visit questionnaires 
Research 
code: 
Date of 
filling of the form: 
Date of filling of the form: 
Name: 
Tel or Mobile No: 
Place of 
birth: 
Week of 
gestation…… 
Date of Birth (age): 
Anthropometric Measurements 
:Mother anthropometrics  
 Ht....................cm               Current Wt.................kg                    
 Prepregnancy Wt.................. kg 
 Current BMI…………. kg/ m2  
 Before pregnancy BMI…………. kg/ m2   
 
 Waist:  .........................  cm                               
Hips:  .........................  cm                               
      Waist-hips ratio:  .........................  cm                          
Mid arm Circumference....................... cm                          
     
 Caliper: 
Skin Fold thickness (fat %) .................... 
Triceps...................… 
Biceps....................… 
Suprailiac....................                   
Subscapular.................. 
 
 Blood Pressure:  ....................  
 
Clinical Measurements 
o Pregnancy symptoms:  
Nausea         vomiting           morning sickness        headache          mood swings  
abdominal bloating           frequent urination     constipation      tender swallow breast 
            
o Any complains or diagnosis……………………………… 
 
Gestational HTN        Anemia                     Viral or Bacterial illnesses 
Preeclampsia             Respiratory                 Gastrointestinal           bacterial vaginosis 
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First and Second visit 
Dietary intake of vitamin D and calcium Questionnaire 
Breakfast cereals and bread 
Daily 
 
Weekly Amount 
Cornflakes 1 2 3 1 2 3 4 5 6 M R No .......…  Cup/ week 
Cornflakes with sugar and Coco 
Pops 
1 2 3 1 2 3 4 5 6 M R No ……… Cup/ week 
 Weciabix, Shredded wheat 1 2 3 1 2 3 4 5 6 M R No …........ Cup/ week 
 Bran flakes, Wheat flakes or Sultana 1 2 3 1 2 3 4 5 6 M R No …........ Cup/ week 
 Brown Bread 1 2 3 1 2 3 4 5 6 M R No 
………..toast/ week or 
………..1/4 loaf 
White Bread 1 2 3 1 2 3 4 5 6 M R No 
………..toast/ week or 
………..1/4 loaf 
White Bread(Samoli,burger) 1 2 3 1 2 3 4 5 6 M R No 
………..toast/ week or 
………..1/4 loaf 
Shaboorah (bran or white) 1 2 3 1 2 3 4 5 6 M R No ………..pieces/week 
*M (1-3 times per month), R(rarely), NO (don’t take it at all) 
Meat and Fish 
Daily 
 
Weekly Amount 
White fish (hamoor), fish fingers 1 2 3 1 2 3 4 5 6 M R No 
 .......…  gm  
Fried / Grilled 
Oysters, shrimp 1 2 3 1 2 3 4 5 6 M R No 
.......… gm  
Fried / Grilled 
Canned fish (canned salmon, sardines,) 1 2 3 1 2 3 4 5 6 M R No 
.......… piece  
With oil / water 
Tuna fresh or canned             1 2 3 1 2 3 4 5 6 M R No 
Can/large/small 
With oil / water 
Red meat (  ............. ) 1 2 3 1 2 3 4 5 6 M R No 
….gm/week 
With fat 
Little fat  
Without fat 
Chicken Type   ).............. ) 1 2 3 1 2 3 4 5 6 M R No 
….gm/week 
Skin/without skin 
Liver, brain and kidneys 1 2 3 1 2 3 4 5 6 M R No 
….gm/week 
With fat 
Little fat  
Without fat 
Egg 
How many eggs do you eat? 1 2 3  1 2 3 4 5 6 M R No ………Egg/ week 
What kind of eggs do you eat?       
Fats 
What kind of fats used in your food?           Ghee          Margarine         Butte             Vegetables oil 
Daily 
 
Weekly Amount 
How many times do you use veg oil? 
Type…. 
1 2 3 1 2 3 4 5 6 M R No 
........Spoon/ week 
How many times do you use olive 
oil? 
1 2 3 1 2 3 4 5 6 M R No 
........Spoon/ week 
How many times do you use butter 
or ghee? 
Type…. 
1 2 3 1 2 3 4 5 6 M R No 
........Spoon/ week 
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How many times do you eat Tahini? 
Type…. 
1 2 3 1 2 3 4 5 6 M R No 
........Spoon/ week 
How many times do you usually 
have almonds or peanuts? 
Type…… 
1 2 3 1 2 3 4 5 6 M R No 
...........Cup/ week 
*Table spoon (15 ml), cup (240 ml) 
 
Dairy And its Products 
Do you usually drink milk?  
 Yes                     No                                 
If milk is liquid of which type? 
  Cow            Camel                      Goat                 Sheep                    Other  
How many times do you drink fresh milk? 
Daily Weekly Amount 
Full fat 1 2 3  1 2 3 4 5 6 M R No .......… Cup/ week 
Low fat 1 2 3 1 2 3 4 5 6 M R No ………Cup/ week 
Skim fat 1 2 3 1 2 3 4 5 6 M R No …........Cup/ week 
 How many times do you drink dried milk? 
Daily Weekly Amount 
Full fat 1 2 3  1 2 3 4 5 6 M R No .......… Cup/ week 
Low fat 1 2 3 1 2 3 4 5 6 M R No ………Cup/ week 
Skim fat 1 2 3 1 2 3 4 5 6 M R No …........Cup/ week 
 How many time do you drink canned milk?      
Daily Weekly Amount 
Full fat 1 2 3  1 2 3 4 5 6 M R No .......… Cup/ week 
Low fat 1 2 3 1 2 3 4 5 6 M R No ………Cup/ week 
Full fat 1 2 3 1 2 3 4 5 6 M R No …........Cup/ week 
Concentrated milk 1 2 3 1 2 3 4 5 6 M R No .......… Cup/ week 
Chocolate  1 2 3 1 2 3 4 5 6 M R No ………Cup/ week 
With Strawberry 1 2 3 1 2 3 4 5 6 M R No …........Cup/ week 
With Banana 1 2 3 1 2 3 4 5 6 M R No .......… Cup/ week 
other 1 2 3 1 2 3 4 5 6 M R No ………Cup/ week 
How many times do you drink Laban?        
Daily Weekly Amount 
Full fat 1 2 3  1 2 3 4 5 6 M R No .......… Cup/ week 
Low fat 1 2 3  1 2 3 4 5 6 M R No .......… Cup/ week 
Skim fat 1 2 3  1 2 3 4 5 6 M R No .......… Cup/ week 
How many times do you have yoghurt?                  
Daily Weekly Amount 
Full fat 1 2 3  1 2 3 4 5 6 M R No .......… Cup/ week 
Low fat 1 2 3 1 2 3 4 5 6 M R No .......… Cup/ week 
Skim fat 1 2 3 1 2 3 4 5 6 M R No .......… Cup/ week 
How many times do you have these products?      
Daily Weekly Amount 
Triangle Cheese  1 2 3  1 2 3 4 5 6 M R No ……Piece/ week 
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Kerry Cheese  1 2 3 1 2 3 4 5 6 M R No ……Piece/ week 
White Cheese 1 2 3 1 2 3 4 5 6 M R No ……Spoon/ week 
Yellow cheese 1 2 3 1 2 3 4 5 6 M R No ……Spoon/ week 
Fatty cheese 1 2 3 1 2 3 4 5 6 M R No ……Spoon/ week 
Geshtah 1 2 3 1 2 3 4 5 6 M R No ……Spoon/ week 
Labnah 1 2 3 1 2 3 4 5 6 M R No ……Spoon/ week 
Cream 1 2 3 1 2 3 4 5 6 M R No ……Spoon/ week 
Mozzarella 1 2 3 1 2 3 4 5 6 M R No ……..gm/ week 
Tofu 1 2 3 1 2 3 4 5 6 M R No ……Piece / week 
* Food spoon= 15 gm 
 
Vegetables and Fruits 
How many times do you eat the following? 
Daily Weekly Amount 
Orange 1 2 3  1 2 3 4 5 6 M R No ………One/ week 
Fig 1 2 3 1 2 3 4 5 6 M R No ………One/ week 
Dried fruits (raisins,peache) 1 2 3 1 2 3 4 5 6 M R No ….......Cup / week 
(fresh or cooked) kale 1 2 3 1 2 3 4 5 6 M R No ……...Cup / week 
(fresh or cooked) celery 1 2 3 1 2 3 4 5 6 M R No ……...Cup / week 
Spinach (fresh or cooked) 1 2 3 1 2 3 4 5 6 M R No …...…Cup / week 
  (fresh or cooked) broccoli 1 2 3 1 2 3 4 5 6 M R No …...…Cup / week 
Mashroom (fresh or sundried) 1 2 3 1 2 3 4 5 6 M R No ……...Cup / week 
Potatoes (fried or cooked)  1 2 3 1 2 3 4 5 6 M R No ………One/ week 
Homos,lentis 1 2 3 1 2 3 4 5 6 M R No ...……Cup / week 
Fool (black beans) 1 2 3 1 2 3 4 5 6 M R No …..….Cup / week 
*Cup = 240 m 
Cultural Food and others 
 Weekly Amount 
How many times do you have Greesh per week? 1 2 3 4 5 6 M R No ……...Cup/ week 
How many times do you have Saleeq per week? 1 2 3 4 5 6 M R No ……...Cup/ week 
How many times do you have Harees per week? 1 2 3 4 5 6 M R No ….......Cup/ week 
How many times do you have Marase or msabeb 
per week? 
1 2 3 4 5 6 M R No ……...Cup/ week 
How many times do you have Pasta with cheese 
or milk (lasagna, fettuccine, bashamel  ( per week? 
1 2 3 4 5 6 M R No ……...Cup/ week 
How many times do you have pizza per week? 1 2 3 4 5 6 M R No ...…...pieces/week 
Sweets 
Daily 
 
Weekly Amount 
How many times do you have Ice 
cream? 
1 2 3 1 2 3 4 5 6 M R No 
……Piece/week 
Type…………    
How many times do you have 
carbonated beverages? 
1 2 3 1 2 3 4 5 6 M R No 
……Piece/week 
Type…………    
How many times do you have 
chocolate? 
1 2 3 1 2 3 4 5 6 M R No 
……Piece/week 
Type…………    
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How many times do you have 
muffins or cake or donuts? 
1 2 3 1 2 3 4 5 6 M R No 
……Piece/week 
Type…………    
How many times do you have 
biscuits? 
1 2 3 1 2 3 4 5 6 M R No 
…....Piece/week 
Type…………    
How many times do you have cream 
caramel or custard? 
1 2 3 1 2 3 4 5 6 M R No 
……Piece/week 
Type…………   
Tea and Coffee 
Daily 
 
Weekly Amount 
How many times do you drink red 
tea? 
1 2 3 1 2 3 4 5 6 M R No 
…..Cup/ week 
Type 
(……………) 
How many times do you drink green 
tea? 
1 2 3 1 2 3 4 5 6 M R No 
……Cup/ week 
Type 
(……………) 
Water 
 Daily Amount 
How many times do you drink water? 
1-3 
cups 
3-6 cups 6-12 cups 
More than 12 
cups 
Kind? Bottled Water 
water from 
Tanks 
 Tape water 
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Supplements Intake 
Do you take Multivitamin?      
     
  Yes      No 
Since when?..................................... 
 
Do you take it regularly?  
Yes No  
How many times?  
Daily  3-4 times a week      once a week 
Do you take Folic Acid?    
       
Yes     No 
Since when?..................................... 
 
Do you take it regularly?  
Yes No 
How many times?  
Daily  3-4 times a week       once a week 
Do you take Iron pills?      
      Yes     No 
Since when?..................................... 
 
Do you take it regularly?  
Yes No 
How many times?  
Daily  3-4 times a week       once a week 
Do you take vitamin D supplement? 
If yes, which kind?? 
…………………………………….. 
       
Yes   No 
 
 
Since when?..................................... 
 
Do you take it regularly?  
Yes No 
How many times?  
Daily  3-4 times a week       once a week 
 
Amount……………IU or microgram 
Do you take cod liver oil?      
       
Yes     No 
Since when?..................................... 
Do you take it regularly?  
Yes No 
How many times?  
Daily  3-4 times a week       once a week 
Do you take any herbs? 
        
Yes   No 
First kind……. 
Since when?  ..................................... 
Do you take it regularly? 
Yes No 
How many times?         
Daily  3-4 times a week        once a week 
 
Amount………... 
 Second kind………. 
Since when?  ..................................... 
Do you take it regularly?  
Yes No 
How many times? 
Daily  3-4 times a week         once a week 
 
Amount…………... 
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Sun Exposure 
Current Season Summer              Winter         
What is the extent of your exposure to the sun? 
 No exposure        Daily Minutes 
(….…)   Weekly Minutes (…….)  
What is the time of exposure to the sun?  
 at sunrise       at noon         before 
sunset 
What is the nature of your work? 
Outside/ directly under the sun 
Inside (in covered rooms/ paces) 
What are the parts of the body most exposed to the sun?  
 
Face    hands   
Face and hands     Face, hands and 
feet 
What is the extent of clothing cover to the body during 
exposure to the sun?  
 
Body except face     
Body except face and hands   
 Body except face, hands and feet       
The whole body 
Body except hands and feet 
Do you use sun protection creams? 
 
 Yes (type………………)     
 No     
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Physical activity (International Physical Activity Questionnaire) (IPAQ) 
READ:  I am going to ask you about the time you spent being physically active in the last 7 
days. Please answer each question even if you do not consider yourself to be an active person.  
Think about the activities you do at work, as part of your house and yard work, to get from 
place to place, and in your spare time for recreation, exercise or sport. 
  
READ:  Now, think about all the vigorous activities which take hard physical effort that you 
did in the last 7 days.  Vigorous activities make you breathe much harder than normal and 
may include heavy lifting, digging, aerobics, or fast bicycling.  Think only about those 
physical activities that you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities? 
 
_____ Days per week    [VDAY; Range 0-7, 8,9] 
    8.Don't Know/Not Sure  
    9.Refused 
2. How much time did you usually spend doing vigorous physical activities on one of those days?  
 
__ __ Hours per day     [VDHRS; Range: 0-16]  
__ __ Minutes per day [VDMIN; Range: 0-960, 998, 999]  
998.Don't Know/Not Sure  
999.Refused 
Interviewer probe: An average time for one of the days on which you do vigorous activity 
is being sought. If the respondent can't answer because the pattern of time spent varies widely 
from day to day, ask: "How much time in total would you spend over the last 7 days doing 
vigorous physical activities?” 
  
__ __ Hours per week           [VWHRS; Range: 0-112]  
__ __   Minutes per week     [VWMIN; Range: 0-6720, 9998, 9999]  
 9998.Don't Know/Not Sure  
 9999.Refused   
READ:  Now think about activities which take moderate physical effort that you did in the 
last 7 days.  Moderate physical activities make you breathe somewhat harder than normal 
and may include carrying light loads, bicycling at a regular pace, or doubles tennis.  Do not 
include walking.  Again, think about only those physical activities that you did for at least 10 
minutes at a time. 
 
3. During the last 7 days, on how many days did you do moderate physical activities? 
 
____Days per week           [MDAY; Range: 0-7, 8, 9] 
8.Don't Know/Not Sure  
9.Refused  
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4. How much time did you usually spend doing moderate physical activities on one of those days? 
 
__ __Hours per day        [MDHRS; Range: 0-16] 
__ __   Minutes per day  [MDMIN; Range: 0-960, 998, 999] 
  998.Don't Know/Not Sure  
  999.Refused   
[Interviewer probe: An average time for one of the days on which you do moderate activity 
is being sought. If the respondent can't answer because the pattern of time spent varies widely 
from day to day, or includes time spent in multiple jobs, ask: “What is the total amount of time 
you spent over the last 7 days doing moderate physical activities?” 
 
__ __ Hours per week       [MWHRS; Range: 0-112] 
__ __ Minutes per week   [MWMIN; Range: 0-6720, 9998, 9999] 
 9998. Don't Know/Not Sure  
 9999. Refused 
READ:  Now think about the time you spent walking in the last 7 days.  This includes at work 
and at home, walking to travel from place to place, and any other walking that you might do 
solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a time? 
 
____ Days per week    [WDAY; Range: 0-7, 8, 9]  
   8.   Don't Know/Not Sure  
   9.   Refused   
6. How much time did you usually spend walking on one of those days? 
 
__ __ Hours per day [WDHRS; Range: 0-16]  
__ __ Minutes per day [WDMIN; Range: 0-960, 998, 999] 
  998. Don't Know/Not Sure  
  999. Refused 
[Interviewer probe: An average time for one of the days on which you walk is being sought.  
If the respondent can't answer because the pattern of time spent varies widely from day to day, 
ask: “What is the total amount of time you spent walking over the last 7 days?” 
 
__ __   Hours per week[WWHRS; Range: 0-112] 
__ __   Minutes per week[WWMIN; Range: 0-6720, 9998, 9999]  
 9998.  Don't Know/Not Sure  
 9999.Refused 
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READ: Now think about the time you spent sitting on week days during the last 7 
days.  Include time spent at work, at home, while doing course work, and during leisure time.  
This may include time spent sitting at a desk, visiting friends, reading or sitting or lying down 
to watch television. 
 
    7.  During the last 7 days, how much time did you usually spend sitting on a week day? 
 
__ __ Hours per weekday [SDHRS; 0-16]                      
__ __ Minutes per weekday    [SDMIN; Range: 0-960, 998, 999] 
998.Don't Know/Not Sure  
999.Refused 
[Interviewer probe]: An average time per day spent sitting is being sought.  If the 
respondent can't answer because the pattern of time spent varies widely from day to day, ask: 
“What is the total amount of time you spent sitting last Wednesday?” 
 
__ __ Hours on Wednesday[SWHRS; Range 0-16] 
__ __ Minutes on Wednesday [SWMIN; Range: 0-960, 998, 999] 
998.Don't Know/Not Sure  
999.Refused  
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Appendix V- Determinants of change in 25(OH)D between early and mid-
pregnancy, for the whole cohort and deficient and non-deficient groups (Chapter 
4)  
 Over all Non-Deficient Deficient 
Parameters causing change 
 in Vitamin D 
B 
P-
value 
B 
P-
value 
B 
P-
value 
Pre-pregnancy BMI -0.03± 0.08 0.703 -0.002± 0.005 0.718 0.001± 0.003 0.809 
BMI at 1st visit 0.00 ± 0.003 0.856 -0.001± 0.005 0.874 0.001± 0.003 0.641 
BMI at 2nd visit 0.00 ± 0.003 0.951 -0.001± 0.006 0.880 0.001± 0.003 0.733 
GWG 
-0.001 ± 
0.004 
0.723 0.005± 0.008 0.492 -0.002± 0.004 0.559 
Multivitaminv at 1st visit -0.06 ± 0.05 0.158 -0.21±0.09 0.021 -0.03 ± 0.05 0.472 
Multivitaminv at 2nd visit 0.07± 0.04 0.058 0.01 ± 0.08 0.915 0.09 ± 0.04 0.025 
Low intensity PA (>1000mins/day) at 1st visit -0.18 ± 0.05 0.000 -0.05± 0.07 0.458 -0.06± 0.08 0.406 
Low intensity PA (>1000mins/day) at 2nd visit 0.13 ± 0.05 0.005 0.16 ± 0.07 0.032 0.18± 0.05 0.000 
Sun Exposure at 1st visit 0.05 ± 0.04 0.198 -0.006 ± 0.07 0.934 0.07 ± 0.04 0.075 
Sun Exposure at 2nd visit 0.01± 0.04 0.734 0.12 ± 0.08 0.144 -0.001 ± 0.04 0.983 
Vitamin D intake at 1st visit -0.07 ± 0.12 0.569 0.16 ± 0.15 0.280 -0.10 ± 0.16 0.537 
Vitamin D intake at 2nd visit 0.19 ± 0.11 0.083 -- --- 0.14 ± 0.10 0.175 
Calcium intake at 1st visit -0.04 ± 0.08 0.590 0.17 ± 0.15 0.260 -0.08 ± 0.09 0.329 
Calcium intake at 2nd visit 0.04 ± 0.06 0.445 0.24± 0.11 0.031 0.01± 0.06 0.863 
Obesity at 1st visit 0.03 ± 0.04 0.469 -0.04 ± 0.07 0.612 0.04 ± 0.04 0.311 
Obesity at 2nd visit 0.01 ± 0.03 0.667 0.03 ± 0.07 0.678 0.01 ± 0.04 0.740 
Season (summer) at 1st visit -0.02 ± 0.03 0.547 0.03 ± 0.07 0.718 -0.02 ± 0.04 0.542 
Season (summer) at 2nd visit -0.03 ± 0.03 0.381 -0.08 ± 0.07 0.217 -0.01 ± 0.04 0.734 
Body Fat (%) at 1st visit 0.00 ± 0.003 0.889 
-0.002 ± 
0.006 
0.739 0.004 ± 0.003 0.208 
Body Fat (%) at 2nd visit 0.00 ± 0.005 0.964 -0.01 ± 0.01 0.207 0.01 ± 0.01 0.226 
HbA1c at 1st visit 0.04 ± 0.04 0.212 -0.05 ± 0.06 0.458 0.04 ± 0.04 0.296 
HbA1c at 2nd visit -0.07 ± 0.04 0.065 0.02 ± 0.08 0.832 -0.11 ± 0.04 0.005 
Sqrt HOMA-B 0.001 ± 0.001 0.637 0.0 ± 0.004 0.975 0.00 ± 0.001 0.436 
Sqrt HOMA-IR -0.02 ± 0.02 0.329 -0.04 ± 0.06 0.500 -0.02 ± 0.02 0.303 
Metabolic syndrome 0.03 ± 0.04 0.525 0.03 ± 0.10 0.782 0.01 ± 0.05 0.824 
TG (≥ 1.7 mmol/l) at 1st visit -0.04 ± 0.04 0.213 -0.17 ± 0.07 0.021 -0.03 ± 0.04 0.414 
TG (≥ 1.7 mmol/l) at 2nd visit 0.05 ± 0.04 0.188 -0.05 ± 0.07 0.509 0.05 ± 0.04 0.160 
Low HDL-cholesterol (< 1.03 mmol/l) at 1st visit 0.02 ± 0.03 0.585 0.07 ± 0.07 0.325 -0.02 ± 0.04 0.608 
Low HDL-cholesterol (< 1.03 mmol/l) at 2nd visit -0.04 ± 0.04 0.220 -0.06 ± 0.08 0.485 -0.07 ± 0.04 0.057 
Note: the blank is because no patients in the non-deficient group took vitamin D (>600 IU/day). The change of 
vitamin D between visits is calculated by vitamin D at visit 2 – vitamin D at visit 1. Positive sign shows it helps 
increase the level of Vitamin D at mid-pregnancy. 
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Appendix VI- Gestational weight gain according to BMI in both visits (Chapter 
5) 
 Total Gestational weight gain P-values 
Mean SD Median Q1 Q3 
Pre- pregnancy BMI 
underweight 9.2 3.9 8.6 6 11.55 
0.001 
Normal 7.9 3.8 7.85 5.3 9.5 
Overweight 7.2 4.1 7.1 4.9 9.05 
Obese 5.7 4.8 5.35 ABC 3.65 7.6 
BMI at 1st visit 
underweight 8.0 4.3 6.5 5.2 9.6 
0.001 
Normal 8.2 3.8 8.1 5.55 9.95 
Overweight 7.4 3.8 7 4.9 9 
Obese 5.9 4.9 5.6B 4 8 
BMI at 2nd visit 
underweight 6.8 2.5 5.5 5.2 9.6 
0.583 
Normal 7.1 3.6 7.4 4.6 9 
Overweight 7.6 3.5 7.35 4.9 9 
Obese 6.9 5.1 6.4 4.5 9.3 
Note: superscripts ABC indicates significance from Underweight Normal and Overweight respectively.   
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Appendix VII- Correlations (Chapter 5) 
 
 
 
Figure Correlation between Log fasting glucose (mmol/l) with sqrt A) Log Insulin 
(uU/ml) at early pregnancy and B) sqrt HOMA-IR and C) sqrt HOMA-β at mid-
pregnancy.
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